IXGDF,IGNORE,USUBJID,COMPOUND,STUDY,STUDYDES,PART,EXTENS,CENTER,SUBJECT,INDNAME,TRTNAME,TRTNAMER,VISIT,VISNAME,BASE,SCREEN,DATEDAY,DATETIME,DURATION,NT,TIME,TIMEUNIT,TYPENAME,NAME,VALUE,VALUETXT,UNIT,ULOQ,LLOQ,ROUTE,INTERVAL,NRDOSES,COMMENT
1,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-May-1981,07:00,0,-14,-24.97916667,Days,Demographics,Age,72,,Years,NaN,NaN,,NaN,NaN,NaN
2,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-May-1981,07:00,0,-14,-24.97916667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
3,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-May-1981,07:00,0,-14,-24.97916667,Days,Demographics,Weight,101,,kg,NaN,NaN,,NaN,NaN,NaN
4,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-May-1981,12:38,0,0,-12.74444444,Days,PD,Efficacy marker,44.504,,mm,NaN,NaN,,NaN,NaN,NaN
5,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-May-1981,07:00,0,0,-11.97916667,Days,Demographics,Weight,102,,kg,NaN,NaN,,NaN,NaN,NaN
6,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,06:19,0,0,-0.007638889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
7,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,06:30,0.0833333332557231,0,0,Days,Dose,Dose Z,1530,,mg,NaN,NaN,iv,NaN,NaN,NaN
8,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,08:50,0,0.0833,0.097222222,Days,PK,Plasma concentration Z,2019.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
9,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-May-1981,06:30,0,1,1,Days,PK,Plasma concentration Z,1476,,ug/ml,NaN,0.8,,NaN,NaN,NaN
10,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-Jun-1981,06:30,0,7,7,Days,PK,Plasma concentration Z,422.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
11,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jun-1981,06:30,0,14,14,Days,PK,Plasma concentration Z,294,,ug/ml,NaN,0.8,,NaN,NaN,NaN
12,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jun-1981,09:04,0,14,14.10694444,Days,PD,Efficacy marker,45.678,,mm,NaN,NaN,,NaN,NaN,NaN
13,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-Jun-1981,06:30,0,21,21,Days,PK,Plasma concentration Z,213.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
14,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-Jun-1981,06:30,0,28,28,Days,PK,Plasma concentration Z,157.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
15,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-Jun-1981,10:30,0,28,28.16666667,Days,PD,Efficacy marker,46.038,,mm,NaN,NaN,,NaN,NaN,NaN
16,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-Jul-1981,06:30,0,42,42,Days,PK,Plasma concentration Z,93.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
17,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-Jul-1981,06:30,0,56,56,Days,PK,Plasma concentration Z,53.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
18,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-Aug-1981,06:30,0,70,70,Days,PK,Plasma concentration Z,27.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
19,NaN,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-Aug-1981,06:30,0,84,84,Days,PK,Plasma concentration Z,16.521,,ug/ml,NaN,0.8,,NaN,NaN,NaN
20,NaN,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,04-May-1981,07:00,0,-14,-25,Days,Demographics,Age,78,,Years,NaN,NaN,,NaN,NaN,NaN
21,NaN,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,04-May-1981,07:00,0,-14,-25,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
22,NaN,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,04-May-1981,07:00,0,-14,-25,Days,Demographics,Weight,60.9,,kg,NaN,NaN,,NaN,NaN,NaN
23,NaN,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,20-May-1981,07:00,0,0,-9,Days,Demographics,Weight,59.8,,kg,NaN,NaN,,NaN,NaN,NaN
24,NaN,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,23-May-1981,15:53,0,0,-5.629861111,Days,PD,Efficacy marker,37.927,,mm,NaN,NaN,,NaN,NaN,NaN
25,NaN,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,29-May-1981,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
26,NaN,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,6,VISIT 06,0,0,12-Jun-1981,09:50,0,14,14.11805556,Days,PD,Efficacy marker,36.851,,mm,NaN,NaN,,NaN,NaN,NaN
27,NaN,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,8,VISIT 08,0,0,27-Jun-1981,09:09,0,28,29.08958333,Days,PD,Efficacy marker,37.873,,mm,NaN,NaN,,NaN,NaN,NaN
28,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,03-May-1981,07:00,0,-14,-26.02152778,Days,Demographics,Age,72,,Years,NaN,NaN,,NaN,NaN,NaN
29,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,03-May-1981,07:00,0,-14,-26.02152778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
30,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,03-May-1981,07:00,0,-14,-26.02152778,Days,Demographics,Weight,67.3,,kg,NaN,NaN,,NaN,NaN,NaN
31,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,20-May-1981,07:00,0,0,-9.021527778,Days,Demographics,Weight,68.2,,kg,NaN,NaN,,NaN,NaN,NaN
32,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,23-May-1981,17:04,0,0,-5.602083333,Days,PD,Efficacy marker,25.447,,mm,NaN,NaN,,NaN,NaN,NaN
33,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,07:15,0,0,-0.011111111,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
34,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,07:31,0.0833333333721384,0,0,Days,Dose,Dose Z,1023,,mg,NaN,NaN,iv,NaN,NaN,NaN
35,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,10:01,0,0.166,0.104166667,Days,PK,Plasma concentration Z,1850.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
36,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,11:30,0,0.166,0.165972222,Days,PK,Plasma concentration Z,2220,,ug/ml,NaN,0.8,,NaN,NaN,NaN
37,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-May-1981,07:30,0,1,0.999305556,Days,PK,Plasma concentration Z,1362,,ug/ml,NaN,0.8,,NaN,NaN,NaN
38,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-Jun-1981,07:30,0,7,6.999305556,Days,PK,Plasma concentration Z,410.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
39,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jun-1981,07:30,0,14,13.99930556,Days,PK,Plasma concentration Z,272.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
40,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jun-1981,10:13,0,14,14.1125,Days,PD,Efficacy marker,26.451,,mm,NaN,NaN,,NaN,NaN,NaN
41,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-Jun-1981,07:55,0,21,21.01666667,Days,PK,Plasma concentration Z,194.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
42,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-Jun-1981,08:02,0,28,28.02152778,Days,PK,Plasma concentration Z,169.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
43,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-Jun-1981,13:11,0,28,30.23611111,Days,PD,Efficacy marker,26.933,,mm,NaN,NaN,,NaN,NaN,NaN
44,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-Jul-1981,07:42,0,42,42.00763889,Days,PK,Plasma concentration Z,99.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
45,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-Jul-1981,08:00,0,56,56.02013889,Days,PK,Plasma concentration Z,63.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
46,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,08-Aug-1981,08:23,0,70,71.03611111,Days,PK,Plasma concentration Z,40.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
47,NaN,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-Aug-1981,07:30,0,84,83.99930556,Days,PK,Plasma concentration Z,20.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
48,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-22.02777778,Days,Demographics,Age,71,,Years,NaN,NaN,,NaN,NaN,NaN
49,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-22.02777778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
50,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-22.02777778,Days,Demographics,Weight,85,,kg,NaN,NaN,,NaN,NaN,NaN
51,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-May-1981,11:53,0,0,-12.82430556,Days,PD,Efficacy marker,29.153,,mm,NaN,NaN,,NaN,NaN,NaN
52,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-May-1981,07:00,0,0,-12.02777778,Days,Demographics,Weight,87,,kg,NaN,NaN,,NaN,NaN,NaN
53,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,07:25,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
54,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,07:40,0.0833333332557231,0,0,Days,Dose,Dose Z,1305,,mg,NaN,NaN,iv,NaN,NaN,NaN
55,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,09:53,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,1982.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
56,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,11:40,0,0.166,0.166666667,Days,PK,Plasma concentration Z,2379.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
57,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-May-1981,07:40,0,1,1,Days,PK,Plasma concentration Z,1634.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
58,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-Jun-1981,07:40,0,7,7,Days,PK,Plasma concentration Z,507.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
59,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jun-1981,07:40,0,14,14,Days,PK,Plasma concentration Z,330,,ug/ml,NaN,0.8,,NaN,NaN,NaN
60,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-Jun-1981,13:05,0,14,15.22569444,Days,PD,Efficacy marker,30.688,,mm,NaN,NaN,,NaN,NaN,NaN
61,Ignore example 1,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-Jun-1981,07:44,0,21,21.00277778,Days,PK,Plasma concentration Z,248.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
62,Ignore example 2,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-Jun-1981,07:40,0,28,28,Days,PK,Plasma concentration Z,193.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
63,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-Jun-1981,10:22,0,28,29.1125,Days,PD,Efficacy marker,30.817,,mm,NaN,NaN,,NaN,NaN,NaN
64,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-Jul-1981,07:40,0,42,42,Days,PK,Plasma concentration Z,88.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
65,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-Jul-1981,07:40,0,56,56,Days,PK,Plasma concentration Z,60.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
66,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-Aug-1981,07:47,0,70,70.00486111,Days,PK,Plasma concentration Z,27.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
67,NaN,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-Aug-1981,07:44,0,84,84.00277778,Days,PK,Plasma concentration Z,13.539,,ug/ml,NaN,0.8,,NaN,NaN,NaN
68,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-May-1981,07:00,0,-14,-21.03472222,Days,Demographics,Age,77,,Years,NaN,NaN,,NaN,NaN,NaN
69,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-May-1981,07:00,0,-14,-21.03472222,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
70,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-May-1981,07:00,0,-14,-21.03472222,Days,Demographics,Weight,56.8,,kg,NaN,NaN,,NaN,NaN,NaN
71,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,20-May-1981,07:00,0,0,-9.034722222,Days,Demographics,Weight,55,,kg,NaN,NaN,,NaN,NaN,NaN
72,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,20-May-1981,07:18,0,0,-9.022222222,Days,PD,Efficacy marker,22.126,,mm,NaN,NaN,,NaN,NaN,NaN
73,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,07:35,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
74,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,07:50,0.0833333333721384,0,0,Days,Dose,Dose Z,825,,mg,NaN,NaN,iv,NaN,NaN,NaN
75,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,10:05,0,0.0833,0.09375,Days,PK,Plasma concentration Z,1332,,ug/ml,NaN,0.8,,NaN,NaN,NaN
76,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,11:50,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1416,,ug/ml,NaN,0.8,,NaN,NaN,NaN
77,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-May-1981,07:50,0,1,1,Days,PK,Plasma concentration Z,945.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
78,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-Jun-1981,07:50,0,7,7,Days,PK,Plasma concentration Z,276,,ug/ml,NaN,0.8,,NaN,NaN,NaN
79,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jun-1981,07:50,0,14,14,Days,PK,Plasma concentration Z,170.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
80,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-Jun-1981,07:22,0,14,14.98055556,Days,PD,Efficacy marker,23.604,,mm,NaN,NaN,,NaN,NaN,NaN
81,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-Jun-1981,07:50,0,21,21,Days,PK,Plasma concentration Z,130.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
82,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-Jun-1981,07:58,0,28,28.00555556,Days,PK,Plasma concentration Z,102.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
83,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-Jun-1981,09:38,0,28,29.075,Days,PD,Efficacy marker,24.234,,mm,NaN,NaN,,NaN,NaN,NaN
84,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-Jul-1981,07:57,0,42,42.00486111,Days,PK,Plasma concentration Z,64.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
85,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-Jul-1981,07:50,0,56,56,Days,PK,Plasma concentration Z,33.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
86,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-Aug-1981,07:36,0,70,69.99027778,Days,PK,Plasma concentration Z,16.719,,ug/ml,NaN,0.8,,NaN,NaN,NaN
87,NaN,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-Aug-1981,07:51,0,84,84.00069444,Days,PK,Plasma concentration Z,8.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
88,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-May-1981,07:00,0,-14,-21.05555556,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
89,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-May-1981,07:00,0,-14,-21.05555556,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
90,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-May-1981,07:00,0,-14,-21.05555556,Days,Demographics,Weight,74,,kg,NaN,NaN,,NaN,NaN,NaN
91,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-May-1981,10:24,0,0,-12.91388889,Days,PD,Efficacy marker,25.198,,mm,NaN,NaN,,NaN,NaN,NaN
92,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-May-1981,07:00,0,0,-12.05555556,Days,Demographics,Weight,74.1,,kg,NaN,NaN,,NaN,NaN,NaN
93,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,08:14,0,0,-0.004166667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
94,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,08:20,0.0833333332557231,0,0,Days,Dose,Dose Z,1111.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
95,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,10:30,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,1958.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
96,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,12:20,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1983.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
97,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-May-1981,08:22,0,1,1.001388889,Days,PK,Plasma concentration Z,1172.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
98,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-Jun-1981,08:21,0,7,7.000694444,Days,PK,Plasma concentration Z,438,,ug/ml,NaN,0.8,,NaN,NaN,NaN
99,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jun-1981,08:21,0,14,14.00069444,Days,PK,Plasma concentration Z,284.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
100,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-Jun-1981,12:22,0,14,15.16805556,Days,PD,Efficacy marker,26.852,,mm,NaN,NaN,,NaN,NaN,NaN
101,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-Jun-1981,08:20,0,21,21,Days,PK,Plasma concentration Z,213.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
102,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-Jun-1981,08:22,0,28,28.00138889,Days,PK,Plasma concentration Z,162.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
103,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-Jun-1981,11:09,0,28,29.11736111,Days,PD,Efficacy marker,26.289,,mm,NaN,NaN,,NaN,NaN,NaN
104,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-Jul-1981,08:20,0,42,42,Days,PK,Plasma concentration Z,99.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
105,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-Jul-1981,08:22,0,56,56.00138889,Days,PK,Plasma concentration Z,66.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
106,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-Aug-1981,08:20,0,70,70,Days,PK,Plasma concentration Z,43.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
107,NaN,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-Aug-1981,08:35,0,84,84.01041667,Days,PK,Plasma concentration Z,21.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
108,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-May-1981,07:00,0,-14,-20.09375,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
109,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-May-1981,07:00,0,-14,-20.09375,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
110,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-May-1981,07:00,0,-14,-20.09375,Days,Demographics,Weight,70,,kg,NaN,NaN,,NaN,NaN,NaN
111,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-May-1981,11:17,0,0,-12.91527778,Days,PD,Efficacy marker,30.764,,mm,NaN,NaN,,NaN,NaN,NaN
112,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-May-1981,07:00,0,0,-12.09375,Days,Demographics,Weight,70,,kg,NaN,NaN,,NaN,NaN,NaN
113,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,09:00,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
114,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,09:15,0.0833333333721384,0,0,Days,Dose,Dose Z,1050,,mg,NaN,NaN,iv,NaN,NaN,NaN
115,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,11:28,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,1755.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
116,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-May-1981,13:15,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1761.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
117,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-May-1981,09:15,0,1,1,Days,PK,Plasma concentration Z,1272,,ug/ml,NaN,0.8,,NaN,NaN,NaN
118,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-Jun-1981,09:15,0,7,7,Days,PK,Plasma concentration Z,315.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
119,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jun-1981,09:15,0,14,14,Days,PK,Plasma concentration Z,204,,ug/ml,NaN,0.8,,NaN,NaN,NaN
120,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-Jun-1981,13:51,0,14,15.19166667,Days,PD,Efficacy marker,32.17,,mm,NaN,NaN,,NaN,NaN,NaN
121,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-Jun-1981,09:17,0,21,21.00138889,Days,PK,Plasma concentration Z,151.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
122,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-Jun-1981,09:15,0,28,28,Days,PK,Plasma concentration Z,115.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
123,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-Jun-1981,13:33,0,28,29.17916667,Days,PD,Efficacy marker,33.057,,mm,NaN,NaN,,NaN,NaN,NaN
124,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-Jul-1981,09:15,0,42,42,Days,PK,Plasma concentration Z,61.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
125,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-Jul-1981,09:15,0,56,56,Days,PK,Plasma concentration Z,36.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
126,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-Aug-1981,08:34,0,70,69.97152778,Days,PK,Plasma concentration Z,16.38,,ug/ml,NaN,0.8,,NaN,NaN,NaN
127,NaN,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-Aug-1981,09:15,0,84,84,Days,PK,Plasma concentration Z,6.54,,ug/ml,NaN,0.8,,NaN,NaN,NaN
128,NaN,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,14-May-1981,07:00,0,-14,-15.12152778,Days,Demographics,Age,77,,Years,NaN,NaN,,NaN,NaN,NaN
129,NaN,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,14-May-1981,07:00,0,-14,-15.12152778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
130,NaN,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,14-May-1981,07:00,0,-14,-15.12152778,Days,Demographics,Weight,60.4,,kg,NaN,NaN,,NaN,NaN,NaN
131,NaN,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,24-May-1981,07:00,0,0,-5.121527778,Days,Demographics,Weight,59.8,,kg,NaN,NaN,,NaN,NaN,NaN
132,NaN,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,24-May-1981,08:11,0,0,-5.072222222,Days,PD,Efficacy marker,27.949,,mm,NaN,NaN,,NaN,NaN,NaN
133,NaN,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,29-May-1981,09:55,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
134,NaN,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,6,VISIT 06,0,0,13-Jun-1981,06:22,0,14,14.85208333,Days,PD,Efficacy marker,28.196,,mm,NaN,NaN,,NaN,NaN,NaN
135,NaN,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,8,VISIT 08,0,0,26-Jun-1981,12:42,0,28,28.11597222,Days,PD,Efficacy marker,28.466,,mm,NaN,NaN,,NaN,NaN,NaN
136,NaN,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-21.97569444,Days,Demographics,Age,76,,Years,NaN,NaN,,NaN,NaN,NaN
137,NaN,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-21.97569444,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
138,NaN,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-21.97569444,Days,Demographics,Weight,65.9,,kg,NaN,NaN,,NaN,NaN,NaN
139,NaN,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,01-Jul-1981,07:00,0,0,-7.975694444,Days,Demographics,Weight,61.7,,kg,NaN,NaN,,NaN,NaN,NaN
140,NaN,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,01-Jul-1981,13:42,0,0,-7.696527778,Days,PD,Efficacy marker,28.216,,mm,NaN,NaN,,NaN,NaN,NaN
141,NaN,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,09-Jul-1981,06:25,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
142,NaN,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,6,VISIT 06,0,0,23-Jul-1981,08:47,0,14,14.09861111,Days,PD,Efficacy marker,27.762,,mm,NaN,NaN,,NaN,NaN,NaN
143,NaN,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,8,VISIT 08,0,0,07-Aug-1981,13:07,0,28,29.27916667,Days,PD,Efficacy marker,27.585,,mm,NaN,NaN,,NaN,NaN,NaN
144,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,26-Jun-1981,07:00,0,-14,-12.99652778,Days,Demographics,Age,76,,Years,NaN,NaN,,NaN,NaN,NaN
145,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,26-Jun-1981,07:00,0,-14,-12.99652778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
146,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,26-Jun-1981,07:00,0,-14,-12.99652778,Days,Demographics,Weight,57.1,,kg,NaN,NaN,,NaN,NaN,NaN
147,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,02-Jul-1981,07:00,0,0,-6.996527778,Days,Demographics,Weight,56.8,,kg,NaN,NaN,,NaN,NaN,NaN
148,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-Jul-1981,13:47,0,0,-5.713888889,Days,PD,Efficacy marker,19.381,,mm,NaN,NaN,,NaN,NaN,NaN
149,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,06:40,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
150,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,06:55,0.0833333332557231,0,0,Days,Dose,Dose Z,85.2,,mg,NaN,NaN,iv,NaN,NaN,NaN
151,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,09:13,0,0.0833,0.095833333,Days,PK,Plasma concentration Z,130.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
152,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,10:57,0,0.166,0.168055556,Days,PK,Plasma concentration Z,158.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
153,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-Jul-1981,06:55,0,1,1,Days,PK,Plasma concentration Z,107.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
154,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-Jul-1981,06:55,0,7,7,Days,PK,Plasma concentration Z,30.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
155,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-Jul-1981,06:55,0,14,14,Days,PK,Plasma concentration Z,13.839,,ug/ml,NaN,0.8,,NaN,NaN,NaN
156,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-Jul-1981,09:52,0,14,14.12291667,Days,PD,Efficacy marker,19.754,,mm,NaN,NaN,,NaN,NaN,NaN
157,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-Jul-1981,06:55,0,21,21,Days,PK,Plasma concentration Z,6.321,,ug/ml,NaN,0.8,,NaN,NaN,NaN
158,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-Aug-1981,06:55,0,28,28,Days,PK,Plasma concentration Z,2.301,,ug/ml,NaN,0.8,,NaN,NaN,NaN
159,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,07-Aug-1981,12:32,0,28,29.23402778,Days,PD,Efficacy marker,20.87,,mm,NaN,NaN,,NaN,NaN,NaN
160,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-Aug-1981,06:55,0,42,42,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
161,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-Sep-1981,07:47,0,56,56.03611111,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
162,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-Sep-1981,06:55,0,70,70,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
163,NaN,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-Oct-1981,06:55,0,84,84,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
164,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,24-Jun-1981,07:00,0,-14,-15.01736111,Days,Demographics,Age,83,,Years,NaN,NaN,,NaN,NaN,NaN
165,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,24-Jun-1981,07:00,0,-14,-15.01736111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
166,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,24-Jun-1981,07:00,0,-14,-15.01736111,Days,Demographics,Weight,54.9,,kg,NaN,NaN,,NaN,NaN,NaN
167,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,02-Jul-1981,07:00,0,0,-7.017361111,Days,Demographics,Weight,54.6,,kg,NaN,NaN,,NaN,NaN,NaN
168,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-Jul-1981,13:11,0,0,-5.759722222,Days,PD,Efficacy marker,18.829,,mm,NaN,NaN,,NaN,NaN,NaN
169,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,07:11,0,0,-0.009722222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
170,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,07:25,0.0833333333721384,0,0,Days,Dose,Dose Z,81.9,,mg,NaN,NaN,iv,NaN,NaN,NaN
171,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,09:40,0,0.0833,0.09375,Days,PK,Plasma concentration Z,182.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
172,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,11:25,0,0.166,0.166666667,Days,PK,Plasma concentration Z,197.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
173,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-Jul-1981,07:25,0,1,1,Days,PK,Plasma concentration Z,122.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
174,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-Jul-1981,07:25,0,7,7,Days,PK,Plasma concentration Z,25.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
175,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-Jul-1981,07:25,0,14,14,Days,PK,Plasma concentration Z,12.519,,ug/ml,NaN,0.8,,NaN,NaN,NaN
176,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-Jul-1981,10:36,0,14,14.13263889,Days,PD,Efficacy marker,19.368,,mm,NaN,NaN,,NaN,NaN,NaN
177,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-Jul-1981,07:25,0,21,21,Days,PK,Plasma concentration Z,7.08,,ug/ml,NaN,0.8,,NaN,NaN,NaN
178,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-Aug-1981,07:25,0,28,28,Days,PK,Plasma concentration Z,3.081,,ug/ml,NaN,0.8,,NaN,NaN,NaN
179,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,07-Aug-1981,13:53,0,28,29.26944444,Days,PD,Efficacy marker,19.429,,mm,NaN,NaN,,NaN,NaN,NaN
180,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-Aug-1981,07:25,0,42,42,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
181,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-Sep-1981,07:27,0,56,56.00138889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
182,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,18-Sep-1981,07:34,0,70,71.00625,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
183,NaN,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-Oct-1981,07:22,0,84,83.99791667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
184,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,25-Jun-1981,07:00,0,-14,-14.04166667,Days,Demographics,Age,75,,Years,NaN,NaN,,NaN,NaN,NaN
185,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,25-Jun-1981,07:00,0,-14,-14.04166667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
186,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,25-Jun-1981,07:00,0,-14,-14.04166667,Days,Demographics,Weight,51.9,,kg,NaN,NaN,,NaN,NaN,NaN
187,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-Jul-1981,07:00,0,0,-6.041666667,Days,Demographics,Weight,50.9,,kg,NaN,NaN,,NaN,NaN,NaN
188,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,04-Jul-1981,10:55,0,0,-4.878472222,Days,PD,Efficacy marker,22.856,,mm,NaN,NaN,,NaN,NaN,NaN
189,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,07:45,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
190,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,08:00,0.0833333332557231,0,0,Days,Dose,Dose Z,76.05,,mg,NaN,NaN,iv,NaN,NaN,NaN
191,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,10:11,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,135.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
192,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,12:00,0,0.166,0.166666667,Days,PK,Plasma concentration Z,151.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
193,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-Jul-1981,08:01,0,1,1.000694444,Days,PK,Plasma concentration Z,93.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
194,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-Jul-1981,08:02,0,7,7.001388889,Days,PK,Plasma concentration Z,24.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
195,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,22-Jul-1981,08:14,0,14,13.00972222,Days,PK,Plasma concentration Z,13.881,,ug/ml,NaN,0.8,,NaN,NaN,NaN
196,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-Jul-1981,11:24,0,14,14.14166667,Days,PD,Efficacy marker,23.759,,mm,NaN,NaN,,NaN,NaN,NaN
197,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-Jul-1981,08:02,0,21,21.00138889,Days,PK,Plasma concentration Z,5.019,,ug/ml,NaN,0.8,,NaN,NaN,NaN
198,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-Aug-1981,07:18,0,28,27.97083333,Days,PD,Efficacy marker,24.28,,mm,NaN,NaN,,NaN,NaN,NaN
199,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-Aug-1981,09:11,0,28,28.04930556,Days,PK,Plasma concentration Z,1.278,,ug/ml,NaN,0.8,,NaN,NaN,NaN
200,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-Aug-1981,08:00,0,42,42,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
201,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-Sep-1981,08:00,0,56,56,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
202,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-Sep-1981,07:36,0,70,69.98333333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
203,NaN,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-Oct-1981,08:00,0,84,84,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
204,NaN,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.06597222,Days,Demographics,Age,76,,Years,NaN,NaN,,NaN,NaN,NaN
205,NaN,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.06597222,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
206,NaN,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.06597222,Days,Demographics,Weight,69.09,,kg,NaN,NaN,,NaN,NaN,NaN
207,NaN,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,01-Jul-1981,07:00,0,0,-8.065972222,Days,Demographics,Weight,67.8,,kg,NaN,NaN,,NaN,NaN,NaN
208,NaN,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,01-Jul-1981,10:13,0,0,-7.931944444,Days,PD,Efficacy marker,34.916,,mm,NaN,NaN,,NaN,NaN,NaN
209,NaN,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,09-Jul-1981,08:35,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
210,NaN,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,6,VISIT 06,0,0,24-Jul-1981,08:30,0,14,14.99652778,Days,PD,Efficacy marker,35.219,,mm,NaN,NaN,,NaN,NaN,NaN
211,NaN,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,8,VISIT 08,0,0,07-Aug-1981,15:32,0,28,29.28958333,Days,PD,Efficacy marker,35.767,,mm,NaN,NaN,,NaN,NaN,NaN
212,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.08680556,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
213,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.08680556,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
214,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.08680556,Days,Demographics,Weight,79.5,,kg,NaN,NaN,,NaN,NaN,NaN
215,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,01-Jul-1981,07:00,0,0,-8.086805556,Days,Demographics,Weight,80.1,,kg,NaN,NaN,,NaN,NaN,NaN
216,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,01-Jul-1981,14:14,0,0,-7.785416667,Days,PD,Efficacy marker,30.687,,mm,NaN,NaN,,NaN,NaN,NaN
217,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,08:50,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
218,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,09:05,0.0833333332557231,0,0,Days,Dose,Dose Z,120.15,,mg,NaN,NaN,iv,NaN,NaN,NaN
219,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,11:16,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,182.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
220,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,13:05,0,0.166,0.166666667,Days,PK,Plasma concentration Z,181.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
221,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-Jul-1981,09:05,0,1,1,Days,PK,Plasma concentration Z,112.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
222,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-Jul-1981,09:05,0,7,7,Days,PK,Plasma concentration Z,44.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
223,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-Jul-1981,09:05,0,14,14,Days,PK,Plasma concentration Z,21.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
224,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,24-Jul-1981,09:03,0,14,14.99861111,Days,PD,Efficacy marker,31.477,,mm,NaN,NaN,,NaN,NaN,NaN
225,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-Jul-1981,09:05,0,21,21,Days,PK,Plasma concentration Z,9.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
226,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-Aug-1981,09:05,0,28,28,Days,PK,Plasma concentration Z,5.739,,ug/ml,NaN,0.8,,NaN,NaN,NaN
227,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,07-Aug-1981,14:42,0,28,29.23402778,Days,PD,Efficacy marker,31.977,,mm,NaN,NaN,,NaN,NaN,NaN
228,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-Aug-1981,08:57,0,42,41.99444444,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
229,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-Sep-1981,09:18,0,56,56.00902778,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
230,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-Sep-1981,09:10,0,70,70.00347222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
231,NaN,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-Oct-1981,09:05,0,84,84,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
232,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.11111111,Days,Demographics,Age,70,,Years,NaN,NaN,,NaN,NaN,NaN
233,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.11111111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
234,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,17-Jun-1981,07:00,0,-14,-22.11111111,Days,Demographics,Weight,73.18,,kg,NaN,NaN,,NaN,NaN,NaN
235,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,01-Jul-1981,07:00,0,0,-8.111111111,Days,Demographics,Weight,73.8,,kg,NaN,NaN,,NaN,NaN,NaN
236,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-Jul-1981,09:15,0,0,-6.017361111,Days,PD,Efficacy marker,27.824,,mm,NaN,NaN,,NaN,NaN,NaN
237,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,09:25,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
238,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,09:40,0.0833333333721384,0,0,Days,Dose,Dose Z,110.7,,mg,NaN,NaN,iv,NaN,NaN,NaN
239,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,12:03,0,0.0833,0.099305556,Days,PK,Plasma concentration Z,196.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
240,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-Jul-1981,13:40,0,0.166,0.166666667,Days,PK,Plasma concentration Z,210,,ug/ml,NaN,0.8,,NaN,NaN,NaN
241,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-Jul-1981,09:43,0,1,1.002083333,Days,PK,Plasma concentration Z,158.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
242,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-Jul-1981,09:40,0,7,7,Days,PK,Plasma concentration Z,32.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
243,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-Jul-1981,09:40,0,14,14,Days,PK,Plasma concentration Z,16.659,,ug/ml,NaN,0.8,,NaN,NaN,NaN
244,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,24-Jul-1981,14:05,0,14,15.18402778,Days,PD,Efficacy marker,29.158,,mm,NaN,NaN,,NaN,NaN,NaN
245,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-Jul-1981,09:40,0,21,21,Days,PK,Plasma concentration Z,8.379,,ug/ml,NaN,0.8,,NaN,NaN,NaN
246,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-Aug-1981,09:42,0,28,28.00138889,Days,PK,Plasma concentration Z,3.42,,ug/ml,NaN,0.8,,NaN,NaN,NaN
247,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,07-Aug-1981,11:44,0,28,29.08611111,Days,PD,Efficacy marker,29.655,,mm,NaN,NaN,,NaN,NaN,NaN
248,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-Aug-1981,09:30,0,42,41.99305556,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
249,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-Sep-1981,09:40,0,56,56,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
250,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-Sep-1981,09:36,0,70,69.99722222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
251,NaN,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-Oct-1981,09:38,0,84,83.99861111,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
252,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,22-Jul-1981,07:00,0,-14,-17,Days,Demographics,Age,70,,Years,NaN,NaN,,NaN,NaN,NaN
253,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,22-Jul-1981,07:00,0,-14,-17,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
254,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,22-Jul-1981,07:00,0,-14,-17,Days,Demographics,Weight,65.6,,kg,NaN,NaN,,NaN,NaN,NaN
255,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,29-Jul-1981,07:00,0,0,-10,Days,Demographics,Weight,64.9,,kg,NaN,NaN,,NaN,NaN,NaN
256,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,30-Jul-1981,07:39,0,0,-8.972916667,Days,PD,Efficacy marker,24.813,,mm,NaN,NaN,,NaN,NaN,NaN
257,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-Aug-1981,06:25,0,0,-0.024305556,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
258,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-Aug-1981,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,97.35,,mg,NaN,NaN,iv,NaN,NaN,NaN
259,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-Aug-1981,09:19,0,0.0833,0.096527778,Days,PK,Plasma concentration Z,189,,ug/ml,NaN,0.8,,NaN,NaN,NaN
260,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-Aug-1981,11:00,0,0.166,0.166666667,Days,PK,Plasma concentration Z,168.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
261,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,09-Aug-1981,07:00,0,1,1,Days,PK,Plasma concentration Z,111.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
262,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,15-Aug-1981,07:00,0,7,7,Days,PK,Plasma concentration Z,28.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
263,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,22-Aug-1981,07:01,0,14,14.00069444,Days,PK,Plasma concentration Z,13.959,,ug/ml,NaN,0.8,,NaN,NaN,NaN
264,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,22-Aug-1981,10:09,0,14,14.13125,Days,PD,Efficacy marker,26.545,,mm,NaN,NaN,,NaN,NaN,NaN
265,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,29-Aug-1981,07:00,0,21,21,Days,PK,Plasma concentration Z,6.9,,ug/ml,NaN,0.8,,NaN,NaN,NaN
266,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,05-Sep-1981,07:00,0,28,28,Days,PK,Plasma concentration Z,2.94,,ug/ml,NaN,0.8,,NaN,NaN,NaN
267,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,05-Sep-1981,15:31,0,28,28.35486111,Days,PD,Efficacy marker,25.824,,mm,NaN,NaN,,NaN,NaN,NaN
268,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,19-Sep-1981,07:00,0,42,42,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
269,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-Oct-1981,07:00,0,56,56,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
270,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-Oct-1981,07:05,0,70,70.00347222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
271,NaN,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,31-Oct-1981,07:00,0,84,84,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
272,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05208333,Days,Demographics,Age,35,,Years,NaN,NaN,,NaN,NaN,NaN
273,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05208333,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
274,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05208333,Days,Demographics,Weight,96.5,,kg,NaN,NaN,,NaN,NaN,NaN
275,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,13-May-1981,07:00,0,0,-10.05208333,Days,Demographics,Weight,95,,kg,NaN,NaN,,NaN,NaN,NaN
276,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,06:44,0,0,-0.063194444,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
277,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,08:15,0.0833333333721384,0,0,Days,Dose,Dose Z,1425,,mg,NaN,NaN,iv,NaN,NaN,NaN
278,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,10:22,0,0.0833,0.088194444,Days,PK,Plasma concentration Z,1868.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
279,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,12:15,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1874.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
280,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-May-1981,08:15,0,1,1,Days,PK,Plasma concentration Z,1434,,ug/ml,NaN,0.8,,NaN,NaN,NaN
281,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-May-1981,08:15,0,7,7,Days,PK,Plasma concentration Z,444,,ug/ml,NaN,0.8,,NaN,NaN,NaN
282,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-Jun-1981,08:19,0,14,14.00277778,Days,PK,Plasma concentration Z,296.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
283,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Jun-1981,08:14,0,21,20.99930556,Days,PK,Plasma concentration Z,222,,ug/ml,NaN,0.8,,NaN,NaN,NaN
284,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-Jun-1981,08:15,0,28,28,Days,PK,Plasma concentration Z,173.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
285,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-Jul-1981,08:15,0,42,42,Days,PK,Plasma concentration Z,100.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
286,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-Jul-1981,08:15,0,56,56,Days,PK,Plasma concentration Z,63,,ug/ml,NaN,0.8,,NaN,NaN,NaN
287,NaN,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-Aug-1981,08:15,0,70,70,Days,PK,Plasma concentration Z,28.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
288,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05416667,Days,Demographics,Age,53,,Years,NaN,NaN,,NaN,NaN,NaN
289,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05416667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
290,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05416667,Days,Demographics,Weight,107.5,,kg,NaN,NaN,,NaN,NaN,NaN
291,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,13-May-1981,07:00,0,0,-10.05416667,Days,Demographics,Weight,109.5,,kg,NaN,NaN,,NaN,NaN,NaN
292,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,06:48,0,0,-0.0625,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
293,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,08:18,0.0833333333721384,0,0,Days,Dose,Dose Z,1642.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
294,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,10:32,0,0.0833,0.093055556,Days,PK,Plasma concentration Z,1716,,ug/ml,NaN,0.8,,NaN,NaN,NaN
295,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,12:18,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1812,,ug/ml,NaN,0.8,,NaN,NaN,NaN
296,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-May-1981,08:18,0,1,1,Days,PK,Plasma concentration Z,1404,,ug/ml,NaN,0.8,,NaN,NaN,NaN
297,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-May-1981,08:18,0,7,7,Days,PK,Plasma concentration Z,453.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
298,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-Jun-1981,08:21,0,14,14.00208333,Days,PK,Plasma concentration Z,288,,ug/ml,NaN,0.8,,NaN,NaN,NaN
299,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Jun-1981,08:18,0,21,21,Days,PK,Plasma concentration Z,212.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
300,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-Jun-1981,08:18,0,28,28,Days,PK,Plasma concentration Z,163.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
301,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-Jul-1981,08:17,0,42,41.99930556,Days,PK,Plasma concentration Z,88.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
302,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-Jul-1981,08:22,0,56,56.00277778,Days,PK,Plasma concentration Z,56.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
303,NaN,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-Aug-1981,08:18,0,70,70,Days,PK,Plasma concentration Z,26.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
304,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05625,Days,Demographics,Age,32,,Years,NaN,NaN,,NaN,NaN,NaN
305,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05625,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
306,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-May-1981,07:00,0,-14,-22.05625,Days,Demographics,Weight,92.9,,kg,NaN,NaN,,NaN,NaN,NaN
307,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,13-May-1981,07:00,0,0,-10.05625,Days,Demographics,Weight,91.9,,kg,NaN,NaN,,NaN,NaN,NaN
308,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,06:51,0,0,-0.0625,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
309,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,08:21,0.0833333333721384,0,0,Days,Dose,Dose Z,1378.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
310,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,10:24,0,0.0833,0.085416667,Days,PK,Plasma concentration Z,2559.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
311,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,12:20,0,0.166,0.165972222,Days,PK,Plasma concentration Z,1767.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
312,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-May-1981,08:21,0,1,1,Days,PK,Plasma concentration Z,1161.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
313,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-May-1981,08:21,0,7,7,Days,PK,Plasma concentration Z,405.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
314,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-Jun-1981,08:23,0,14,14.00138889,Days,PK,Plasma concentration Z,267.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
315,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Jun-1981,08:21,0,21,21,Days,PK,Plasma concentration Z,206.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
316,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-Jun-1981,08:21,0,28,28,Days,PK,Plasma concentration Z,156.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
317,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-Jul-1981,08:21,0,42,42,Days,PK,Plasma concentration Z,85.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
318,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-Jul-1981,08:20,0,56,55.99930556,Days,PK,Plasma concentration Z,51,,ug/ml,NaN,0.8,,NaN,NaN,NaN
319,NaN,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-Aug-1981,08:21,0,70,70,Days,PK,Plasma concentration Z,22.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
320,NaN,ZY100404126,Z,Y1,FIH HV Study ,2,0,4,4126,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.05833333,Days,Demographics,Age,30,,Years,NaN,NaN,,NaN,NaN,NaN
321,NaN,ZY100404126,Z,Y1,FIH HV Study ,2,0,4,4126,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.05833333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
322,NaN,ZY100404126,Z,Y1,FIH HV Study ,2,0,4,4126,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.05833333,Days,Demographics,Weight,92,,kg,NaN,NaN,,NaN,NaN,NaN
323,NaN,ZY100404126,Z,Y1,FIH HV Study ,2,0,4,4126,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,13-May-1981,07:00,0,0,-10.05833333,Days,Demographics,Weight,93.9,,kg,NaN,NaN,,NaN,NaN,NaN
324,NaN,ZY100404126,Z,Y1,FIH HV Study ,2,0,4,4126,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,23-May-1981,08:24,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
325,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,10-May-1981,07:00,0,-14,-13.06041667,Days,Demographics,Age,31,,Years,NaN,NaN,,NaN,NaN,NaN
326,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,10-May-1981,07:00,0,-14,-13.06041667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
327,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,10-May-1981,07:00,0,-14,-13.06041667,Days,Demographics,Weight,95.5,,kg,NaN,NaN,,NaN,NaN,NaN
328,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,13-May-1981,07:00,0,0,-10.06041667,Days,Demographics,Weight,95.8,,kg,NaN,NaN,,NaN,NaN,NaN
329,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,06:56,0,0,-0.063194444,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
330,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,08:27,0.0833333333721384,0,0,Days,Dose,Dose Z,1437,,mg,NaN,NaN,iv,NaN,NaN,NaN
331,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,10:26,0,0.0833,0.082638889,Days,PK,Plasma concentration Z,1478.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
332,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,12:27,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1500,,ug/ml,NaN,0.8,,NaN,NaN,NaN
333,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-May-1981,08:27,0,1,1,Days,PK,Plasma concentration Z,1068,,ug/ml,NaN,0.8,,NaN,NaN,NaN
334,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-May-1981,08:27,0,7,7,Days,PK,Plasma concentration Z,464.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
335,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-Jun-1981,08:28,0,14,14.00069444,Days,PK,Plasma concentration Z,315.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
336,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Jun-1981,08:27,0,21,21,Days,PK,Plasma concentration Z,231.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
337,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-Jun-1981,08:27,0,28,28,Days,PK,Plasma concentration Z,194.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
338,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-Jul-1981,08:27,0,42,42,Days,PK,Plasma concentration Z,110.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
339,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-Jul-1981,08:27,0,56,56,Days,PK,Plasma concentration Z,78.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
340,NaN,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-Aug-1981,08:27,0,70,70,Days,PK,Plasma concentration Z,22.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
341,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.0625,Days,Demographics,Age,32,,Years,NaN,NaN,,NaN,NaN,NaN
342,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.0625,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
343,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.0625,Days,Demographics,Weight,115.7,,kg,NaN,NaN,,NaN,NaN,NaN
344,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,13-May-1981,07:00,0,0,-10.0625,Days,Demographics,Weight,114.3,,kg,NaN,NaN,,NaN,NaN,NaN
345,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,07:00,0,0,-0.0625,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
346,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,08:30,0.0833333333721384,0,0,Days,Dose,Dose Z,1714.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
347,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,10:35,0,0.0833,0.086805556,Days,PK,Plasma concentration Z,1623.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
348,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,12:30,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1572,,ug/ml,NaN,0.8,,NaN,NaN,NaN
349,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-May-1981,08:29,0,1,0.999305556,Days,PK,Plasma concentration Z,1368,,ug/ml,NaN,0.8,,NaN,NaN,NaN
350,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-May-1981,08:30,0,7,7,Days,PK,Plasma concentration Z,518.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
351,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-Jun-1981,08:30,0,14,14,Days,PK,Plasma concentration Z,255.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
352,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Jun-1981,08:29,0,21,20.99930556,Days,PK,Plasma concentration Z,174.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
353,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-Jun-1981,08:30,0,28,28,Days,PK,Plasma concentration Z,120,,ug/ml,NaN,0.8,,NaN,NaN,NaN
354,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-Jul-1981,08:29,0,42,41.99930556,Days,PK,Plasma concentration Z,56.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
355,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-Jul-1981,08:29,0,56,55.99930556,Days,PK,Plasma concentration Z,25.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
356,NaN,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-Aug-1981,08:30,0,70,70,Days,PK,Plasma concentration Z,4.119,,ug/ml,NaN,0.8,,NaN,NaN,NaN
357,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.06458333,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
358,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.06458333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
359,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-May-1981,07:00,0,-14,-16.06458333,Days,Demographics,Weight,78.8,,kg,NaN,NaN,,NaN,NaN,NaN
360,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,13-May-1981,07:00,0,0,-10.06458333,Days,Demographics,Weight,79.2,,kg,NaN,NaN,,NaN,NaN,NaN
361,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,07:03,0,0,-0.0625,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
362,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,08:33,0.0833333333721384,0,0,Days,Dose,Dose Z,1188,,mg,NaN,NaN,iv,NaN,NaN,NaN
363,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,10:45,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,1962,,ug/ml,NaN,0.8,,NaN,NaN,NaN
364,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-May-1981,12:33,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1940.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
365,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-May-1981,08:33,0,1,1,Days,PK,Plasma concentration Z,1482,,ug/ml,NaN,0.8,,NaN,NaN,NaN
366,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-May-1981,08:33,0,7,7,Days,PK,Plasma concentration Z,471.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
367,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-Jun-1981,08:33,0,14,14,Days,PK,Plasma concentration Z,288,,ug/ml,NaN,0.8,,NaN,NaN,NaN
368,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Jun-1981,08:33,0,21,21,Days,PK,Plasma concentration Z,216,,ug/ml,NaN,0.8,,NaN,NaN,NaN
369,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-Jun-1981,08:33,0,28,28,Days,PK,Plasma concentration Z,160.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
370,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-Jul-1981,08:33,0,42,42,Days,PK,Plasma concentration Z,98.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
371,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-Jul-1981,08:33,0,56,56,Days,PK,Plasma concentration Z,52.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
372,NaN,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-Aug-1981,08:33,0,70,70,Days,PK,Plasma concentration Z,14.559,,ug/ml,NaN,0.8,,NaN,NaN,NaN
373,NaN,ZY100404130,Z,Y1,FIH HV Study ,2,0,4,4130,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,16-May-1981,07:00,0,-14,-22.06666667,Days,Demographics,Age,52,,Years,NaN,NaN,,NaN,NaN,NaN
374,NaN,ZY100404130,Z,Y1,FIH HV Study ,2,0,4,4130,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,16-May-1981,07:00,0,-14,-22.06666667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
375,NaN,ZY100404130,Z,Y1,FIH HV Study ,2,0,4,4130,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,16-May-1981,07:00,0,-14,-22.06666667,Days,Demographics,Weight,105.3,,kg,NaN,NaN,,NaN,NaN,NaN
376,NaN,ZY100404130,Z,Y1,FIH HV Study ,2,0,4,4130,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,28-May-1981,07:00,0,0,-10.06666667,Days,Demographics,Weight,105.1,,kg,NaN,NaN,,NaN,NaN,NaN
377,NaN,ZY100404130,Z,Y1,FIH HV Study ,2,0,4,4130,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,07-Jun-1981,08:36,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
378,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,18-Oct-1980,07:00,0,-14,-14.09097222,Days,Demographics,Age,61,,Years,NaN,NaN,,NaN,NaN,NaN
379,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,18-Oct-1980,07:00,0,-14,-14.09097222,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
380,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,18-Oct-1980,07:00,0,-14,-14.09097222,Days,Demographics,Weight,59.8,,kg,NaN,NaN,,NaN,NaN,NaN
381,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,25-Oct-1980,06:30,0,0,-7.111805556,Days,PD,Efficacy marker,21.152,,mm,NaN,NaN,,NaN,NaN,NaN
382,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,25-Oct-1980,07:00,0,0,-7.090972222,Days,Demographics,Weight,61.2,,kg,NaN,NaN,,NaN,NaN,NaN
383,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,01-Nov-1980,09:11,0.0833333333721384,0,0,Days,Dose,Dose Z,918,,mg,NaN,NaN,iv,NaN,NaN,NaN
384,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,01-Nov-1980,11:10,0,0.0833,0.082638889,Days,PK,Plasma concentration Z,998.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
385,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,17-Nov-1980,14:10,0,14,16.20763889,Days,PK,Plasma concentration Z,159.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
386,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-Nov-1980,14:00,0,28,29.20069444,Days,PK,Plasma concentration Z,119.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
387,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-Dec-1980,13:16,0,42,42.17013889,Days,PK,Plasma concentration Z,42.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
388,NaN,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,21-Feb-1981,14:36,0,112,112.2256944,Days,PD,Efficacy marker,22.223,,mm,NaN,NaN,,NaN,NaN,NaN
389,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,18-Oct-1980,07:00,0,-14,-21.09722222,Days,Demographics,Age,71,,Years,NaN,NaN,,NaN,NaN,NaN
390,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,18-Oct-1980,07:00,0,-14,-21.09722222,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
391,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,18-Oct-1980,07:00,0,-14,-21.09722222,Days,Demographics,Weight,84.1,,kg,NaN,NaN,,NaN,NaN,NaN
392,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,25-Oct-1980,13:48,0,0,-13.81388889,Days,PD,Efficacy marker,23.043,,mm,NaN,NaN,,NaN,NaN,NaN
393,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,27-Oct-1980,07:00,0,0,-12.09722222,Days,Demographics,Weight,87.4,,kg,NaN,NaN,,NaN,NaN,NaN
394,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,08-Nov-1980,09:20,0.0833333333721384,0,0,Days,Dose,Dose Z,1311,,mg,NaN,NaN,iv,NaN,NaN,NaN
395,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,08-Nov-1980,11:40,0,0.0833,0.097222222,Days,PK,Plasma concentration Z,1362,,ug/ml,NaN,0.8,,NaN,NaN,NaN
396,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,23-Nov-1980,11:06,0,14,15.07361111,Days,PK,Plasma concentration Z,176.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
397,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,07-Dec-1980,15:21,0,28,29.25069444,Days,PK,Plasma concentration Z,100.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
398,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,20-Dec-1980,13:05,0,42,42.15625,Days,PK,Plasma concentration Z,57.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
399,NaN,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-Feb-1981,12:00,0,112,111.1111111,Days,PD,Efficacy marker,22.945,,mm,NaN,NaN,,NaN,NaN,NaN
400,NaN,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,17-Oct-1980,07:00,0,-14,-16.09097222,Days,Demographics,Age,78,,Years,NaN,NaN,,NaN,NaN,NaN
401,NaN,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,17-Oct-1980,07:00,0,-14,-16.09097222,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
402,NaN,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,17-Oct-1980,07:00,0,-14,-16.09097222,Days,Demographics,Weight,83.64,,kg,NaN,NaN,,NaN,NaN,NaN
403,NaN,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,31-Oct-1980,06:51,0,0,-2.097222222,Days,PD,Efficacy marker,23.364,,mm,NaN,NaN,,NaN,NaN,NaN
404,NaN,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,01-Nov-1980,07:00,0,0,-1.090972222,Days,Demographics,Weight,81,,kg,NaN,NaN,,NaN,NaN,NaN
405,NaN,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,02-Nov-1980,09:11,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
406,NaN,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,19-Feb-1981,12:30,0,112,109.1381944,Days,PD,Efficacy marker,23.437,,mm,NaN,NaN,,NaN,NaN,NaN
407,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,19-Oct-1980,07:00,0,-14,-19.10555556,Days,Demographics,Age,76,,Years,NaN,NaN,,NaN,NaN,NaN
408,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,19-Oct-1980,07:00,0,-14,-19.10555556,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
409,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,19-Oct-1980,07:00,0,-14,-19.10555556,Days,Demographics,Weight,77.5,,kg,NaN,NaN,,NaN,NaN,NaN
410,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,23-Oct-1980,15:36,0,0,-14.74722222,Days,PD,Efficacy marker,16.993,,mm,NaN,NaN,,NaN,NaN,NaN
411,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,25-Oct-1980,07:00,0,0,-13.10555556,Days,Demographics,Weight,77.1,,kg,NaN,NaN,,NaN,NaN,NaN
412,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-Nov-1980,09:30,0,0,-0.001388889,Days,PK,Plasma concentration Z,0.933,,ug/ml,NaN,0.8,,NaN,NaN,NaN
413,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-Nov-1980,09:32,0.0833333333721384,0,0,Days,Dose,Dose Z,1156.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
414,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-Nov-1980,11:40,0,0.0833,0.088888889,Days,PK,Plasma concentration Z,1826.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
415,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,22-Nov-1980,09:47,0,14,15.01041667,Days,PK,Plasma concentration Z,258,,ug/ml,NaN,0.8,,NaN,NaN,NaN
416,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-Dec-1980,09:18,0,28,27.99027778,Days,PK,Plasma concentration Z,156.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
417,NaN,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,19-Dec-1980,09:30,0,42,41.99861111,Days,PK,Plasma concentration Z,95.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
418,NaN,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Oct-1980,07:00,0,-14,-27.11458333,Days,Demographics,Age,52,,Years,NaN,NaN,,NaN,NaN,NaN
419,NaN,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Oct-1980,07:00,0,-14,-27.11458333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
420,NaN,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Oct-1980,07:00,0,-14,-27.11458333,Days,Demographics,Weight,103.2,,kg,NaN,NaN,,NaN,NaN,NaN
421,NaN,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,14-Nov-1980,12:16,0,0,-5.895138889,Days,PD,Efficacy marker,25.637,,mm,NaN,NaN,,NaN,NaN,NaN
422,NaN,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,15-Nov-1980,07:00,0,0,-5.114583333,Days,Demographics,Weight,104.2,,kg,NaN,NaN,,NaN,NaN,NaN
423,NaN,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,20-Nov-1980,09:45,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
424,NaN,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-Mar-1981,14:55,0,112,120.2152778,Days,PD,Efficacy marker,24.502,,mm,NaN,NaN,,NaN,NaN,NaN
425,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-27.08819444,Days,Demographics,Age,68,,Years,NaN,NaN,,NaN,NaN,NaN
426,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-27.08819444,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
427,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-27.08819444,Days,Demographics,Weight,114.8,,kg,NaN,NaN,,NaN,NaN,NaN
428,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,10-Nov-1980,06:38,0,0,-17.10347222,Days,PD,Efficacy marker,36.453,,mm,NaN,NaN,,NaN,NaN,NaN
429,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,24-Nov-1980,07:00,0,0,-3.088194444,Days,Demographics,Weight,117.3,,kg,NaN,NaN,,NaN,NaN,NaN
430,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,27-Nov-1980,09:07,0.0833333333721384,0,0,Days,Dose,Dose Z,1759.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
431,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,27-Nov-1980,11:08,0,0.0833,0.084027778,Days,PK,Plasma concentration Z,1460.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
432,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,15-Dec-1980,08:26,0,14,17.97152778,Days,PK,Plasma concentration Z,197.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
433,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,26-Dec-1980,09:54,0,28,29.03263889,Days,PK,Plasma concentration Z,110.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
434,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-Jan-1981,10:25,0,42,46.05416667,Days,PK,Plasma concentration Z,50.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
435,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,26-Feb-1981,08:35,0,84,90.97777778,Days,PK,Plasma concentration Z,4.08,,ug/ml,NaN,0.8,,NaN,NaN,NaN
436,NaN,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-Mar-1981,13:46,0,112,113.19375,Days,PD,Efficacy marker,35.673,,mm,NaN,NaN,,NaN,NaN,NaN
437,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Oct-1980,07:00,0,-14,-36.08333333,Days,Demographics,Age,68,,Years,NaN,NaN,,NaN,NaN,NaN
438,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Oct-1980,07:00,0,-14,-36.08333333,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
439,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Oct-1980,07:00,0,-14,-36.08333333,Days,Demographics,Weight,87.8,,kg,NaN,NaN,,NaN,NaN,NaN
440,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,07-Nov-1980,07:25,0,0,-22.06597222,Days,PD,Efficacy marker,38.399,,mm,NaN,NaN,,NaN,NaN,NaN
441,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,24-Nov-1980,07:00,0,0,-5.083333333,Days,Demographics,Weight,89.3,,kg,NaN,NaN,,NaN,NaN,NaN
442,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-Nov-1980,08:59,0,0,-0.000694444,Days,PK,Plasma concentration Z,2.139,,ug/ml,NaN,0.8,,NaN,NaN,NaN
443,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-Nov-1980,09:00,0.0833333333721384,0,0,Days,Dose,Dose Z,1339.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
444,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-Nov-1980,11:01,0,0.0833,0.084027778,Days,PK,Plasma concentration Z,1596,,ug/ml,NaN,0.8,,NaN,NaN,NaN
445,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,13-Dec-1980,08:30,0,14,13.97916667,Days,PK,Plasma concentration Z,216,,ug/ml,NaN,0.8,,NaN,NaN,NaN
446,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,27-Dec-1980,09:55,0,28,28.03819444,Days,PK,Plasma concentration Z,124.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
447,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,10-Jan-1981,09:28,0,42,42.01944444,Days,PK,Plasma concentration Z,99.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
448,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,21-Mar-1981,09:54,0,112,112.0375,Days,PK,Plasma concentration Z,7.74,,ug/ml,NaN,0.8,,NaN,NaN,NaN
449,NaN,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,21-Mar-1981,14:27,0,112,112.2270833,Days,PD,Efficacy marker,41.392,,mm,NaN,NaN,,NaN,NaN,NaN
450,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-73.08819444,Days,Demographics,Age,70,,Years,NaN,NaN,,NaN,NaN,NaN
451,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-73.08819444,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
452,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-73.08819444,Days,Demographics,Weight,91.7,,kg,NaN,NaN,,NaN,NaN,NaN
453,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-Nov-1980,10:29,0,0,-64.94305556,Days,PD,Efficacy marker,21.419,,mm,NaN,NaN,,NaN,NaN,NaN
454,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,11-Jan-1981,07:00,0,0,-1.088194444,Days,Demographics,Weight,94.7,,kg,NaN,NaN,,NaN,NaN,NaN
455,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,12-Jan-1981,09:07,0.0833333333721384,0,0,Days,Dose,Dose Z,1420.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
456,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,12-Jan-1981,11:40,0,0.166,0.10625,Days,PK,Plasma concentration Z,1358.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
457,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,23-Jan-1981,10:27,0,14,11.05555556,Days,PK,Plasma concentration Z,279.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
458,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,07-Feb-1981,10:00,0,28,26.03680556,Days,PK,Plasma concentration Z,95.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
459,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,21-Feb-1981,10:10,0,42,40.04375,Days,PK,Plasma concentration Z,53.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
460,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,06-Apr-1981,11:59,0,84,84.11944444,Days,PK,Plasma concentration Z,6.039,,ug/ml,NaN,0.8,,NaN,NaN,NaN
461,NaN,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,10-May-1981,13:29,0,112,118.1819444,Days,PD,Efficacy marker,24.718,,mm,NaN,NaN,,NaN,NaN,NaN
462,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-Oct-1980,07:00,0,-14,-85.07291667,Days,Demographics,Age,45,,Years,NaN,NaN,,NaN,NaN,NaN
463,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-Oct-1980,07:00,0,-14,-85.07291667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
464,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-Oct-1980,07:00,0,-14,-85.07291667,Days,Demographics,Weight,56.1,,kg,NaN,NaN,,NaN,NaN,NaN
465,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-Jan-1981,07:00,0,0,-3.072916667,Days,Demographics,Weight,58.1,,kg,NaN,NaN,,NaN,NaN,NaN
466,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-Jan-1981,13:02,0,0,-2.821527778,Days,PD,Efficacy marker,19.606,,mm,NaN,NaN,,NaN,NaN,NaN
467,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,19-Jan-1981,08:44,0,0,-0.000694444,Days,PK,Plasma concentration Z,0.417,,ug/ml,NaN,0.8,,NaN,NaN,NaN
468,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,19-Jan-1981,08:45,0.0833333332557231,0,0,Days,Dose,Dose Z,871.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
469,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,19-Jan-1981,10:55,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,1004.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
470,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,05-Feb-1981,10:30,0,14,17.07291667,Days,PK,Plasma concentration Z,264,,ug/ml,NaN,0.8,,NaN,NaN,NaN
471,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,01-Mar-1981,10:00,0,42,41.05208333,Days,PK,Plasma concentration Z,38.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
472,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Apr-1981,10:00,0,84,84.05208333,Days,PK,Plasma concentration Z,0.708,,ug/ml,NaN,0.8,,NaN,NaN,NaN
473,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,08-May-1981,13:05,0,112,109.1805556,Days,PD,Efficacy marker,20.226,,mm,NaN,NaN,,NaN,NaN,NaN
474,NaN,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,09-May-1981,12:30,0,112,110.15625,Days,PK,Plasma concentration Z,0.405,,ug/ml,NaN,0.8,,NaN,NaN,NaN
475,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,25-Oct-1980,07:00,0,-14,-13.17013889,Days,Demographics,Age,75,,Years,NaN,NaN,,NaN,NaN,NaN
476,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,25-Oct-1980,07:00,0,-14,-13.17013889,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
477,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,25-Oct-1980,07:00,0,-14,-13.17013889,Days,Demographics,Weight,96.2,,kg,NaN,NaN,,NaN,NaN,NaN
478,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,02-Nov-1980,07:00,0,0,-5.170138889,Days,Demographics,Weight,96.6,,kg,NaN,NaN,,NaN,NaN,NaN
479,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,02-Nov-1980,15:53,0,0,-4.8,Days,PD,Efficacy marker,26.918,,mm,NaN,NaN,,NaN,NaN,NaN
480,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-Nov-1980,11:05,0.0833333333721384,0,0,Days,Dose,Dose Z,1449,,mg,NaN,NaN,iv,NaN,NaN,NaN
481,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-Nov-1980,14:00,0,0.166,0.121527778,Days,PK,Plasma concentration Z,1413.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
482,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,21-Nov-1980,06:25,0,14,13.80555556,Days,PK,Plasma concentration Z,199.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
483,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-Dec-1980,06:33,0,28,27.81111111,Days,PK,Plasma concentration Z,132.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
484,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,19-Dec-1980,06:36,0,42,41.81319444,Days,PK,Plasma concentration Z,98.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
485,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Feb-1981,06:53,0,84,97.825,Days,PK,Plasma concentration Z,9.18,,ug/ml,NaN,0.8,,NaN,NaN,NaN
486,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-Feb-1981,06:50,0,112,111.8229167,Days,PK,Plasma concentration Z,3.939,,ug/ml,NaN,0.8,,NaN,NaN,NaN
487,NaN,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-Feb-1981,13:47,0,112,112.1125,Days,PD,Efficacy marker,29.847,,mm,NaN,NaN,,NaN,NaN,NaN
488,NaN,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,25-Oct-1980,07:00,0,-14,-20.07291667,Days,Demographics,Age,74,,Years,NaN,NaN,,NaN,NaN,NaN
489,NaN,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,25-Oct-1980,07:00,0,-14,-20.07291667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
490,NaN,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,25-Oct-1980,07:00,0,-14,-20.07291667,Days,Demographics,Weight,98.4,,kg,NaN,NaN,,NaN,NaN,NaN
491,NaN,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-Nov-1980,07:00,0,0,-5.072916667,Days,Demographics,Weight,99.3,,kg,NaN,NaN,,NaN,NaN,NaN
492,NaN,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-Nov-1980,16:54,0,0,-4.660416667,Days,PD,Efficacy marker,18.569,,mm,NaN,NaN,,NaN,NaN,NaN
493,NaN,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,14-Nov-1980,08:45,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
494,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-14.01736111,Days,Demographics,Age,62,,Years,NaN,NaN,,NaN,NaN,NaN
495,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-14.01736111,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
496,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,31-Oct-1980,07:00,0,-14,-14.01736111,Days,Demographics,Weight,82.6,,kg,NaN,NaN,,NaN,NaN,NaN
497,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-Nov-1980,07:00,0,0,-5.017361111,Days,Demographics,Weight,82.1,,kg,NaN,NaN,,NaN,NaN,NaN
498,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-Nov-1980,11:02,0,0,-4.849305556,Days,PD,Efficacy marker,17.731,,mm,NaN,NaN,,NaN,NaN,NaN
499,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,14-Nov-1980,07:25,0.0833333333721384,0,0,Days,Dose,Dose Z,1231.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
500,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,14-Nov-1980,09:56,0,0.166,0.104861111,Days,PK,Plasma concentration Z,1536,,ug/ml,NaN,0.8,,NaN,NaN,NaN
501,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,28-Nov-1980,10:22,0,14,14.12291667,Days,PK,Plasma concentration Z,171.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
502,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,12-Dec-1980,11:04,0,28,28.15208333,Days,PK,Plasma concentration Z,102.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
503,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,28-Dec-1980,08:30,0,42,44.04513889,Days,PK,Plasma concentration Z,54.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
504,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-Feb-1981,13:55,0,84,91.27083333,Days,PK,Plasma concentration Z,4.479,,ug/ml,NaN,0.8,,NaN,NaN,NaN
505,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-Feb-1981,08:50,0,112,106.0590278,Days,PK,Plasma concentration Z,1.035,,ug/ml,NaN,0.8,,NaN,NaN,NaN
506,NaN,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-Feb-1981,13:39,0,112,106.2597222,Days,PD,Efficacy marker,18.795,,mm,NaN,NaN,,NaN,NaN,NaN
507,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-Nov-1980,07:00,0,-14,-12.07291667,Days,Demographics,Age,68,,Years,NaN,NaN,,NaN,NaN,NaN
508,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-Nov-1980,07:00,0,-14,-12.07291667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
509,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-Nov-1980,07:00,0,-14,-12.07291667,Days,Demographics,Weight,47.4,,kg,NaN,NaN,,NaN,NaN,NaN
510,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-Nov-1980,07:00,0,0,-5.072916667,Days,Demographics,Weight,47.2,,kg,NaN,NaN,,NaN,NaN,NaN
511,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-Nov-1980,16:18,0,0,-4.685416667,Days,PD,Efficacy marker,12.721,,mm,NaN,NaN,,NaN,NaN,NaN
512,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-Nov-1980,08:45,0.0833333332557231,0,0,Days,Dose,Dose Z,708,,mg,NaN,NaN,iv,NaN,NaN,NaN
513,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-Nov-1980,11:03,0,0.0833,0.095833333,Days,PK,Plasma concentration Z,936,,ug/ml,NaN,0.8,,NaN,NaN,NaN
514,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,28-Nov-1980,08:13,0,14,14.97777778,Days,PK,Plasma concentration Z,135.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
515,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,12-Dec-1980,08:44,0,28,28.99930556,Days,PK,Plasma concentration Z,77.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
516,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,26-Dec-1980,08:33,0,42,42.99166667,Days,PK,Plasma concentration Z,68.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
517,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,14-Feb-1981,09:24,0,84,93.02708333,Days,PK,Plasma concentration Z,2.841,,ug/ml,NaN,0.8,,NaN,NaN,NaN
518,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,01-Mar-1981,08:50,0,112,108.0034722,Days,PK,Plasma concentration Z,0.507,,ug/ml,NaN,0.8,,NaN,NaN,NaN
519,NaN,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,01-Mar-1981,16:41,0,112,108.3305556,Days,PD,Efficacy marker,12.549,,mm,NaN,NaN,,NaN,NaN,NaN
520,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-Nov-1980,07:00,0,-14,-12.03125,Days,Demographics,Age,77,,Years,NaN,NaN,,NaN,NaN,NaN
521,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-Nov-1980,07:00,0,-14,-12.03125,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
522,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,01-Nov-1980,07:00,0,-14,-12.03125,Days,Demographics,Weight,70.8,,kg,NaN,NaN,,NaN,NaN,NaN
523,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-Nov-1980,07:00,0,0,-5.03125,Days,Demographics,Weight,70.3,,kg,NaN,NaN,,NaN,NaN,NaN
524,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-Nov-1980,12:50,0,0,-4.788194444,Days,PD,Efficacy marker,28.574,,mm,NaN,NaN,,NaN,NaN,NaN
525,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-Nov-1980,07:45,0.0833333333721384,0,0,Days,Dose,Dose Z,1054.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
526,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-Nov-1980,10:08,0,0.0833,0.099305556,Days,PK,Plasma concentration Z,897.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
527,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,28-Nov-1980,06:18,0,14,14.93958333,Days,PK,Plasma concentration Z,132.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
528,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,12-Dec-1980,06:39,0,28,28.95416667,Days,PK,Plasma concentration Z,78.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
529,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,26-Dec-1980,06:34,0,42,42.95069444,Days,PK,Plasma concentration Z,100.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
530,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,14-Feb-1981,07:08,0,84,92.97430556,Days,PK,Plasma concentration Z,2.061,,ug/ml,NaN,0.8,,NaN,NaN,NaN
531,NaN,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,01-Mar-1981,15:24,0,112,108.31875,Days,PD,Efficacy marker,29.79,,mm,NaN,NaN,,NaN,NaN,NaN
532,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-35.00138889,Days,Demographics,Age,62,,Years,NaN,NaN,,NaN,NaN,NaN
533,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-35.00138889,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
534,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-35.00138889,Days,Demographics,Weight,77.7,,kg,NaN,NaN,,NaN,NaN,NaN
535,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,26-Apr-1982,07:22,0,0,-4.986111111,Days,PD,Efficacy marker,34.552,,mm,NaN,NaN,,NaN,NaN,NaN
536,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,27-Apr-1982,07:00,0,0,-4.001388889,Days,Demographics,Weight,77.9,,kg,NaN,NaN,,NaN,NaN,NaN
537,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,01-May-1982,07:02,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
538,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-May-1982,10:39,0,28,25.15069444,Days,PD,Efficacy marker,34.788,,mm,NaN,NaN,,NaN,NaN,NaN
539,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,29-May-1982,07:15,0.0833333332557231,28,28.00902778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
540,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,23-Jun-1982,14:53,0,56,53.32708333,Days,PD,Efficacy marker,35.752,,mm,NaN,NaN,,NaN,NaN,NaN
541,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,26-Jun-1982,07:04,0.0833333332557231,56,56.00138889,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
542,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,19-Jul-1982,09:47,0,84,79.11458333,Days,PD,Efficacy marker,35.559,,mm,NaN,NaN,,NaN,NaN,NaN
543,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,24-Jul-1982,06:28,0.0833333333721384,84,83.97638889,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
544,NaN,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,21-Aug-1982,10:17,0,112,112.1354167,Days,PD,Efficacy marker,36.197,,mm,NaN,NaN,,NaN,NaN,NaN
545,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,03-Apr-1982,07:00,0,-14,-28.04027778,Days,Demographics,Age,67,,Years,NaN,NaN,,NaN,NaN,NaN
546,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,03-Apr-1982,07:00,0,-14,-28.04027778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
547,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,03-Apr-1982,07:00,0,-14,-28.04027778,Days,Demographics,Weight,72.6,,kg,NaN,NaN,,NaN,NaN,NaN
548,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-Apr-1982,07:00,0,0,-4.040277778,Days,Demographics,Weight,73,,kg,NaN,NaN,,NaN,NaN,NaN
549,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-Apr-1982,10:24,0,0,-2.898611111,Days,PD,Efficacy marker,25.804,,mm,NaN,NaN,,NaN,NaN,NaN
550,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-May-1982,07:52,0,0,-0.004166667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
551,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-May-1982,07:58,0.0833333333721384,0,0,Days,Dose,Dose Z,368,,mg,NaN,NaN,iv,NaN,NaN,NaN
552,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-May-1982,10:09,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,518.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
553,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-May-1982,11:40,0,28,25.15416667,Days,PD,Efficacy marker,28.266,,mm,NaN,NaN,,NaN,NaN,NaN
554,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-May-1982,08:00,0,28,28.00138889,Days,PK,Plasma concentration Z,41.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
555,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-May-1982,08:11,0.0833333332557231,28,28.00902778,Days,Dose,Dose Z,374,,mg,NaN,NaN,iv,NaN,NaN,NaN
556,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-May-1982,10:27,0,28,28.10347222,Days,PK,Plasma concentration Z,591.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
557,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-Jun-1982,08:26,0,56,53.01944444,Days,PD,Efficacy marker,28.692,,mm,NaN,NaN,,NaN,NaN,NaN
558,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,26-Jun-1982,07:49,0,56,55.99375,Days,PK,Plasma concentration Z,61.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
559,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,26-Jun-1982,08:12,0.0833333333721384,56,56.00972222,Days,Dose,Dose Z,365,,mg,NaN,NaN,iv,NaN,NaN,NaN
560,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,26-Jun-1982,10:24,0,56,56.10138889,Days,PK,Plasma concentration Z,579.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
561,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Jul-1982,07:57,0,84,80.99930556,Days,PD,Efficacy marker,28.954,,mm,NaN,NaN,,NaN,NaN,NaN
562,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jul-1982,07:47,0,84,83.99236111,Days,PK,Plasma concentration Z,75.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
563,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jul-1982,08:02,0.0833333333721384,84,84.00277778,Days,Dose,Dose Z,358,,mg,NaN,NaN,iv,NaN,NaN,NaN
564,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jul-1982,10:14,0,84,84.09444444,Days,PK,Plasma concentration Z,516,,ug/ml,NaN,0.8,,NaN,NaN,NaN
565,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jul-1982,12:02,0,84,84.16944444,Days,PK,Plasma concentration Z,564,,ug/ml,NaN,0.8,,NaN,NaN,NaN
566,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jul-1982,14:03,0,84,84.25347222,Days,PK,Plasma concentration Z,540,,ug/ml,NaN,0.8,,NaN,NaN,NaN
567,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,30-Jul-1982,12:04,0,91,90.17083333,Days,PK,Plasma concentration Z,242.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
568,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,06-Aug-1982,10:44,0,98,97.11527778,Days,PK,Plasma concentration Z,142.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
569,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,21-Aug-1982,14:28,0,112,112.2708333,Days,PK,Plasma concentration Z,78.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
570,NaN,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,01-Sep-1982,10:45,0,112,123.1159722,Days,PD,Efficacy marker,28.343,,mm,NaN,NaN,,NaN,NaN,NaN
571,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Apr-1982,07:00,0,-14,-42,Days,Demographics,Age,59,,Years,NaN,NaN,,NaN,NaN,NaN
572,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Apr-1982,07:00,0,-14,-42,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
573,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Apr-1982,07:00,0,-14,-42,Days,Demographics,Weight,69.2,,kg,NaN,NaN,,NaN,NaN,NaN
574,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-May-1982,06:45,0,0,-5.010416667,Days,PD,Efficacy marker,35.206,,mm,NaN,NaN,,NaN,NaN,NaN
575,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-May-1982,07:00,0,0,-5,Days,Demographics,Weight,70.6,,kg,NaN,NaN,,NaN,NaN,NaN
576,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-May-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
577,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,16-Jun-1982,19:01,0,28,23.50069444,Days,PD,Efficacy marker,35.109,,mm,NaN,NaN,,NaN,NaN,NaN
578,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-Jun-1982,07:10,0.0833333333721384,28,28.00694444,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
579,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,14-Jul-1982,17:02,0,56,51.41805556,Days,PD,Efficacy marker,36.104,,mm,NaN,NaN,,NaN,NaN,NaN
580,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-Jul-1982,05:50,0.0833333333721384,56,55.95138889,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
581,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-Aug-1982,17:51,0,84,81.45208333,Days,PD,Efficacy marker,36.122,,mm,NaN,NaN,,NaN,NaN,NaN
582,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-Aug-1982,06:15,0.0833333333721384,84,83.96875,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
583,NaN,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,25-Sep-1982,18:29,0,112,124.4784722,Days,PD,Efficacy marker,35.899,,mm,NaN,NaN,,NaN,NaN,NaN
584,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Apr-1982,07:00,0,-14,-42.0125,Days,Demographics,Age,53,,Years,NaN,NaN,,NaN,NaN,NaN
585,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Apr-1982,07:00,0,-14,-42.0125,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
586,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Apr-1982,07:00,0,-14,-42.0125,Days,Demographics,Weight,68.6,,kg,NaN,NaN,,NaN,NaN,NaN
587,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-May-1982,07:00,0,0,-5.0125,Days,Demographics,Weight,69.2,,kg,NaN,NaN,,NaN,NaN,NaN
588,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-May-1982,19:26,0,0,-4.494444444,Days,PD,Efficacy marker,32.043,,mm,NaN,NaN,,NaN,NaN,NaN
589,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-May-1982,07:18,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
590,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,16-Jun-1982,16:58,0,28,23.40277778,Days,PD,Efficacy marker,32.829,,mm,NaN,NaN,,NaN,NaN,NaN
591,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-Jun-1982,07:14,0.0833333333721384,28,27.99722222,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
592,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,14-Jul-1982,15:51,0,56,51.35625,Days,PD,Efficacy marker,33.027,,mm,NaN,NaN,,NaN,NaN,NaN
593,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-Jul-1982,05:45,0.0833333332557231,56,55.93541667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
594,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,11-Aug-1982,15:57,0,84,79.36041667,Days,PD,Efficacy marker,33.213,,mm,NaN,NaN,,NaN,NaN,NaN
595,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-Aug-1982,06:05,0.0833333332557231,84,83.94930556,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
596,NaN,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,12-Sep-1982,17:09,0,112,111.4104167,Days,PD,Efficacy marker,32.038,,mm,NaN,NaN,,NaN,NaN,NaN
597,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,16-Apr-1982,07:00,0,-14,-37.00277778,Days,Demographics,Age,64,,Years,NaN,NaN,,NaN,NaN,NaN
598,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,16-Apr-1982,07:00,0,-14,-37.00277778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
599,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,16-Apr-1982,07:00,0,-14,-37.00277778,Days,Demographics,Weight,79.8,,kg,NaN,NaN,,NaN,NaN,NaN
600,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-May-1982,07:00,0,0,-4.002777778,Days,Demographics,Weight,80.1,,kg,NaN,NaN,,NaN,NaN,NaN
601,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-May-1982,07:41,0,0,-3.974305556,Days,PD,Efficacy marker,24.179,,mm,NaN,NaN,,NaN,NaN,NaN
602,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-May-1982,06:53,0,0,-0.007638889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
603,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-May-1982,07:04,0.0833333332557231,0,0,Days,Dose,Dose Z,404,,mg,NaN,NaN,iv,NaN,NaN,NaN
604,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-May-1982,09:18,0,0.0833,0.093055556,Days,PK,Plasma concentration Z,494.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
605,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,16-Jun-1982,18:08,0,28,24.46111111,Days,PD,Efficacy marker,26.368,,mm,NaN,NaN,,NaN,NaN,NaN
606,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-Jun-1982,06:45,0,28,27.98680556,Days,PK,Plasma concentration Z,38.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
607,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-Jun-1982,07:02,0.0833333333721384,28,27.99861111,Days,Dose,Dose Z,407.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
608,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-Jun-1982,09:12,0,28.0833,28.08888889,Days,PK,Plasma concentration Z,518.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
609,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-Jul-1982,14:54,0,56,52.32638889,Days,PD,Efficacy marker,26.887,,mm,NaN,NaN,,NaN,NaN,NaN
610,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-Jul-1982,06:53,0,56,55.99236111,Days,PK,Plasma concentration Z,60.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
611,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-Jul-1982,07:26,0.0833333332557231,56,56.01527778,Days,Dose,Dose Z,407,,mg,NaN,NaN,iv,NaN,NaN,NaN
612,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-Jul-1982,09:33,0,56.0833,56.10347222,Days,PK,Plasma concentration Z,558,,ug/ml,NaN,0.8,,NaN,NaN,NaN
613,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Aug-1982,05:57,0,84,82.95347222,Days,PK,Plasma concentration Z,71.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
614,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Aug-1982,06:12,0.0833333333721384,84,82.96388889,Days,Dose,Dose Z,398.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
615,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Aug-1982,08:19,0,84.0833,83.05208333,Days,PK,Plasma concentration Z,468,,ug/ml,NaN,0.8,,NaN,NaN,NaN
616,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Aug-1982,10:15,0,84.166,83.13263889,Days,PK,Plasma concentration Z,531.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
617,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Aug-1982,12:14,0,84.25,83.21527778,Days,PK,Plasma concentration Z,555.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
618,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,19-Aug-1982,07:06,0,91,88.00138889,Days,PK,Plasma concentration Z,237.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
619,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,26-Aug-1982,05:45,0,98,94.94513889,Days,PK,Plasma concentration Z,148.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
620,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-Aug-1982,17:24,0,98,96.43055556,Days,PD,Efficacy marker,27.311,,mm,NaN,NaN,,NaN,NaN,NaN
621,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,12-Sep-1982,06:36,0,112,111.9805556,Days,PK,Plasma concentration Z,152.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
622,NaN,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,12-Sep-1982,14:22,0,112,112.3041667,Days,PD,Efficacy marker,29.013,,mm,NaN,NaN,,NaN,NaN,NaN
623,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.04375,Days,Demographics,Age,70,,Years,NaN,NaN,,NaN,NaN,NaN
624,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.04375,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
625,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.04375,Days,Demographics,Weight,87.2,,kg,NaN,NaN,,NaN,NaN,NaN
626,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-May-1982,07:00,0,0,-5.04375,Days,Demographics,Weight,87.7,,kg,NaN,NaN,,NaN,NaN,NaN
627,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,26-May-1982,14:11,0,0,-2.744444444,Days,PD,Efficacy marker,48.98,,mm,NaN,NaN,,NaN,NaN,NaN
628,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:49,0,0,-0.009722222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
629,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,08:03,0.0833333332557231,0,0,Days,Dose,Dose Z,443.75,,mg,NaN,NaN,iv,NaN,NaN,NaN
630,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,10:19,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,417.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
631,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-Jun-1982,09:22,0,28,25.05486111,Days,PD,Efficacy marker,51.107,,mm,NaN,NaN,,NaN,NaN,NaN
632,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,07:42,0,28,27.98541667,Days,PK,Plasma concentration Z,29.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
633,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,08:00,0.0833333332557231,28,27.99791667,Days,Dose,Dose Z,439.75,,mg,NaN,NaN,iv,NaN,NaN,NaN
634,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,10:09,0,28,28.0875,Days,PK,Plasma concentration Z,474,,ug/ml,NaN,0.8,,NaN,NaN,NaN
635,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,22-Jul-1982,13:09,0,56,54.2125,Days,PD,Efficacy marker,50.992,,mm,NaN,NaN,,NaN,NaN,NaN
636,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,07:46,0,56,55.98819444,Days,PK,Plasma concentration Z,48.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
637,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,08:19,0.0833333333721384,56,56.01111111,Days,Dose,Dose Z,432.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
638,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,10:33,0,56,56.10416667,Days,PK,Plasma concentration Z,417.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
639,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Aug-1982,10:24,0,84,81.09791667,Days,PD,Efficacy marker,50.315,,mm,NaN,NaN,,NaN,NaN,NaN
640,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,07:35,0,84,83.98055556,Days,PK,Plasma concentration Z,48.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
641,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,08:02,0.0833333333721384,84,83.99930556,Days,Dose,Dose Z,431,,mg,NaN,NaN,iv,NaN,NaN,NaN
642,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,10:13,0,84,84.09027778,Days,PK,Plasma concentration Z,422.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
643,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,12:02,0,84,84.16597222,Days,PK,Plasma concentration Z,510,,ug/ml,NaN,0.8,,NaN,NaN,NaN
644,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,14:02,0,84,84.24930556,Days,PK,Plasma concentration Z,489.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
645,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,31-Aug-1982,13:42,0,91,94.23541667,Days,PK,Plasma concentration Z,116.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
646,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,03-Sep-1982,09:39,0,98,97.06666667,Days,PK,Plasma concentration Z,91.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
647,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Sep-1982,09:30,0,112,111.0604167,Days,PK,Plasma concentration Z,61.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
648,NaN,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Sep-1982,16:01,0,112,111.3319444,Days,PD,Efficacy marker,49.761,,mm,NaN,NaN,,NaN,NaN,NaN
649,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.01319444,Days,Demographics,Age,64,,Years,NaN,NaN,,NaN,NaN,NaN
650,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.01319444,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
651,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.01319444,Days,Demographics,Weight,82,,kg,NaN,NaN,,NaN,NaN,NaN
652,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-May-1982,07:00,0,0,-5.013194444,Days,Demographics,Weight,83.4,,kg,NaN,NaN,,NaN,NaN,NaN
653,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-May-1982,11:20,0,0,-0.832638889,Days,PD,Efficacy marker,42.431,,mm,NaN,NaN,,NaN,NaN,NaN
654,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:04,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
655,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:19,0.0833333333721384,0,0,Days,Dose,Dose Z,421,,mg,NaN,NaN,iv,NaN,NaN,NaN
656,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,09:29,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,561.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
657,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,07:57,0,28,23.02638889,Days,PD,Efficacy marker,44.994,,mm,NaN,NaN,,NaN,NaN,NaN
658,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,07:03,0,28,27.98888889,Days,PK,Plasma concentration Z,40.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
659,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,09:15,0,28,28.08055556,Days,PK,Plasma concentration Z,39.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
660,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-Jul-1982,10:11,0,56,53.11944444,Days,PD,Efficacy marker,44.156,,mm,NaN,NaN,,NaN,NaN,NaN
661,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-Jul-1982,12:00,0,56,53.19513889,Days,PK,Plasma concentration Z,12.861,,ug/ml,NaN,0.8,,NaN,NaN,NaN
662,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Aug-1982,13:58,0,84,81.27708333,Days,PK,Plasma concentration Z,0.48,,ug/ml,NaN,0.8,,NaN,NaN,NaN
663,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Aug-1982,16:37,0,84,81.3875,Days,PD,Efficacy marker,42.768,,mm,NaN,NaN,,NaN,NaN,NaN
664,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,27-Aug-1982,10:36,0,91,90.13680556,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
665,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,03-Sep-1982,10:22,0,98,97.12708333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
666,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Sep-1982,08:26,0,112,111.0465278,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
667,NaN,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,18-Sep-1982,13:15,0,112,112.2472222,Days,PD,Efficacy marker,41.652,,mm,NaN,NaN,,NaN,NaN,NaN
668,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,09-May-1982,07:00,0,-14,-22,Days,Demographics,Age,54,,Years,NaN,NaN,,NaN,NaN,NaN
669,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,09-May-1982,07:00,0,-14,-22,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
670,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,09-May-1982,07:00,0,-14,-22,Days,Demographics,Weight,72.4,,kg,NaN,NaN,,NaN,NaN,NaN
671,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,26-May-1982,14:54,0,0,-4.670833333,Days,PD,Efficacy marker,33.302,,mm,NaN,NaN,,NaN,NaN,NaN
672,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-May-1982,07:00,0,0,-2,Days,Demographics,Weight,72.2,,kg,NaN,NaN,,NaN,NaN,NaN
673,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,31-May-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
674,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-Jun-1982,17:52,0,28,23.45277778,Days,PD,Efficacy marker,32.637,,mm,NaN,NaN,,NaN,NaN,NaN
675,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,28-Jun-1982,07:04,0.0833333332557231,28,28.00277778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
676,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,25-Jul-1982,04:37,0,56,54.90069444,Days,PD,Efficacy marker,34.09,,mm,NaN,NaN,,NaN,NaN,NaN
677,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,26-Jul-1982,06:01,0.0833333333721384,56,55.95902778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
678,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-Aug-1982,17:59,0,84,79.45763889,Days,PD,Efficacy marker,32.994,,mm,NaN,NaN,,NaN,NaN,NaN
679,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,23-Aug-1982,06:41,0.0833333332557231,84,83.98680556,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
680,NaN,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,22-Sep-1982,18:54,0,112,114.4958333,Days,PD,Efficacy marker,32.835,,mm,NaN,NaN,,NaN,NaN,NaN
681,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,23-May-1982,07:00,0,-14,-42.99791667,Days,Demographics,Age,59,,Years,NaN,NaN,,NaN,NaN,NaN
682,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,23-May-1982,07:00,0,-14,-42.99791667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
683,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,23-May-1982,07:00,0,-14,-42.99791667,Days,Demographics,Weight,82.3,,kg,NaN,NaN,,NaN,NaN,NaN
684,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-Jun-1982,16:06,0,0,-4.61875,Days,PD,Efficacy marker,35.276,,mm,NaN,NaN,,NaN,NaN,NaN
685,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,01-Jul-1982,07:00,0,0,-3.997916667,Days,Demographics,Weight,81.6,,kg,NaN,NaN,,NaN,NaN,NaN
686,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-Jul-1982,06:22,0,0,-0.024305556,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
687,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-Jul-1982,06:57,0.0833333333721384,0,0,Days,Dose,Dose Z,412.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
688,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-Jul-1982,09:05,0,0.0833,0.088888889,Days,PK,Plasma concentration Z,518.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
689,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,28-Jul-1982,12:14,0,28,23.22013889,Days,PD,Efficacy marker,37.333,,mm,NaN,NaN,,NaN,NaN,NaN
690,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,31-Jul-1982,14:56,0,28,26.33263889,Days,PK,Plasma concentration Z,44.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
691,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,31-Jul-1982,15:19,0.0833333332557231,28,26.34861111,Days,Dose,Dose Z,416,,mg,NaN,NaN,iv,NaN,NaN,NaN
692,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,31-Jul-1982,17:25,0,28,26.43611111,Days,PK,Plasma concentration Z,585.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
693,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,25-Aug-1982,10:21,0,56,51.14166667,Days,PD,Efficacy marker,37.22,,mm,NaN,NaN,,NaN,NaN,NaN
694,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Aug-1982,05:12,0,56,54.92708333,Days,PK,Plasma concentration Z,56.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
695,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Aug-1982,05:31,0.0833333332557231,56,54.94027778,Days,Dose,Dose Z,419.75,,mg,NaN,NaN,iv,NaN,NaN,NaN
696,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Aug-1982,07:42,0,56,55.03125,Days,PK,Plasma concentration Z,626.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
697,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Sep-1982,10:45,0,84,79.15833333,Days,PD,Efficacy marker,39.112,,mm,NaN,NaN,,NaN,NaN,NaN
698,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Sep-1982,13:34,0,84,79.27569444,Days,PK,Plasma concentration Z,72.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
699,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,02-Oct-1982,13:05,0,91,89.25555556,Days,PK,Plasma concentration Z,48.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
700,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,13-Oct-1982,12:05,0,98,100.2138889,Days,PK,Plasma concentration Z,30.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
701,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,22-Oct-1982,15:57,0,112,109.375,Days,PK,Plasma concentration Z,19.419,,ug/ml,NaN,0.8,,NaN,NaN,NaN
702,NaN,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,24-Oct-1982,15:59,0,112,111.3763889,Days,PD,Efficacy marker,38.497,,mm,NaN,NaN,,NaN,NaN,NaN
703,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-May-1982,07:00,0,-14,-31.99444444,Days,Demographics,Age,51,,Years,NaN,NaN,,NaN,NaN,NaN
704,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-May-1982,07:00,0,-14,-31.99444444,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
705,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-May-1982,07:00,0,-14,-31.99444444,Days,Demographics,Weight,56.6,,kg,NaN,NaN,,NaN,NaN,NaN
706,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-Jun-1982,07:00,0,0,-4.994444444,Days,Demographics,Weight,56.85,,kg,NaN,NaN,,NaN,NaN,NaN
707,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-Jun-1982,14:23,0,0,-4.686805556,Days,PD,Efficacy marker,22.644,,mm,NaN,NaN,,NaN,NaN,NaN
708,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,02-Jul-1982,06:33,0,0,-0.013194444,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
709,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,02-Jul-1982,06:52,0.0833333333721384,0,0,Days,Dose,Dose Z,287,,mg,NaN,NaN,iv,NaN,NaN,NaN
710,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,02-Jul-1982,09:04,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,384,,ug/ml,NaN,0.8,,NaN,NaN,NaN
711,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-Jul-1982,03:17,0,28,22.85069444,Days,PD,Efficacy marker,25.449,,mm,NaN,NaN,,NaN,NaN,NaN
712,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Aug-1982,06:24,0,28,29.98055556,Days,PK,Plasma concentration Z,32.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
713,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Aug-1982,06:33,0.0833333332557231,28,29.98680556,Days,Dose,Dose Z,290.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
714,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Aug-1982,08:42,0,28,30.07638889,Days,PK,Plasma concentration Z,522,,ug/ml,NaN,0.8,,NaN,NaN,NaN
715,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,22-Aug-1982,15:30,0,56,51.35972222,Days,PD,Efficacy marker,25.793,,mm,NaN,NaN,,NaN,NaN,NaN
716,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-Aug-1982,07:44,0,56,56.03611111,Days,PK,Plasma concentration Z,62.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
717,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-Aug-1982,07:55,0.0833333333721384,56,56.04375,Days,Dose,Dose Z,286.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
718,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-Aug-1982,10:08,0,56,56.13611111,Days,PK,Plasma concentration Z,482.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
719,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,19-Sep-1982,16:26,0,84,79.39861111,Days,PD,Efficacy marker,25.527,,mm,NaN,NaN,,NaN,NaN,NaN
720,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Sep-1982,08:37,0,84,84.07291667,Days,PK,Plasma concentration Z,70.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
721,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,01-Oct-1982,09:06,0,91,91.09305556,Days,PK,Plasma concentration Z,57,,ug/ml,NaN,0.8,,NaN,NaN,NaN
722,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,08-Oct-1982,09:12,0,98,98.09722222,Days,PK,Plasma concentration Z,47.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
723,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,20-Oct-1982,12:39,0,112,110.2409722,Days,PK,Plasma concentration Z,28.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
724,NaN,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,22-Oct-1982,15:37,0,112,112.3645833,Days,PD,Efficacy marker,25.827,,mm,NaN,NaN,,NaN,NaN,NaN
725,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-Jun-1982,07:00,0,-14,-35.99027778,Days,Demographics,Age,72,,Years,NaN,NaN,,NaN,NaN,NaN
726,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-Jun-1982,07:00,0,-14,-35.99027778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
727,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-Jun-1982,07:00,0,-14,-35.99027778,Days,Demographics,Weight,71.7,,kg,NaN,NaN,,NaN,NaN,NaN
728,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-Jul-1982,07:00,0,0,-4.990277778,Days,Demographics,Weight,71.9,,kg,NaN,NaN,,NaN,NaN,NaN
729,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-Jul-1982,10:30,0,0,-4.844444444,Days,PD,Efficacy marker,25.944,,mm,NaN,NaN,,NaN,NaN,NaN
730,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Jul-1982,06:29,0,0,-0.011805556,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
731,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Jul-1982,06:46,0.0833333333721384,0,0,Days,Dose,Dose Z,357,,mg,NaN,NaN,iv,NaN,NaN,NaN
732,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Jul-1982,08:53,0,0.0833,0.088194444,Days,PK,Plasma concentration Z,447.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
733,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,31-Jul-1982,10:23,0,28,23.15069444,Days,PD,Efficacy marker,26.892,,mm,NaN,NaN,,NaN,NaN,NaN
734,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,05-Aug-1982,06:45,0,28,27.99930556,Days,PK,Plasma concentration Z,49.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
735,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,05-Aug-1982,07:25,0.0833333333721384,28,28.02708333,Days,Dose,Dose Z,354,,mg,NaN,NaN,iv,NaN,NaN,NaN
736,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,05-Aug-1982,09:33,0,28.0833,28.11597222,Days,PK,Plasma concentration Z,555.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
737,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-Aug-1982,11:34,0,56,53.2,Days,PD,Efficacy marker,27.596,,mm,NaN,NaN,,NaN,NaN,NaN
738,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,02-Sep-1982,06:43,0,56,55.99791667,Days,PK,Plasma concentration Z,61.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
739,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,02-Sep-1982,07:08,0.0833333333721384,56,56.01527778,Days,Dose,Dose Z,357,,mg,NaN,NaN,iv,NaN,NaN,NaN
740,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,02-Sep-1982,09:16,0,56.0833,56.10416667,Days,PK,Plasma concentration Z,482.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
741,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-Sep-1982,07:03,0,84,84.01180556,Days,PK,Plasma concentration Z,87.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
742,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-Sep-1982,07:20,0.0833333333721384,84,84.02361111,Days,Dose,Dose Z,353,,mg,NaN,NaN,iv,NaN,NaN,NaN
743,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-Sep-1982,09:33,0,84.0833,84.11597222,Days,PK,Plasma concentration Z,567.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
744,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-Sep-1982,11:20,0,84.166,84.19027778,Days,PK,Plasma concentration Z,554.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
745,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-Sep-1982,13:20,0,84.25,84.27361111,Days,PK,Plasma concentration Z,566.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
746,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,08-Oct-1982,10:38,0,91,92.16111111,Days,PK,Plasma concentration Z,192.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
747,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,15-Oct-1982,09:36,0,98,99.11805556,Days,PK,Plasma concentration Z,132.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
748,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-Oct-1982,08:16,0,112,112.0625,Days,PK,Plasma concentration Z,94.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
749,NaN,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-Oct-1982,10:18,0,112,112.1472222,Days,PD,Efficacy marker,27.853,,mm,NaN,NaN,,NaN,NaN,NaN
750,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,10-Jun-1982,07:00,0,-14,-34.99930556,Days,Demographics,Age,64,,Years,NaN,NaN,,NaN,NaN,NaN
751,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,10-Jun-1982,07:00,0,-14,-34.99930556,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
752,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,10-Jun-1982,07:00,0,-14,-34.99930556,Days,Demographics,Weight,71.3,,kg,NaN,NaN,,NaN,NaN,NaN
753,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-Jul-1982,07:00,0,0,-4.999305556,Days,Demographics,Weight,70.1,,kg,NaN,NaN,,NaN,NaN,NaN
754,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-Jul-1982,09:50,0,0,-4.88125,Days,PD,Efficacy marker,30.446,,mm,NaN,NaN,,NaN,NaN,NaN
755,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-Jul-1982,06:59,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
756,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-Aug-1982,10:23,0,28,23.14166667,Days,PD,Efficacy marker,30.895,,mm,NaN,NaN,,NaN,NaN,NaN
757,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-Aug-1982,07:44,0.0833333333721384,28,28.03125,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
758,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-Sep-1982,10:47,0,56,51.15833333,Days,PD,Efficacy marker,30.802,,mm,NaN,NaN,,NaN,NaN,NaN
759,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-Sep-1982,07:40,0.0833333332557231,56,56.02847222,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
760,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-Oct-1982,10:17,0,84,79.1375,Days,PD,Efficacy marker,31.247,,mm,NaN,NaN,,NaN,NaN,NaN
761,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,07-Oct-1982,07:30,0.0833333333721384,84,84.02152778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
762,NaN,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,04-Nov-1982,10:45,0,112,112.1569444,Days,PD,Efficacy marker,31.189,,mm,NaN,NaN,,NaN,NaN,NaN
763,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Jun-1982,07:00,0,-14,-41.97638889,Days,Demographics,Age,56,,Years,NaN,NaN,,NaN,NaN,NaN
764,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Jun-1982,07:00,0,-14,-41.97638889,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
765,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Jun-1982,07:00,0,-14,-41.97638889,Days,Demographics,Weight,91,,kg,NaN,NaN,,NaN,NaN,NaN
766,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,25-Jul-1982,07:00,0,0,-4.976388889,Days,Demographics,Weight,91.5,,kg,NaN,NaN,,NaN,NaN,NaN
767,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,25-Jul-1982,09:03,0,0,-4.890972222,Days,PD,Efficacy marker,46.381,,mm,NaN,NaN,,NaN,NaN,NaN
768,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,30-Jul-1982,05:48,0,0,-0.026388889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
769,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,30-Jul-1982,06:26,0.0833333333721384,0,0,Days,Dose,Dose Z,458,,mg,NaN,NaN,iv,NaN,NaN,NaN
770,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,30-Jul-1982,08:39,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,536.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
771,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,27-Aug-1982,06:05,0,28,27.98541667,Days,PK,Plasma concentration Z,30.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
772,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,27-Aug-1982,06:36,0.0833333332557231,28,28.00694444,Days,Dose,Dose Z,463,,mg,NaN,NaN,iv,NaN,NaN,NaN
773,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,27-Aug-1982,08:47,0,28,28.09791667,Days,PK,Plasma concentration Z,546,,ug/ml,NaN,0.8,,NaN,NaN,NaN
774,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,04-Sep-1982,15:25,0,28,36.37430556,Days,PD,Efficacy marker,48.082,,mm,NaN,NaN,,NaN,NaN,NaN
775,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Sep-1982,17:38,0,56,51.46666667,Days,PD,Efficacy marker,48.545,,mm,NaN,NaN,,NaN,NaN,NaN
776,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Sep-1982,06:26,0,56,56,Days,PK,Plasma concentration Z,40.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
777,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Sep-1982,06:40,0.0833333333721384,56,56.00972222,Days,Dose,Dose Z,464.25,,mg,NaN,NaN,iv,NaN,NaN,NaN
778,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Sep-1982,08:51,0,56,56.10069444,Days,PK,Plasma concentration Z,440.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
779,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,17-Oct-1982,16:00,0,84,79.39861111,Days,PD,Efficacy marker,49.831,,mm,NaN,NaN,,NaN,NaN,NaN
780,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Oct-1982,06:03,0,84,83.98402778,Days,PK,Plasma concentration Z,57.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
781,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Oct-1982,06:30,0.0833333332557231,84,84.00277778,Days,Dose,Dose Z,455,,mg,NaN,NaN,iv,NaN,NaN,NaN
782,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Oct-1982,08:45,0,84,84.09652778,Days,PK,Plasma concentration Z,522,,ug/ml,NaN,0.8,,NaN,NaN,NaN
783,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Oct-1982,10:30,0,84,84.16944444,Days,PK,Plasma concentration Z,432,,ug/ml,NaN,0.8,,NaN,NaN,NaN
784,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Oct-1982,12:31,0,84,84.25347222,Days,PK,Plasma concentration Z,498,,ug/ml,NaN,0.8,,NaN,NaN,NaN
785,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,29-Oct-1982,09:05,0,91,91.11041667,Days,PK,Plasma concentration Z,159.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
786,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,05-Nov-1982,08:30,0,98,98.08611111,Days,PK,Plasma concentration Z,121.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
787,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Nov-1982,09:16,0,112,110.1180556,Days,PK,Plasma concentration Z,58.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
788,NaN,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,18-Nov-1982,10:08,0,112,111.1541667,Days,PD,Efficacy marker,50.9,,mm,NaN,NaN,,NaN,NaN,NaN
789,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,21-Jun-1982,07:00,0,-14,-34.96041667,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
790,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,21-Jun-1982,07:00,0,-14,-34.96041667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
791,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,21-Jun-1982,07:00,0,-14,-34.96041667,Days,Demographics,Weight,56.8,,kg,NaN,NaN,,NaN,NaN,NaN
792,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-Jul-1982,07:00,0,0,-3.960416667,Days,Demographics,Weight,58,,kg,NaN,NaN,,NaN,NaN,NaN
793,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-Jul-1982,10:32,0,0,-3.813194444,Days,PD,Efficacy marker,27.844,,mm,NaN,NaN,,NaN,NaN,NaN
794,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-Jul-1982,05:23,0,0,-0.027777778,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
795,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-Jul-1982,06:03,0.0833333333721384,0,0,Days,Dose,Dose Z,290.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
796,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-Jul-1982,08:09,0,0.0833,0.0875,Days,PK,Plasma concentration Z,872.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
797,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,18-Aug-1982,15:54,0,28,23.41041667,Days,PD,Efficacy marker,30.331,,mm,NaN,NaN,,NaN,NaN,NaN
798,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Aug-1982,16:03,0,28,26.41666667,Days,PK,Plasma concentration Z,41.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
799,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,15-Sep-1982,08:37,0,56,51.10694444,Days,PK,Plasma concentration Z,8.979,,ug/ml,NaN,0.8,,NaN,NaN,NaN
800,NaN,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,15-Sep-1982,10:21,0,56,51.17916667,Days,PD,Efficacy marker,31.06,,mm,NaN,NaN,,NaN,NaN,NaN
801,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Jul-1982,07:00,0,-14,-35.97777778,Days,Demographics,Age,74,,Years,NaN,NaN,,NaN,NaN,NaN
802,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Jul-1982,07:00,0,-14,-35.97777778,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
803,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Jul-1982,07:00,0,-14,-35.97777778,Days,Demographics,Weight,77.9,,kg,NaN,NaN,,NaN,NaN,NaN
804,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,18-Aug-1982,07:00,0,0,-3.977777778,Days,Demographics,Weight,78.2,,kg,NaN,NaN,,NaN,NaN,NaN
805,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,18-Aug-1982,12:57,0,0,-3.729861111,Days,PD,Efficacy marker,35.687,,mm,NaN,NaN,,NaN,NaN,NaN
806,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,22-Aug-1982,06:07,0,0,-0.014583333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
807,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,22-Aug-1982,06:28,0.0833333333721384,0,0,Days,Dose,Dose Z,396,,mg,NaN,NaN,iv,NaN,NaN,NaN
808,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,22-Aug-1982,08:41,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,446.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
809,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,15-Sep-1982,15:26,0,28,24.37361111,Days,PD,Efficacy marker,38.397,,mm,NaN,NaN,,NaN,NaN,NaN
810,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-Sep-1982,05:56,0,28,27.97777778,Days,PK,Plasma concentration Z,40.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
811,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-Sep-1982,06:30,0.0833333332557231,28,28.00138889,Days,Dose,Dose Z,396.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
812,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-Sep-1982,08:43,0,28,28.09375,Days,PK,Plasma concentration Z,488.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
813,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,13-Oct-1982,10:26,0,56,52.16527778,Days,PD,Efficacy marker,38.811,,mm,NaN,NaN,,NaN,NaN,NaN
814,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-Oct-1982,06:11,0,56,55.98819444,Days,PK,Plasma concentration Z,58.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
815,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-Oct-1982,06:25,0.0833333333721384,56,55.99791667,Days,Dose,Dose Z,403.75,,mg,NaN,NaN,iv,NaN,NaN,NaN
816,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-Oct-1982,08:35,0,56,56.08819444,Days,PK,Plasma concentration Z,438,,ug/ml,NaN,0.8,,NaN,NaN,NaN
817,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,11-Nov-1982,10:12,0,84,81.15555556,Days,PD,Efficacy marker,39.442,,mm,NaN,NaN,,NaN,NaN,NaN
818,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Nov-1982,06:12,0,84,83.98888889,Days,PK,Plasma concentration Z,106.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
819,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Nov-1982,06:25,0.0833333333721384,84,83.99791667,Days,Dose,Dose Z,408.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
820,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Nov-1982,08:40,0,84,84.09166667,Days,PK,Plasma concentration Z,576,,ug/ml,NaN,0.8,,NaN,NaN,NaN
821,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Nov-1982,10:25,0,84,84.16458333,Days,PK,Plasma concentration Z,537.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
822,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Nov-1982,12:25,0,84,84.24791667,Days,PK,Plasma concentration Z,525.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
823,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,19-Nov-1982,12:15,0,91,89.24097222,Days,PK,Plasma concentration Z,236.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
824,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,28-Nov-1982,07:04,0,98,98.025,Days,PK,Plasma concentration Z,127.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
825,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,09-Dec-1982,14:44,0,112,109.3444444,Days,PD,Efficacy marker,39.048,,mm,NaN,NaN,,NaN,NaN,NaN
826,NaN,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-Dec-1982,06:47,0,112,115.0131944,Days,PK,Plasma concentration Z,0.474,,ug/ml,NaN,0.8,,NaN,NaN,NaN
827,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,22-Jul-1982,07:00,0,-14,-34.975,Days,Demographics,Age,74,,Years,NaN,NaN,,NaN,NaN,NaN
828,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,22-Jul-1982,07:00,0,-14,-34.975,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
829,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,22-Jul-1982,07:00,0,-14,-34.975,Days,Demographics,Weight,73.55,,kg,NaN,NaN,,NaN,NaN,NaN
830,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Aug-1982,07:00,0,0,-4.975,Days,Demographics,Weight,73.05,,kg,NaN,NaN,,NaN,NaN,NaN
831,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Aug-1982,08:07,0,0,-4.928472222,Days,PD,Efficacy marker,27.126,,mm,NaN,NaN,,NaN,NaN,NaN
832,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-Aug-1982,06:24,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
833,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-Sep-1982,06:33,0.0833333332557231,28,28.00625,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
834,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-Oct-1982,16:30,0,28,36.42083333,Days,PD,Efficacy marker,26.562,,mm,NaN,NaN,,NaN,NaN,NaN
835,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,21-Oct-1982,06:35,0.0833333333721384,56,56.00763889,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
836,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,01-Nov-1982,08:41,0,56,67.09513889,Days,PD,Efficacy marker,28.052,,mm,NaN,NaN,,NaN,NaN,NaN
837,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,14-Nov-1982,10:32,0,84,80.17222222,Days,PD,Efficacy marker,27.347,,mm,NaN,NaN,,NaN,NaN,NaN
838,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-Nov-1982,06:30,0.0833333332557231,84,84.00416667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
839,NaN,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,15-Dec-1982,10:02,0,112,111.1513889,Days,PD,Efficacy marker,27.011,,mm,NaN,NaN,,NaN,NaN,NaN
840,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-33.05069444,Days,Demographics,Age,70,,Years,NaN,NaN,,NaN,NaN,NaN
841,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-33.05069444,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
842,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-33.05069444,Days,Demographics,Weight,84.7,,kg,NaN,NaN,,NaN,NaN,NaN
843,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-Aug-1982,07:00,0,0,-5.050694444,Days,Demographics,Weight,84.4,,kg,NaN,NaN,,NaN,NaN,NaN
844,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-Aug-1982,10:10,0,0,-4.91875,Days,PD,Efficacy marker,35.643,,mm,NaN,NaN,,NaN,NaN,NaN
845,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,27-Aug-1982,07:57,0,0,-0.011111111,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
846,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,27-Aug-1982,08:13,0.0833333333721384,0,0,Days,Dose,Dose Z,427.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
847,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,27-Aug-1982,10:25,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,446.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
848,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-Sep-1982,10:31,0,28,23.09583333,Days,PD,Efficacy marker,37.549,,mm,NaN,NaN,,NaN,NaN,NaN
849,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-Sep-1982,14:50,0,28,27.27569444,Days,PK,Plasma concentration Z,29.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
850,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-Oct-1982,10:06,0,56,51.07847222,Days,PD,Efficacy marker,37.631,,mm,NaN,NaN,,NaN,NaN,NaN
851,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,22-Oct-1982,13:14,0,56,56.20902778,Days,PK,Plasma concentration Z,4.86,,ug/ml,NaN,0.8,,NaN,NaN,NaN
852,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,17-Nov-1982,10:28,0,84,82.09375,Days,PD,Efficacy marker,36.779,,mm,NaN,NaN,,NaN,NaN,NaN
853,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,17-Nov-1982,12:09,0,84,82.16388889,Days,PK,Plasma concentration Z,94.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
854,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,27-Nov-1982,09:57,0,91,92.07222222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
855,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,03-Dec-1982,09:45,0,98,98.06388889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
856,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-Dec-1982,14:58,0,112,110.28125,Days,PD,Efficacy marker,36.926,,mm,NaN,NaN,,NaN,NaN,NaN
857,NaN,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Dec-1982,11:54,0,112,112.1534722,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
858,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-28.98402778,Days,Demographics,Age,57,,Years,NaN,NaN,,NaN,NaN,NaN
859,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-28.98402778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
860,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-28.98402778,Days,Demographics,Weight,56.9,,kg,NaN,NaN,,NaN,NaN,NaN
861,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,18-Aug-1982,07:00,0,0,-4.984027778,Days,Demographics,Weight,56.7,,kg,NaN,NaN,,NaN,NaN,NaN
862,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,20-Aug-1982,19:09,0,0,-2.477777778,Days,PD,Efficacy marker,23.656,,mm,NaN,NaN,,NaN,NaN,NaN
863,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,23-Aug-1982,06:37,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
864,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,15-Sep-1982,18:08,0,28,23.47986111,Days,PD,Efficacy marker,23.49,,mm,NaN,NaN,,NaN,NaN,NaN
865,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,20-Sep-1982,06:45,0.0833333333721384,28,28.00555556,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
866,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,13-Oct-1982,18:27,0,56,51.49305556,Days,PD,Efficacy marker,24.083,,mm,NaN,NaN,,NaN,NaN,NaN
867,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,18-Oct-1982,06:13,0.0833333332557231,56,55.98333333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
868,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,11-Nov-1982,17:54,0,84,80.47013889,Days,PD,Efficacy marker,23.888,,mm,NaN,NaN,,NaN,NaN,NaN
869,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,15-Nov-1982,06:01,0.0833333333721384,84,83.975,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
870,NaN,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,10-Dec-1982,17:38,0,112,109.4590278,Days,PD,Efficacy marker,23.001,,mm,NaN,NaN,,NaN,NaN,NaN
871,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Jul-1982,07:00,0,-14,-46.0625,Days,Demographics,Age,72,,Years,NaN,NaN,,NaN,NaN,NaN
872,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Jul-1982,07:00,0,-14,-46.0625,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
873,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Jul-1982,07:00,0,-14,-46.0625,Days,Demographics,Weight,55.2,,kg,NaN,NaN,,NaN,NaN,NaN
874,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,08-Sep-1982,07:00,0,0,-5.0625,Days,Demographics,Weight,57.7,,kg,NaN,NaN,,NaN,NaN,NaN
875,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,08-Sep-1982,15:47,0,0,-4.696527778,Days,PD,Efficacy marker,22.119,,mm,NaN,NaN,,NaN,NaN,NaN
876,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,13-Sep-1982,08:30,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
877,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,11-Oct-1982,09:15,0.0833333333721384,28,28.03125,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
878,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,17-Oct-1982,17:40,0,28,34.38194444,Days,PD,Efficacy marker,22.273,,mm,NaN,NaN,,NaN,NaN,NaN
879,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,08-Nov-1982,07:25,0.0833333333721384,56,55.95486111,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
880,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,17-Nov-1982,18:18,0,56,65.40833333,Days,PD,Efficacy marker,21.28,,mm,NaN,NaN,,NaN,NaN,NaN
881,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,06-Dec-1982,07:35,0.0833333332557231,84,83.96180556,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
882,NaN,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,31-Dec-1982,10:01,0,112,109.0631944,Days,PD,Efficacy marker,20.937,,mm,NaN,NaN,,NaN,NaN,NaN
883,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-32.00902778,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
884,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-32.00902778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
885,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Jul-1982,07:00,0,-14,-32.00902778,Days,Demographics,Weight,70.9,,kg,NaN,NaN,,NaN,NaN,NaN
886,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Aug-1982,07:00,0,0,-5.009027778,Days,Demographics,Weight,70.3,,kg,NaN,NaN,,NaN,NaN,NaN
887,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Aug-1982,18:59,0,0,-4.509722222,Days,PD,Efficacy marker,27.182,,mm,NaN,NaN,,NaN,NaN,NaN
888,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-Aug-1982,07:13,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
889,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-Sep-1982,15:39,0,28,23.35138889,Days,PD,Efficacy marker,27.423,,mm,NaN,NaN,,NaN,NaN,NaN
890,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-Sep-1982,08:10,0.0833333333721384,28,28.03958333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
891,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,17-Oct-1982,14:03,0,56,52.28472222,Days,PD,Efficacy marker,27.49,,mm,NaN,NaN,,NaN,NaN,NaN
892,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,21-Oct-1982,09:06,0.0833333333721384,56,56.07847222,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
893,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-Nov-1982,08:05,0.0833333333721384,84,84.03611111,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
894,NaN,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,16-Dec-1982,10:18,0,112,112.1284722,Days,PD,Efficacy marker,27.609,,mm,NaN,NaN,,NaN,NaN,NaN
895,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-Jul-1982,07:00,0,-14,-25.98888889,Days,Demographics,Age,70,,Years,NaN,NaN,,NaN,NaN,NaN
896,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-Jul-1982,07:00,0,-14,-25.98888889,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
897,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-Jul-1982,07:00,0,-14,-25.98888889,Days,Demographics,Weight,80.8,,kg,NaN,NaN,,NaN,NaN,NaN
898,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,21-Aug-1982,07:00,0,0,-4.988888889,Days,Demographics,Weight,83.4,,kg,NaN,NaN,,NaN,NaN,NaN
899,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,21-Aug-1982,15:11,0,0,-4.647916667,Days,PD,Efficacy marker,44.362,,mm,NaN,NaN,,NaN,NaN,NaN
900,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-Aug-1982,06:31,0,0,-0.009027778,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
901,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-Aug-1982,06:44,0.0833333332557231,0,0,Days,Dose,Dose Z,411.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
902,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-Aug-1982,09:00,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,374.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
903,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,18-Sep-1982,16:25,0,28,23.40347222,Days,PD,Efficacy marker,47.323,,mm,NaN,NaN,,NaN,NaN,NaN
904,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-Sep-1982,06:16,0,28,27.98055556,Days,PK,Plasma concentration Z,41.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
905,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-Sep-1982,06:45,0.0833333333721384,28,28.00069444,Days,Dose,Dose Z,418,,mg,NaN,NaN,iv,NaN,NaN,NaN
906,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-Sep-1982,09:00,0,28,28.09444444,Days,PK,Plasma concentration Z,687.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
907,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,16-Oct-1982,15:31,0,56,51.36597222,Days,PD,Efficacy marker,48.645,,mm,NaN,NaN,,NaN,NaN,NaN
908,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-Oct-1982,06:20,0,56,55.98333333,Days,PK,Plasma concentration Z,62.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
909,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-Oct-1982,06:40,0.0833333333721384,56,55.99722222,Days,Dose,Dose Z,421.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
910,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-Oct-1982,08:46,0,56,56.08472222,Days,PK,Plasma concentration Z,590.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
911,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,13-Nov-1982,14:53,0,84,79.33958333,Days,PD,Efficacy marker,48.546,,mm,NaN,NaN,,NaN,NaN,NaN
912,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Nov-1982,06:28,0,84,83.98888889,Days,PK,Plasma concentration Z,74.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
913,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Nov-1982,06:40,0.0833333333721384,84,83.99722222,Days,Dose,Dose Z,420.75,,mg,NaN,NaN,iv,NaN,NaN,NaN
914,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Nov-1982,08:54,0,84,84.09027778,Days,PK,Plasma concentration Z,354,,ug/ml,NaN,0.8,,NaN,NaN,NaN
915,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Nov-1982,10:40,0,84,84.16388889,Days,PK,Plasma concentration Z,588,,ug/ml,NaN,0.8,,NaN,NaN,NaN
916,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Nov-1982,12:40,0,84,84.24722222,Days,PK,Plasma concentration Z,537.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
917,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,25-Nov-1982,08:55,0,91,91.09097222,Days,PK,Plasma concentration Z,170.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
918,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,01-Dec-1982,08:56,0,98,97.09166667,Days,PK,Plasma concentration Z,132.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
919,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-Dec-1982,07:33,0,112,111.0340278,Days,PK,Plasma concentration Z,155.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
920,NaN,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Dec-1982,10:06,0,112,113.1402778,Days,PD,Efficacy marker,48.769,,mm,NaN,NaN,,NaN,NaN,NaN
921,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,28-Jul-1982,07:00,0,-14,-30.97986111,Days,Demographics,Age,53,,Years,NaN,NaN,,NaN,NaN,NaN
922,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,28-Jul-1982,07:00,0,-14,-30.97986111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
923,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,28-Jul-1982,07:00,0,-14,-30.97986111,Days,Demographics,Weight,81.2,,kg,NaN,NaN,,NaN,NaN,NaN
924,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-Aug-1982,07:00,0,0,-5.979861111,Days,Demographics,Weight,80,,kg,NaN,NaN,,NaN,NaN,NaN
925,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,26-Aug-1982,20:12,0,0,-1.429861111,Days,PD,Efficacy marker,42.391,,mm,NaN,NaN,,NaN,NaN,NaN
926,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,28-Aug-1982,06:02,0,0,-0.020138889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
927,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,28-Aug-1982,06:31,0.0833333333721384,0,0,Days,Dose,Dose Z,401,,mg,NaN,NaN,iv,NaN,NaN,NaN
928,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,28-Aug-1982,08:46,0,0.0833,0.09375,Days,PK,Plasma concentration Z,486,,ug/ml,NaN,0.8,,NaN,NaN,NaN
929,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-Sep-1982,15:27,0,28,22.37222222,Days,PD,Efficacy marker,44.477,,mm,NaN,NaN,,NaN,NaN,NaN
930,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-Sep-1982,06:15,0,28,27.98888889,Days,PK,Plasma concentration Z,35.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
931,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-Sep-1982,06:40,0.0833333333721384,28,28.00625,Days,Dose,Dose Z,412.25,,mg,NaN,NaN,iv,NaN,NaN,NaN
932,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-Sep-1982,08:51,0,28,28.09722222,Days,PK,Plasma concentration Z,446.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
933,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,20-Oct-1982,15:19,0,56,53.36666667,Days,PD,Efficacy marker,45.717,,mm,NaN,NaN,,NaN,NaN,NaN
934,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-Oct-1982,06:35,0,56,56.00277778,Days,PK,Plasma concentration Z,52.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
935,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-Oct-1982,07:00,0.0833333333721384,56,56.02013889,Days,Dose,Dose Z,407.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
936,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-Oct-1982,09:15,0,56,56.11388889,Days,PK,Plasma concentration Z,225.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
937,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Nov-1982,15:44,0,84,78.38402778,Days,PD,Efficacy marker,45.549,,mm,NaN,NaN,,NaN,NaN,NaN
938,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-Nov-1982,06:45,0,84,84.00972222,Days,PK,Plasma concentration Z,138.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
939,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-Nov-1982,07:00,0.0833333333721384,84,84.02013889,Days,Dose,Dose Z,398.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
940,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-Nov-1982,09:12,0,84,84.11180556,Days,PK,Plasma concentration Z,410.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
941,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-Nov-1982,11:00,0,84,84.18680556,Days,PK,Plasma concentration Z,555.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
942,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-Nov-1982,13:00,0,84,84.27013889,Days,PK,Plasma concentration Z,494.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
943,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,27-Nov-1982,09:17,0,91,91.11527778,Days,PK,Plasma concentration Z,193.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
944,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,03-Dec-1982,13:30,0,98,97.29097222,Days,PK,Plasma concentration Z,144.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
945,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Dec-1982,12:43,0,112,111.2583333,Days,PK,Plasma concentration Z,89.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
946,NaN,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,19-Dec-1982,16:15,0,112,113.4055556,Days,PD,Efficacy marker,46.231,,mm,NaN,NaN,,NaN,NaN,NaN
947,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,31-Jul-1982,07:00,0,-14,-49.01388889,Days,Demographics,Age,64,,Years,NaN,NaN,,NaN,NaN,NaN
948,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,31-Jul-1982,07:00,0,-14,-49.01388889,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
949,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,31-Jul-1982,07:00,0,-14,-49.01388889,Days,Demographics,Weight,58.9,,kg,NaN,NaN,,NaN,NaN,NaN
950,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,15-Sep-1982,06:54,0,0,-3.018055556,Days,PD,Efficacy marker,27.893,,mm,NaN,NaN,,NaN,NaN,NaN
951,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,15-Sep-1982,07:00,0,0,-3.013888889,Days,Demographics,Weight,58.6,,kg,NaN,NaN,,NaN,NaN,NaN
952,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,18-Sep-1982,07:20,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
953,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,13-Oct-1982,16:22,0,28,25.37638889,Days,PD,Efficacy marker,29.076,,mm,NaN,NaN,,NaN,NaN,NaN
954,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,16-Oct-1982,08:10,0.0833333333721384,28,28.03472222,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
955,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,08-Nov-1982,07:50,0,56,51.02083333,Days,PD,Efficacy marker,29.042,,mm,NaN,NaN,,NaN,NaN,NaN
956,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,13-Nov-1982,07:15,0.0833333332557231,56,55.99652778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
957,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,11-Dec-1982,07:55,0.0833333333721384,84,84.02430556,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
958,NaN,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,05-Jan-1983,09:06,0,112,109.0736111,Days,PD,Efficacy marker,29.092,,mm,NaN,NaN,,NaN,NaN,NaN
959,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,05-Aug-1982,07:00,0,-14,-17.99166667,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
960,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,05-Aug-1982,07:00,0,-14,-17.99166667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
961,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,05-Aug-1982,07:00,0,-14,-17.99166667,Days,Demographics,Weight,66.75,,kg,NaN,NaN,,NaN,NaN,NaN
962,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,20-Aug-1982,07:00,0,0,-2.991666667,Days,Demographics,Weight,69,,kg,NaN,NaN,,NaN,NaN,NaN
963,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-Aug-1982,09:32,0,0,-0.886111111,Days,PD,Efficacy marker,38.089,,mm,NaN,NaN,,NaN,NaN,NaN
964,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-Aug-1982,06:12,0,0,-0.025,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
965,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-Aug-1982,06:48,0.0833333333721384,0,0,Days,Dose,Dose Z,341,,mg,NaN,NaN,iv,NaN,NaN,NaN
966,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-Aug-1982,09:00,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,381.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
967,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,15-Sep-1982,18:52,0,28,23.50277778,Days,PD,Efficacy marker,38.275,,mm,NaN,NaN,,NaN,NaN,NaN
968,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-Sep-1982,05:38,0,28,27.95138889,Days,PK,Plasma concentration Z,16.899,,ug/ml,NaN,0.8,,NaN,NaN,NaN
969,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-Sep-1982,06:40,0.0833333333721384,28,27.99444444,Days,Dose,Dose Z,343.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
970,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-Sep-1982,08:56,0,28,28.08888889,Days,PK,Plasma concentration Z,261.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
971,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,13-Oct-1982,06:24,0,56,50.98333333,Days,PD,Efficacy marker,39.207,,mm,NaN,NaN,,NaN,NaN,NaN
972,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-Oct-1982,05:30,0,56,55.94583333,Days,PK,Plasma concentration Z,52.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
973,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-Oct-1982,05:58,0.0833333333721384,56,55.96527778,Days,Dose,Dose Z,346,,mg,NaN,NaN,iv,NaN,NaN,NaN
974,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-Oct-1982,08:10,0,56,56.05694444,Days,PK,Plasma concentration Z,486,,ug/ml,NaN,0.8,,NaN,NaN,NaN
975,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,11-Nov-1982,06:41,0,84,79.99513889,Days,PD,Efficacy marker,40.78,,mm,NaN,NaN,,NaN,NaN,NaN
976,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-Nov-1982,05:44,0,84,83.95555556,Days,PK,Plasma concentration Z,87.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
977,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-Nov-1982,06:00,0.0833333333721384,84,83.96666667,Days,Dose,Dose Z,351,,mg,NaN,NaN,iv,NaN,NaN,NaN
978,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-Nov-1982,08:12,0,84,84.05833333,Days,PK,Plasma concentration Z,492,,ug/ml,NaN,0.8,,NaN,NaN,NaN
979,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-Nov-1982,10:00,0,84,84.13333333,Days,PK,Plasma concentration Z,555.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
980,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-Nov-1982,12:00,0,84,84.21666667,Days,PK,Plasma concentration Z,512.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
981,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,22-Nov-1982,08:49,0,91,91.08402778,Days,PK,Plasma concentration Z,230.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
982,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,27-Nov-1982,15:24,0,98,96.35833333,Days,PK,Plasma concentration Z,165.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
983,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-Dec-1982,06:16,0,112,113.9777778,Days,PD,Efficacy marker,40.58,,mm,NaN,NaN,,NaN,NaN,NaN
984,NaN,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-Dec-1982,07:24,0,112,114.025,Days,PK,Plasma concentration Z,188.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
985,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-Aug-1982,07:00,0,-14,-21.02222222,Days,Demographics,Age,54,,Years,NaN,NaN,,NaN,NaN,NaN
986,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-Aug-1982,07:00,0,-14,-21.02222222,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
987,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-Aug-1982,07:00,0,-14,-21.02222222,Days,Demographics,Weight,94.7,,kg,NaN,NaN,,NaN,NaN,NaN
988,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Aug-1982,07:00,0,0,-5.022222222,Days,Demographics,Weight,95.2,,kg,NaN,NaN,,NaN,NaN,NaN
989,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Aug-1982,19:48,0,0,-4.488888889,Days,PD,Efficacy marker,48.788,,mm,NaN,NaN,,NaN,NaN,NaN
990,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-Aug-1982,07:32,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
991,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-Sep-1982,10:40,0,28,23.13055556,Days,PD,Efficacy marker,49.47,,mm,NaN,NaN,,NaN,NaN,NaN
992,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-Sep-1982,08:00,0.0833333332557231,28,28.01944444,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
993,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-Oct-1982,16:39,0,56,51.37986111,Days,PD,Efficacy marker,49.073,,mm,NaN,NaN,,NaN,NaN,NaN
994,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,21-Oct-1982,07:55,0.0833333333721384,56,56.01597222,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
995,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-Nov-1982,10:56,0,84,79.14166667,Days,PD,Efficacy marker,50.02,,mm,NaN,NaN,,NaN,NaN,NaN
996,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-Nov-1982,07:50,0.0833333333721384,84,84.0125,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
997,NaN,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,18-Dec-1982,10:01,0,112,114.1034722,Days,PD,Efficacy marker,49.802,,mm,NaN,NaN,,NaN,NaN,NaN
998,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Aug-1982,07:00,0,-14,-28.23611111,Days,Demographics,Age,57,,Years,NaN,NaN,,NaN,NaN,NaN
999,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Aug-1982,07:00,0,-14,-28.23611111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1000,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-Aug-1982,07:00,0,-14,-28.23611111,Days,Demographics,Weight,73.4,,kg,NaN,NaN,,NaN,NaN,NaN
1001,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,01-Sep-1982,07:00,0,0,-8.236111111,Days,Demographics,Weight,74,,kg,NaN,NaN,,NaN,NaN,NaN
1002,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,06-Sep-1982,11:07,0,0,-3.064583333,Days,PD,Efficacy marker,25.292,,mm,NaN,NaN,,NaN,NaN,NaN
1003,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,09-Sep-1982,12:40,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1004,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-Oct-1982,15:25,0,28,23.11458333,Days,PD,Efficacy marker,25.183,,mm,NaN,NaN,,NaN,NaN,NaN
1005,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-Oct-1982,07:20,0.0833333333721384,28,27.77777778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1006,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-Nov-1982,20:06,0,56,56.30972222,Days,PD,Efficacy marker,24.529,,mm,NaN,NaN,,NaN,NaN,NaN
1007,NaN,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,06-Nov-1982,07:15,0.0833333332557231,56,57.77430556,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1008,NaN,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-24.99861111,Days,Demographics,Age,71,,Years,NaN,NaN,,NaN,NaN,NaN
1009,NaN,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-24.99861111,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1010,NaN,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-24.99861111,Days,Demographics,Weight,75.2,,kg,NaN,NaN,,NaN,NaN,NaN
1011,NaN,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-Aug-1982,07:00,0,0,-4.998611111,Days,Demographics,Weight,75.8,,kg,NaN,NaN,,NaN,NaN,NaN
1012,NaN,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-Aug-1982,14:54,0,0,-4.669444444,Days,PD,Efficacy marker,37.964,,mm,NaN,NaN,,NaN,NaN,NaN
1013,NaN,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,02-Sep-1982,06:58,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1014,NaN,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,25-Sep-1982,16:30,0,28,23.39722222,Days,PD,Efficacy marker,38.541,,mm,NaN,NaN,,NaN,NaN,NaN
1015,NaN,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,30-Sep-1982,06:55,0.0833333332557231,28,27.99791667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1016,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-36.01736111,Days,Demographics,Age,53,,Years,NaN,NaN,,NaN,NaN,NaN
1017,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-36.01736111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1018,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-36.01736111,Days,Demographics,Weight,79.9,,kg,NaN,NaN,,NaN,NaN,NaN
1019,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,08-Sep-1982,17:47,0,0,-4.568055556,Days,PD,Efficacy marker,40.578,,mm,NaN,NaN,,NaN,NaN,NaN
1020,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-Sep-1982,07:00,0,0,-4.017361111,Days,Demographics,Weight,80.1,,kg,NaN,NaN,,NaN,NaN,NaN
1021,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-Sep-1982,07:13,0,0,-0.008333333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1022,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-Sep-1982,07:25,0.0833333333721384,0,0,Days,Dose,Dose Z,399,,mg,NaN,NaN,iv,NaN,NaN,NaN
1023,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-Sep-1982,09:38,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,416.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1024,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,08-Oct-1982,17:04,0,28,25.40208333,Days,PD,Efficacy marker,43.147,,mm,NaN,NaN,,NaN,NaN,NaN
1025,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-Oct-1982,07:19,0,28,27.99583333,Days,PK,Plasma concentration Z,48.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1026,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-Oct-1982,07:39,0.0833333333721384,28,28.00972222,Days,Dose,Dose Z,396.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1027,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-Oct-1982,09:51,0,28,28.10138889,Days,PK,Plasma concentration Z,558,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1028,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-Nov-1982,17:43,0,56,52.42916667,Days,PD,Efficacy marker,43.105,,mm,NaN,NaN,,NaN,NaN,NaN
1029,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-Nov-1982,06:06,0,56,55.94513889,Days,PK,Plasma concentration Z,78.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1030,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-Nov-1982,06:38,0.0833333332557231,56,55.96736111,Days,Dose,Dose Z,399,,mg,NaN,NaN,iv,NaN,NaN,NaN
1031,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-Nov-1982,08:50,0,56,56.05902778,Days,PK,Plasma concentration Z,600,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1032,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,06:55,0,84,83.97916667,Days,PK,Plasma concentration Z,108.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1033,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,07:15,0.0833333332557231,84,83.99305556,Days,Dose,Dose Z,391.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1034,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,09:29,0,84,84.08611111,Days,PK,Plasma concentration Z,582,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1035,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,11:15,0,84,84.15972222,Days,PK,Plasma concentration Z,579.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1036,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,13:15,0,84,84.24305556,Days,PK,Plasma concentration Z,602.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1037,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,13-Dec-1982,07:20,0,91,90.99652778,Days,PK,Plasma concentration Z,260.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1038,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,18-Dec-1982,05:57,0,98,95.93888889,Days,PK,Plasma concentration Z,183.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1039,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,03-Jan-1983,08:44,0,112,112.0548611,Days,PK,Plasma concentration Z,89.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1040,NaN,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-Jan-1983,12:05,0,112,114.1944444,Days,PD,Efficacy marker,44.554,,mm,NaN,NaN,,NaN,NaN,NaN
1041,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-23.98958333,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
1042,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-23.98958333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1043,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-23.98958333,Days,Demographics,Weight,73,,kg,NaN,NaN,,NaN,NaN,NaN
1044,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-Aug-1982,07:00,0,0,-3.989583333,Days,Demographics,Weight,72.6,,kg,NaN,NaN,,NaN,NaN,NaN
1045,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-Aug-1982,12:28,0,0,-3.761805556,Days,PD,Efficacy marker,28.065,,mm,NaN,NaN,,NaN,NaN,NaN
1046,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Sep-1982,06:25,0,0,-0.013888889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1047,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Sep-1982,06:45,0.0833333333721384,0,0,Days,Dose,Dose Z,368,,mg,NaN,NaN,iv,NaN,NaN,NaN
1048,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Sep-1982,09:02,0,0.0833,0.095138889,Days,PK,Plasma concentration Z,465.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1049,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-Sep-1982,15:12,0,28,24.35208333,Days,PD,Efficacy marker,29.647,,mm,NaN,NaN,,NaN,NaN,NaN
1050,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Sep-1982,06:28,0,28,27.98819444,Days,PK,Plasma concentration Z,51,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1051,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Sep-1982,07:00,0.0833333333721384,28,28.01041667,Days,Dose,Dose Z,372,,mg,NaN,NaN,iv,NaN,NaN,NaN
1052,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Sep-1982,09:13,0,28,28.10277778,Days,PK,Plasma concentration Z,660,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1053,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-Oct-1982,15:04,0,56,52.34652778,Days,PD,Efficacy marker,29.953,,mm,NaN,NaN,,NaN,NaN,NaN
1054,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-Oct-1982,07:04,0,56,56.01319444,Days,PK,Plasma concentration Z,60,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1055,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-Oct-1982,07:30,0.0833333333721384,56,56.03125,Days,Dose,Dose Z,373.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1056,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-Oct-1982,09:39,0,56,56.12083333,Days,PK,Plasma concentration Z,561.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1057,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Nov-1982,06:53,0,84,84.00555556,Days,PK,Plasma concentration Z,102.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1058,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Nov-1982,07:15,0.0833333332557231,84,84.02083333,Days,Dose,Dose Z,374.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1059,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Nov-1982,09:30,0,84,84.11458333,Days,PK,Plasma concentration Z,537.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1060,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Nov-1982,11:15,0,84,84.1875,Days,PK,Plasma concentration Z,590.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1061,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Nov-1982,13:15,0,84,84.27083333,Days,PK,Plasma concentration Z,570,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1062,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,01-Dec-1982,12:20,0,91,91.23263889,Days,PK,Plasma concentration Z,255.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1063,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,10-Dec-1982,13:51,0,98,100.2958333,Days,PK,Plasma concentration Z,198.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1064,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,22-Dec-1982,09:30,0,112,112.1145833,Days,PK,Plasma concentration Z,120.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1065,NaN,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,25-Dec-1982,13:10,0,112,115.2673611,Days,PD,Efficacy marker,30.905,,mm,NaN,NaN,,NaN,NaN,NaN
1066,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-35.96805556,Days,Demographics,Age,60,,Years,NaN,NaN,,NaN,NaN,NaN
1067,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-35.96805556,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1068,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-Aug-1982,07:00,0,-14,-35.96805556,Days,Demographics,Weight,79,,kg,NaN,NaN,,NaN,NaN,NaN
1069,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,08-Sep-1982,18:39,0,0,-4.482638889,Days,PD,Efficacy marker,31.018,,mm,NaN,NaN,,NaN,NaN,NaN
1070,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-Sep-1982,07:00,0,0,-3.968055556,Days,Demographics,Weight,80.5,,kg,NaN,NaN,,NaN,NaN,NaN
1071,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-Sep-1982,06:00,0,0,-0.009722222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1072,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-Sep-1982,06:14,0.0833333333721384,0,0,Days,Dose,Dose Z,398.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1073,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-Sep-1982,08:25,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,408,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1074,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-Oct-1982,17:44,0,28,23.47916667,Days,PD,Efficacy marker,32.014,,mm,NaN,NaN,,NaN,NaN,NaN
1075,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-Oct-1982,06:20,0,28,28.00416667,Days,PK,Plasma concentration Z,52.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1076,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-Oct-1982,06:42,0.0833333333721384,28,28.01944444,Days,Dose,Dose Z,400.25,,mg,NaN,NaN,iv,NaN,NaN,NaN
1077,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-Oct-1982,08:49,0,28,28.10763889,Days,PK,Plasma concentration Z,656.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1078,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Nov-1982,18:49,0,56,51.52430556,Days,PD,Efficacy marker,32.821,,mm,NaN,NaN,,NaN,NaN,NaN
1079,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-Nov-1982,06:02,0,56,55.99166667,Days,PK,Plasma concentration Z,102.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1080,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-Nov-1982,06:40,0.0833333333721384,56,56.01805556,Days,Dose,Dose Z,395,,mg,NaN,NaN,iv,NaN,NaN,NaN
1081,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-Nov-1982,08:52,0,56,56.10972222,Days,PK,Plasma concentration Z,570,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1082,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,06:20,0,84,84.00416667,Days,PK,Plasma concentration Z,87,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1083,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,06:35,0.0833333333721384,84,84.01458333,Days,Dose,Dose Z,396,,mg,NaN,NaN,iv,NaN,NaN,NaN
1084,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,08:48,0,84,84.10694444,Days,PK,Plasma concentration Z,4179.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1085,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,10:38,0,84,84.18333333,Days,PK,Plasma concentration Z,582,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1086,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Dec-1982,12:35,0,84,84.26458333,Days,PK,Plasma concentration Z,573.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1087,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,13-Dec-1982,07:00,0,91,91.03194444,Days,PK,Plasma concentration Z,243.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1088,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,18-Dec-1982,06:38,0,98,96.01666667,Days,PK,Plasma concentration Z,140.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1089,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,01-Jan-1983,16:57,0,112,110.4465278,Days,PD,Efficacy marker,34.19,,mm,NaN,NaN,,NaN,NaN,NaN
1090,NaN,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,03-Jan-1983,07:15,0,112,112.0423611,Days,PK,Plasma concentration Z,75.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1091,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42,Days,Demographics,Age,66,,Years,NaN,NaN,,NaN,NaN,NaN
1092,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1093,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42,Days,Demographics,Weight,76.2,,kg,NaN,NaN,,NaN,NaN,NaN
1094,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,27-Mar-1982,15:00,0,0,-4.666666667,Days,PD,Efficacy marker,44.078,,mm,NaN,NaN,,NaN,NaN,NaN
1095,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,31-Mar-1982,07:00,0,0,-1,Days,Demographics,Weight,78.8,,kg,NaN,NaN,,NaN,NaN,NaN
1096,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,01-Apr-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1097,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,29-Apr-1982,07:00,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1098,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,30-Apr-1982,09:07,0,28,29.08819444,Days,PD,Efficacy marker,44.711,,mm,NaN,NaN,,NaN,NaN,NaN
1099,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,22-May-1982,15:26,0,56,51.35138889,Days,PD,Efficacy marker,44.613,,mm,NaN,NaN,,NaN,NaN,NaN
1100,NaN,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,27-May-1982,07:00,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1101,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.00347222,Days,Demographics,Age,67,,Years,NaN,NaN,,NaN,NaN,NaN
1102,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.00347222,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1103,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.00347222,Days,Demographics,Weight,61.8,,kg,NaN,NaN,,NaN,NaN,NaN
1104,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-Mar-1982,15:48,0,0,-4.636805556,Days,PD,Efficacy marker,23.053,,mm,NaN,NaN,,NaN,NaN,NaN
1105,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,31-Mar-1982,07:00,0,0,-1.003472222,Days,Demographics,Weight,61.7,,kg,NaN,NaN,,NaN,NaN,NaN
1106,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Apr-1982,06:50,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1107,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Apr-1982,07:05,0.0833333333721384,0,0,Days,Dose,Dose Z,306.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1108,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Apr-1982,09:24,0,0.0833,0.096527778,Days,PK,Plasma concentration Z,554.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1109,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,24-Apr-1982,16:43,0,28,23.40138889,Days,PD,Efficacy marker,24.527,,mm,NaN,NaN,,NaN,NaN,NaN
1110,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Apr-1982,06:50,0,28,27.98958333,Days,PK,Plasma concentration Z,37.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1111,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Apr-1982,07:05,0.0833333333721384,28,28,Days,Dose,Dose Z,309.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1112,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Apr-1982,09:24,0,28,28.09652778,Days,PK,Plasma concentration Z,582,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1113,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,22-May-1982,17:06,0,56,51.41736111,Days,PD,Efficacy marker,26.111,,mm,NaN,NaN,,NaN,NaN,NaN
1114,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-May-1982,06:50,0,56,55.98958333,Days,PK,Plasma concentration Z,48.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1115,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-May-1982,07:05,0.0833333333721384,56,56,Days,Dose,Dose Z,310,,mg,NaN,NaN,iv,NaN,NaN,NaN
1116,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-May-1982,09:26,0,56,56.09791667,Days,PK,Plasma concentration Z,645.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1117,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,19-Jun-1982,15:55,0,84,79.36805556,Days,PD,Efficacy marker,26.637,,mm,NaN,NaN,,NaN,NaN,NaN
1118,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jun-1982,06:50,0,84,83.98958333,Days,PK,Plasma concentration Z,59.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1119,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jun-1982,07:05,0.0833333333721384,84,84,Days,Dose,Dose Z,308,,mg,NaN,NaN,iv,NaN,NaN,NaN
1120,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jun-1982,09:05,0,84,84.08333333,Days,PK,Plasma concentration Z,525.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1121,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jun-1982,11:05,0,84,84.16666667,Days,PK,Plasma concentration Z,678,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1122,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-Jun-1982,13:05,0,84,84.25,Days,PK,Plasma concentration Z,638.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1123,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,01-Jul-1982,07:05,0,91,91,Days,PK,Plasma concentration Z,177.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1124,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,08-Jul-1982,07:05,0,98,98,Days,PK,Plasma concentration Z,110.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1125,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,21-Jul-1982,15:31,0,112,111.3513889,Days,PD,Efficacy marker,27.734,,mm,NaN,NaN,,NaN,NaN,NaN
1126,NaN,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,22-Jul-1982,07:05,0,112,112,Days,PK,Plasma concentration Z,74.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1127,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.00694444,Days,Demographics,Age,59,,Years,NaN,NaN,,NaN,NaN,NaN
1128,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.00694444,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1129,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.00694444,Days,Demographics,Weight,77.6,,kg,NaN,NaN,,NaN,NaN,NaN
1130,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,27-Mar-1982,16:56,0,0,-4.593055556,Days,PD,Efficacy marker,30.247,,mm,NaN,NaN,,NaN,NaN,NaN
1131,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,31-Mar-1982,07:00,0,0,-1.006944444,Days,Demographics,Weight,77.4,,kg,NaN,NaN,,NaN,NaN,NaN
1132,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,01-Apr-1982,07:10,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1133,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,29-Apr-1982,07:10,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1134,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,03-May-1982,08:56,0,28,32.07361111,Days,PD,Efficacy marker,30.796,,mm,NaN,NaN,,NaN,NaN,NaN
1135,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,22-May-1982,16:44,0,56,51.39861111,Days,PD,Efficacy marker,31.835,,mm,NaN,NaN,,NaN,NaN,NaN
1136,NaN,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,27-May-1982,07:10,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1137,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.01041667,Days,Demographics,Age,75,,Years,NaN,NaN,,NaN,NaN,NaN
1138,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.01041667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1139,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-Feb-1982,07:00,0,-14,-42.01041667,Days,Demographics,Weight,72.8,,kg,NaN,NaN,,NaN,NaN,NaN
1140,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-Mar-1982,17:29,0,0,-4.573611111,Days,PD,Efficacy marker,26.459,,mm,NaN,NaN,,NaN,NaN,NaN
1141,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,31-Mar-1982,07:00,0,0,-1.010416667,Days,Demographics,Weight,75.6,,kg,NaN,NaN,,NaN,NaN,NaN
1142,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Apr-1982,07:00,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1143,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Apr-1982,07:15,0.0833333332557231,0,0,Days,Dose,Dose Z,372,,mg,NaN,NaN,iv,NaN,NaN,NaN
1144,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-Apr-1982,09:39,0,0.166,0.1,Days,PK,Plasma concentration Z,594,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1145,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Apr-1982,07:00,0,28,27.98958333,Days,PK,Plasma concentration Z,44.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1146,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Apr-1982,07:15,0.0833333332557231,28,28,Days,Dose,Dose Z,383,,mg,NaN,NaN,iv,NaN,NaN,NaN
1147,NaN,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-Apr-1982,09:33,0,28,28.09583333,Days,PK,Plasma concentration Z,650.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1148,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,19-Feb-1982,07:00,0,-14,-43,Days,Demographics,Age,51,,Years,NaN,NaN,,NaN,NaN,NaN
1149,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,19-Feb-1982,07:00,0,-14,-43,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1150,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,19-Feb-1982,07:00,0,-14,-43,Days,Demographics,Weight,97.8,,kg,NaN,NaN,,NaN,NaN,NaN
1151,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,01-Apr-1982,18:34,0,0,-1.518055556,Days,PD,Efficacy marker,55.36,,mm,NaN,NaN,,NaN,NaN,NaN
1152,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,02-Apr-1982,07:00,0,0,-1,Days,Demographics,Weight,97,,kg,NaN,NaN,,NaN,NaN,NaN
1153,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-Apr-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1154,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,30-Apr-1982,14:49,0,28,27.32569444,Days,PD,Efficacy marker,54.873,,mm,NaN,NaN,,NaN,NaN,NaN
1155,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-May-1982,07:00,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1156,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-May-1982,07:00,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1157,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,31-May-1982,10:45,0,56,58.15625,Days,PD,Efficacy marker,53.825,,mm,NaN,NaN,,NaN,NaN,NaN
1158,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-Jun-1982,08:27,0,84,79.06041667,Days,PD,Efficacy marker,58.472,,mm,NaN,NaN,,NaN,NaN,NaN
1159,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-Jun-1982,07:02,0.0833333333721384,84,84.00138889,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1160,NaN,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,08-Aug-1982,17:43,0,112,127.4465278,Days,PD,Efficacy marker,55.334,,mm,NaN,NaN,,NaN,NaN,NaN
1161,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-37.00347222,Days,Demographics,Age,67,,Years,NaN,NaN,,NaN,NaN,NaN
1162,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-37.00347222,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1163,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-37.00347222,Days,Demographics,Weight,54.9,,kg,NaN,NaN,,NaN,NaN,NaN
1164,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-Mar-1982,10:17,0,0,-4.866666667,Days,PD,Efficacy marker,21.507,,mm,NaN,NaN,,NaN,NaN,NaN
1165,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,02-Apr-1982,07:00,0,0,-1.003472222,Days,Demographics,Weight,55.9,,kg,NaN,NaN,,NaN,NaN,NaN
1166,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-Apr-1982,07:05,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1167,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-Apr-1982,08:32,0,28,23.06041667,Days,PD,Efficacy marker,21.897,,mm,NaN,NaN,,NaN,NaN,NaN
1168,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-May-1982,07:05,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1169,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-May-1982,07:18,0,56,51.00902778,Days,PD,Efficacy marker,22.196,,mm,NaN,NaN,,NaN,NaN,NaN
1170,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-May-1982,07:06,0.0833333333721384,56,56.00069444,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1171,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-Jun-1982,08:02,0,84,79.03958333,Days,PD,Efficacy marker,23.221,,mm,NaN,NaN,,NaN,NaN,NaN
1172,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-Jun-1982,07:05,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1173,NaN,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,23-Jul-1982,15:32,0,112,111.3520833,Days,PD,Efficacy marker,23.504,,mm,NaN,NaN,,NaN,NaN,NaN
1174,NaN,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
1175,NaN,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1176,NaN,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42,Days,Demographics,Weight,78.6,,kg,NaN,NaN,,NaN,NaN,NaN
1177,NaN,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-Apr-1982,18:12,0,0,-4.533333333,Days,PD,Efficacy marker,32.892,,mm,NaN,NaN,,NaN,NaN,NaN
1178,NaN,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,07-Apr-1982,07:00,0,0,-1,Days,Demographics,Weight,78.5,,kg,NaN,NaN,,NaN,NaN,NaN
1179,NaN,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,06:45,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1180,NaN,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,397.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1181,NaN,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,09:19,0,0.0833,0.096527778,Days,PK,Plasma concentration Z,483.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1182,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42.00347222,Days,Demographics,Age,64,,Years,NaN,NaN,,NaN,NaN,NaN
1183,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42.00347222,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1184,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42.00347222,Days,Demographics,Weight,80.2,,kg,NaN,NaN,,NaN,NaN,NaN
1185,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-Apr-1982,18:40,0,0,-4.517361111,Days,PD,Efficacy marker,28.048,,mm,NaN,NaN,,NaN,NaN,NaN
1186,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,07-Apr-1982,07:00,0,0,-1.003472222,Days,Demographics,Weight,81.9,,kg,NaN,NaN,,NaN,NaN,NaN
1187,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,06:50,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1188,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,07:05,0.0833333333721384,0,0,Days,Dose,Dose Z,410.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1189,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,09:22,0,0.0833,0.095138889,Days,PK,Plasma concentration Z,597.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1190,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-May-1982,15:19,0,28,23.34305556,Days,PD,Efficacy marker,30.802,,mm,NaN,NaN,,NaN,NaN,NaN
1191,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,06:50,0,28,27.98958333,Days,PK,Plasma concentration Z,47.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1192,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,07:05,0.0833333333721384,28,28,Days,Dose,Dose Z,414.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1193,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,09:13,0,28,28.08888889,Days,PK,Plasma concentration Z,600,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1194,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-May-1982,14:56,0,56,51.32708333,Days,PD,Efficacy marker,31.284,,mm,NaN,NaN,,NaN,NaN,NaN
1195,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,06:50,0,56,55.98958333,Days,PK,Plasma concentration Z,53.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1196,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,07:05,0.0833333333721384,56,56,Days,Dose,Dose Z,414.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1197,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,09:00,0,56,56.07986111,Days,PK,Plasma concentration Z,687.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1198,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Jun-1982,16:11,0,84,79.37916667,Days,PD,Efficacy marker,31.897,,mm,NaN,NaN,,NaN,NaN,NaN
1199,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,06:50,0,84,83.98958333,Days,PK,Plasma concentration Z,75,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1200,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,07:05,0.0833333333721384,84,84,Days,Dose,Dose Z,414,,mg,NaN,NaN,iv,NaN,NaN,NaN
1201,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,09:16,0,84,84.09097222,Days,PK,Plasma concentration Z,654,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1202,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,11:05,0,84,84.16666667,Days,PK,Plasma concentration Z,672,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1203,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,13:05,0,84,84.25,Days,PK,Plasma concentration Z,614.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1204,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,08-Jul-1982,07:05,0,91,91,Days,PK,Plasma concentration Z,191.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1205,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,15-Jul-1982,07:05,0,98,98,Days,PK,Plasma concentration Z,130.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1206,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-Jul-1982,15:50,0,112,111.3645833,Days,PD,Efficacy marker,32.082,,mm,NaN,NaN,,NaN,NaN,NaN
1207,NaN,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,29-Jul-1982,07:05,0,112,112,Days,PK,Plasma concentration Z,84.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1208,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42.10763889,Days,Demographics,Age,70,,Years,NaN,NaN,,NaN,NaN,NaN
1209,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42.10763889,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1210,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-Feb-1982,07:00,0,-14,-42.10763889,Days,Demographics,Weight,73.6,,kg,NaN,NaN,,NaN,NaN,NaN
1211,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-Apr-1982,16:31,0,0,-4.711111111,Days,PD,Efficacy marker,39.146,,mm,NaN,NaN,,NaN,NaN,NaN
1212,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,07-Apr-1982,07:00,0,0,-1.107638889,Days,Demographics,Weight,75,,kg,NaN,NaN,,NaN,NaN,NaN
1213,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,09:05,0,0,-0.020833333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1214,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,09:35,0.0833333333721384,0,0,Days,Dose,Dose Z,380.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1215,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,11:48,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,534,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1216,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-May-1982,16:52,0,28,23.30347222,Days,PD,Efficacy marker,41.15,,mm,NaN,NaN,,NaN,NaN,NaN
1217,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,07:10,0,28,27.89930556,Days,PK,Plasma concentration Z,26.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1218,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,07:20,0.0833333333721384,28,27.90625,Days,Dose,Dose Z,389,,mg,NaN,NaN,iv,NaN,NaN,NaN
1219,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,09:34,0,28,27.99930556,Days,PK,Plasma concentration Z,530.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1220,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-May-1982,15:03,0,56,51.22777778,Days,PD,Efficacy marker,43.116,,mm,NaN,NaN,,NaN,NaN,NaN
1221,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,07:05,0,56,55.89583333,Days,PK,Plasma concentration Z,35.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1222,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,07:20,0.0833333333721384,56,55.90625,Days,Dose,Dose Z,396,,mg,NaN,NaN,iv,NaN,NaN,NaN
1223,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,09:36,0,56,56.00069444,Days,PK,Plasma concentration Z,576,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1224,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Jun-1982,16:39,0,84,79.29444444,Days,PD,Efficacy marker,44.212,,mm,NaN,NaN,,NaN,NaN,NaN
1225,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,07:05,0,84,83.89583333,Days,PK,Plasma concentration Z,46.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1226,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,07:20,0.0833333333721384,84,83.90625,Days,Dose,Dose Z,395.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1227,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,09:37,0,84,84.00138889,Days,PK,Plasma concentration Z,588,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1228,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,11:20,0,84,84.07291667,Days,PK,Plasma concentration Z,602.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1229,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,13:20,0,84,84.15625,Days,PK,Plasma concentration Z,519.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1230,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,08-Jul-1982,07:20,0,91,90.90625,Days,PK,Plasma concentration Z,151.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1231,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,15-Jul-1982,07:20,0,98,97.90625,Days,PK,Plasma concentration Z,91.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1232,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-Jul-1982,15:19,0,112,111.2388889,Days,PD,Efficacy marker,43.91,,mm,NaN,NaN,,NaN,NaN,NaN
1233,NaN,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,29-Jul-1982,07:20,0,112,111.90625,Days,PK,Plasma concentration Z,58.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1234,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,13-Mar-1982,07:00,0,-14,-27,Days,Demographics,Age,60,,Years,NaN,NaN,,NaN,NaN,NaN
1235,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,13-Mar-1982,07:00,0,-14,-27,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1236,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,13-Mar-1982,07:00,0,-14,-27,Days,Demographics,Weight,71.8,,kg,NaN,NaN,,NaN,NaN,NaN
1237,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,04-Apr-1982,15:52,0,0,-4.630555556,Days,PD,Efficacy marker,42.368,,mm,NaN,NaN,,NaN,NaN,NaN
1238,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,08-Apr-1982,07:00,0,0,-1,Days,Demographics,Weight,72.6,,kg,NaN,NaN,,NaN,NaN,NaN
1239,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-Apr-1982,06:45,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1240,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-Apr-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,365,,mg,NaN,NaN,iv,NaN,NaN,NaN
1241,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-Apr-1982,09:14,0,0.0833,0.093055556,Days,PK,Plasma concentration Z,458.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1242,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,02-May-1982,15:33,0,28,23.35625,Days,PD,Efficacy marker,44.161,,mm,NaN,NaN,,NaN,NaN,NaN
1243,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-May-1982,06:45,0,28,27.98958333,Days,PK,Plasma concentration Z,32.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1244,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-May-1982,07:00,0.0833333333721384,28,28,Days,Dose,Dose Z,371.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1245,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-May-1982,09:18,0,28,28.09583333,Days,PK,Plasma concentration Z,440.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1246,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-May-1982,15:44,0,56,51.36388889,Days,PD,Efficacy marker,44.998,,mm,NaN,NaN,,NaN,NaN,NaN
1247,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-Jun-1982,06:49,0,56,55.99236111,Days,PK,Plasma concentration Z,45.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1248,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-Jun-1982,07:00,0.0833333333721384,56,56,Days,Dose,Dose Z,369,,mg,NaN,NaN,iv,NaN,NaN,NaN
1249,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-Jun-1982,09:14,0,56,56.09305556,Days,PK,Plasma concentration Z,537.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1250,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-Jun-1982,15:47,0,84,79.36597222,Days,PD,Efficacy marker,45.924,,mm,NaN,NaN,,NaN,NaN,NaN
1251,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,06:45,0,84,83.98958333,Days,PK,Plasma concentration Z,59.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1252,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,07:00,0.0833333333721384,84,84,Days,Dose,Dose Z,364,,mg,NaN,NaN,iv,NaN,NaN,NaN
1253,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,09:15,0,84,84.09375,Days,PK,Plasma concentration Z,494.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1254,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,11:00,0,84,84.16666667,Days,PK,Plasma concentration Z,495.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1255,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,13:00,0,84,84.25,Days,PK,Plasma concentration Z,453.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1256,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,09-Jul-1982,07:00,0,91,91,Days,PK,Plasma concentration Z,95.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1257,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,16-Jul-1982,07:00,0,98,98,Days,PK,Plasma concentration Z,103.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1258,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,29-Jul-1982,17:14,0,112,111.4263889,Days,PD,Efficacy marker,47.218,,mm,NaN,NaN,,NaN,NaN,NaN
1259,NaN,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,30-Jul-1982,07:00,0,112,112,Days,PK,Plasma concentration Z,76.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1260,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-25.00694444,Days,Demographics,Age,63,,Years,NaN,NaN,,NaN,NaN,NaN
1261,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-25.00694444,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1262,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-25.00694444,Days,Demographics,Weight,60.1,,kg,NaN,NaN,,NaN,NaN,NaN
1263,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-Apr-1982,19:09,0,0,-4.500694444,Days,PD,Efficacy marker,24.234,,mm,NaN,NaN,,NaN,NaN,NaN
1264,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,07-Apr-1982,07:00,0,0,-1.006944444,Days,Demographics,Weight,59.7,,kg,NaN,NaN,,NaN,NaN,NaN
1265,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,06:55,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1266,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,07:10,0.0833333333721384,0,0,Days,Dose,Dose Z,303,,mg,NaN,NaN,iv,NaN,NaN,NaN
1267,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-Apr-1982,09:22,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,524.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1268,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-May-1982,17:28,0,28,23.42916667,Days,PD,Efficacy marker,24.848,,mm,NaN,NaN,,NaN,NaN,NaN
1269,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,06:55,0,28,27.98958333,Days,PK,Plasma concentration Z,39.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1270,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,07:10,0.0833333333721384,28,28,Days,Dose,Dose Z,300.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1271,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-May-1982,09:23,0,28,28.09236111,Days,PK,Plasma concentration Z,474,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1272,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-May-1982,16:05,0,56,51.37152778,Days,PD,Efficacy marker,25.704,,mm,NaN,NaN,,NaN,NaN,NaN
1273,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,06:55,0,56,55.98958333,Days,PK,Plasma concentration Z,63.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1274,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,07:10,0.0833333333721384,56,56,Days,Dose,Dose Z,304.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1275,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-Jun-1982,09:24,0,56,56.09305556,Days,PK,Plasma concentration Z,570,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1276,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Jun-1982,15:43,0,84,79.35625,Days,PD,Efficacy marker,26.208,,mm,NaN,NaN,,NaN,NaN,NaN
1277,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,06:55,0,84,83.98958333,Days,PK,Plasma concentration Z,93.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1278,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,07:10,0.0833333333721384,84,84,Days,Dose,Dose Z,304,,mg,NaN,NaN,iv,NaN,NaN,NaN
1279,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,09:27,0,84,84.09513889,Days,PK,Plasma concentration Z,590.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1280,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,11:10,0,84,84.16666667,Days,PK,Plasma concentration Z,596.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1281,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Jul-1982,13:10,0,84,84.25,Days,PK,Plasma concentration Z,483.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1282,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,08-Jul-1982,07:10,0,91,91,Days,PK,Plasma concentration Z,201.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1283,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,15-Jul-1982,07:10,0,98,98,Days,PK,Plasma concentration Z,135.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1284,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-Jul-1982,17:24,0,112,111.4263889,Days,PD,Efficacy marker,26.253,,mm,NaN,NaN,,NaN,NaN,NaN
1285,NaN,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,29-Jul-1982,07:10,0,112,112,Days,PK,Plasma concentration Z,78.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1286,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-25.01041667,Days,Demographics,Age,55,,Years,NaN,NaN,,NaN,NaN,NaN
1287,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-25.01041667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1288,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-25.01041667,Days,Demographics,Weight,72,,kg,NaN,NaN,,NaN,NaN,NaN
1289,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,03-Apr-1982,19:37,0,0,-4.484722222,Days,PD,Efficacy marker,28.049,,mm,NaN,NaN,,NaN,NaN,NaN
1290,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,07-Apr-1982,07:00,0,0,-1.010416667,Days,Demographics,Weight,72.2,,kg,NaN,NaN,,NaN,NaN,NaN
1291,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,08-Apr-1982,07:15,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1292,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-May-1982,18:23,0,28,23.46388889,Days,PD,Efficacy marker,28.244,,mm,NaN,NaN,,NaN,NaN,NaN
1293,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,06-May-1982,07:15,0.0833333332557231,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1294,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-May-1982,17:22,0,56,51.42152778,Days,PD,Efficacy marker,27.725,,mm,NaN,NaN,,NaN,NaN,NaN
1295,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,03-Jun-1982,07:15,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1296,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-Jun-1982,17:31,0,84,79.42777778,Days,PD,Efficacy marker,28.35,,mm,NaN,NaN,,NaN,NaN,NaN
1297,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,01-Jul-1982,07:15,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1298,NaN,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,28-Jul-1982,15:49,0,112,111.3569444,Days,PD,Efficacy marker,28.764,,mm,NaN,NaN,,NaN,NaN,NaN
1299,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-32,Days,Demographics,Age,72,,Years,NaN,NaN,,NaN,NaN,NaN
1300,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-32,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1301,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-Mar-1982,07:00,0,-14,-32,Days,Demographics,Weight,77.6,,kg,NaN,NaN,,NaN,NaN,NaN
1302,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-Apr-1982,14:52,0,0,-4.672222222,Days,PD,Efficacy marker,43.842,,mm,NaN,NaN,,NaN,NaN,NaN
1303,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,14-Apr-1982,07:00,0,0,-1,Days,Demographics,Weight,77.6,,kg,NaN,NaN,,NaN,NaN,NaN
1304,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-Apr-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1305,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,08-May-1982,16:18,0,28,23.3875,Days,PD,Efficacy marker,44.879,,mm,NaN,NaN,,NaN,NaN,NaN
1306,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,13-May-1982,07:00,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1307,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-Jun-1982,15:10,0,56,51.34027778,Days,PD,Efficacy marker,44.502,,mm,NaN,NaN,,NaN,NaN,NaN
1308,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,10-Jun-1982,07:00,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1309,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,03-Jul-1982,15:13,0,84,79.34236111,Days,PD,Efficacy marker,44.474,,mm,NaN,NaN,,NaN,NaN,NaN
1310,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,08-Jul-1982,07:03,0.0833333333721384,84,84.00208333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1311,NaN,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,09-Aug-1982,14:21,0,112,116.30625,Days,PD,Efficacy marker,43.879,,mm,NaN,NaN,,NaN,NaN,NaN
1312,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.09375,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
1313,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.09375,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1314,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.09375,Days,Demographics,Weight,75.1,,kg,NaN,NaN,,NaN,NaN,NaN
1315,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-Apr-1982,15:24,0,0,-4.74375,Days,PD,Efficacy marker,37.907,,mm,NaN,NaN,,NaN,NaN,NaN
1316,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,14-Apr-1982,07:00,0,0,-1.09375,Days,Demographics,Weight,75.2,,kg,NaN,NaN,,NaN,NaN,NaN
1317,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-Apr-1982,08:32,0,0,-0.029861111,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1318,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-Apr-1982,09:15,0.0833333333721384,0,0,Days,Dose,Dose Z,380,,mg,NaN,NaN,iv,NaN,NaN,NaN
1319,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-Apr-1982,11:26,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,483.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1320,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,08-May-1982,17:21,0,28,23.3375,Days,PD,Efficacy marker,40.012,,mm,NaN,NaN,,NaN,NaN,NaN
1321,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-May-1982,07:00,0,28,27.90625,Days,PK,Plasma concentration Z,23.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1322,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-May-1982,07:15,0.0833333332557231,28,27.91666667,Days,Dose,Dose Z,386.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1323,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-May-1982,09:28,0,28,28.00902778,Days,PK,Plasma concentration Z,564,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1324,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-Jun-1982,15:38,0,56,51.26597222,Days,PD,Efficacy marker,41.462,,mm,NaN,NaN,,NaN,NaN,NaN
1325,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-Jun-1982,07:00,0,56,55.90625,Days,PK,Plasma concentration Z,38.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1326,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-Jun-1982,07:15,0.0833333332557231,56,55.91666667,Days,Dose,Dose Z,385,,mg,NaN,NaN,iv,NaN,NaN,NaN
1327,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-Jun-1982,09:30,0,56,56.01041667,Days,PK,Plasma concentration Z,518.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1328,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,03-Jul-1982,15:55,0,84,79.27777778,Days,PD,Efficacy marker,43.362,,mm,NaN,NaN,,NaN,NaN,NaN
1329,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,07:00,0,84,83.90625,Days,PK,Plasma concentration Z,42.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1330,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,07:15,0.0833333332557231,84,83.91666667,Days,Dose,Dose Z,384,,mg,NaN,NaN,iv,NaN,NaN,NaN
1331,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,09:31,0,84,84.01111111,Days,PK,Plasma concentration Z,554.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1332,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,11:15,0,84,84.08333333,Days,PK,Plasma concentration Z,567.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1333,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,13:15,0,84,84.16666667,Days,PK,Plasma concentration Z,537.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1334,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,15-Jul-1982,07:15,0,91,90.91666667,Days,PK,Plasma concentration Z,153,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1335,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,22-Jul-1982,07:15,0,98,97.91666667,Days,PK,Plasma concentration Z,87.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1336,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-Aug-1982,07:15,0,112,111.9166667,Days,PK,Plasma concentration Z,45.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1337,NaN,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-Aug-1982,14:46,0,112,112.2298611,Days,PD,Efficacy marker,42.476,,mm,NaN,NaN,,NaN,NaN,NaN
1338,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.00347222,Days,Demographics,Age,54,,Years,NaN,NaN,,NaN,NaN,NaN
1339,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.00347222,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1340,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.00347222,Days,Demographics,Weight,66.4,,kg,NaN,NaN,,NaN,NaN,NaN
1341,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-Apr-1982,15:53,0,0,-4.633333333,Days,PD,Efficacy marker,19.066,,mm,NaN,NaN,,NaN,NaN,NaN
1342,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,14-Apr-1982,07:00,0,0,-1.003472222,Days,Demographics,Weight,66.3,,kg,NaN,NaN,,NaN,NaN,NaN
1343,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-Apr-1982,07:05,0.0833333333721384,0,0,Days,Dose,Dose Z,332.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1344,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-Apr-1982,07:07,0,0,0.001388889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1345,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-Apr-1982,09:18,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,603.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1346,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,08-May-1982,18:00,0,28,23.45486111,Days,PD,Efficacy marker,19.517,,mm,NaN,NaN,,NaN,NaN,NaN
1347,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-May-1982,06:50,0,28,27.98958333,Days,PK,Plasma concentration Z,37.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1348,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-May-1982,07:05,0.0833333333721384,28,28,Days,Dose,Dose Z,336.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1349,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-May-1982,09:26,0,28,28.09791667,Days,PK,Plasma concentration Z,639.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1350,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-Jun-1982,18:18,0,56,51.46736111,Days,PD,Efficacy marker,19.787,,mm,NaN,NaN,,NaN,NaN,NaN
1351,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-Jun-1982,06:53,0,56,55.99166667,Days,PK,Plasma concentration Z,58.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1352,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-Jun-1982,07:11,0.0833333333721384,56,56.00416667,Days,Dose,Dose Z,333,,mg,NaN,NaN,iv,NaN,NaN,NaN
1353,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-Jun-1982,09:29,0,56,56.1,Days,PK,Plasma concentration Z,690,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1354,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,03-Jul-1982,17:41,0,84,79.44166667,Days,PD,Efficacy marker,19.699,,mm,NaN,NaN,,NaN,NaN,NaN
1355,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,06:50,0,84,83.98958333,Days,PK,Plasma concentration Z,63.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1356,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,07:06,0.0833333333721384,84,84.00069444,Days,Dose,Dose Z,321,,mg,NaN,NaN,iv,NaN,NaN,NaN
1357,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,09:23,0,84,84.09583333,Days,PK,Plasma concentration Z,656.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1358,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,11:05,0,84,84.16666667,Days,PK,Plasma concentration Z,732,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1359,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-Jul-1982,13:05,0,84,84.25,Days,PK,Plasma concentration Z,686.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1360,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,18-Jul-1982,07:52,0,91,94.03263889,Days,PK,Plasma concentration Z,150.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1361,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,22-Jul-1982,07:05,0,98,98,Days,PK,Plasma concentration Z,160.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1362,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-Aug-1982,07:25,0,112,112.0138889,Days,PK,Plasma concentration Z,77.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1363,NaN,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-Aug-1982,16:09,0,112,112.3777778,Days,PD,Efficacy marker,19.748,,mm,NaN,NaN,,NaN,NaN,NaN
1364,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.00347222,Days,Demographics,Age,56,,Years,NaN,NaN,,NaN,NaN,NaN
1365,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.00347222,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1366,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.00347222,Days,Demographics,Weight,53,,kg,NaN,NaN,,NaN,NaN,NaN
1367,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,04-Apr-1982,16:23,0,0,-4.6125,Days,PD,Efficacy marker,24.703,,mm,NaN,NaN,,NaN,NaN,NaN
1368,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,08-Apr-1982,07:00,0,0,-1.003472222,Days,Demographics,Weight,53.8,,kg,NaN,NaN,,NaN,NaN,NaN
1369,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,09-Apr-1982,07:05,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1370,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-May-1982,16:02,0,28,23.37291667,Days,PD,Efficacy marker,24.934,,mm,NaN,NaN,,NaN,NaN,NaN
1371,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-May-1982,07:05,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1372,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,03-Jun-1982,16:01,0,56,55.37222222,Days,PD,Efficacy marker,25.656,,mm,NaN,NaN,,NaN,NaN,NaN
1373,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-Jun-1982,07:05,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1374,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,27-Jun-1982,15:12,0,84,79.33819444,Days,PD,Efficacy marker,25.636,,mm,NaN,NaN,,NaN,NaN,NaN
1375,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-Jul-1982,07:05,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1376,NaN,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,29-Jul-1982,17:39,0,112,111.4402778,Days,PD,Efficacy marker,26.156,,mm,NaN,NaN,,NaN,NaN,NaN
1377,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.00694444,Days,Demographics,Age,54,,Years,NaN,NaN,,NaN,NaN,NaN
1378,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.00694444,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1379,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.00694444,Days,Demographics,Weight,60.2,,kg,NaN,NaN,,NaN,NaN,NaN
1380,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,04-Apr-1982,16:47,0,0,-4.599305556,Days,PD,Efficacy marker,25.115,,mm,NaN,NaN,,NaN,NaN,NaN
1381,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,08-Apr-1982,07:00,0,0,-1.006944444,Days,Demographics,Weight,59.7,,kg,NaN,NaN,,NaN,NaN,NaN
1382,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-Apr-1982,06:55,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1383,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-Apr-1982,07:10,0.0833333333721384,0,0,Days,Dose,Dose Z,301.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1384,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-Apr-1982,09:26,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,495.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1385,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,02-May-1982,17:08,0,28,23.41527778,Days,PD,Efficacy marker,28.244,,mm,NaN,NaN,,NaN,NaN,NaN
1386,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-May-1982,06:55,0,28,27.98958333,Days,PK,Plasma concentration Z,31.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1387,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-May-1982,07:10,0.0833333333721384,28,28,Days,Dose,Dose Z,307.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1388,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-May-1982,09:23,0,28,28.09236111,Days,PK,Plasma concentration Z,462,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1389,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-May-1982,18:05,0,56,51.45486111,Days,PD,Efficacy marker,28.889,,mm,NaN,NaN,,NaN,NaN,NaN
1390,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-Jun-1982,06:57,0,56,55.99097222,Days,PK,Plasma concentration Z,45.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1391,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-Jun-1982,07:10,0.0833333333721384,56,56,Days,Dose,Dose Z,309,,mg,NaN,NaN,iv,NaN,NaN,NaN
1392,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-Jun-1982,09:27,0,56,56.09513889,Days,PK,Plasma concentration Z,519.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1393,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-Jun-1982,16:22,0,84,79.38333333,Days,PD,Efficacy marker,30.74,,mm,NaN,NaN,,NaN,NaN,NaN
1394,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,06:55,0,84,83.98958333,Days,PK,Plasma concentration Z,51.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1395,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,07:10,0.0833333333721384,84,84,Days,Dose,Dose Z,314,,mg,NaN,NaN,iv,NaN,NaN,NaN
1396,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,09:24,0,84,84.09305556,Days,PK,Plasma concentration Z,531.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1397,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,11:10,0,84,84.16666667,Days,PK,Plasma concentration Z,519.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1398,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Jul-1982,13:10,0,84,84.25,Days,PK,Plasma concentration Z,525.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1399,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,09-Jul-1982,07:10,0,91,91,Days,PK,Plasma concentration Z,155.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1400,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,16-Jul-1982,07:10,0,98,98,Days,PK,Plasma concentration Z,111,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1401,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,30-Jul-1982,07:10,0,112,112,Days,PK,Plasma concentration Z,63.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1402,NaN,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,01-Aug-1982,17:29,0,112,114.4298611,Days,PD,Efficacy marker,30.059,,mm,NaN,NaN,,NaN,NaN,NaN
1403,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.01041667,Days,Demographics,Age,52,,Years,NaN,NaN,,NaN,NaN,NaN
1404,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.01041667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1405,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-23.01041667,Days,Demographics,Weight,63.2,,kg,NaN,NaN,,NaN,NaN,NaN
1406,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,04-Apr-1982,17:21,0,0,-4.579166667,Days,PD,Efficacy marker,26.688,,mm,NaN,NaN,,NaN,NaN,NaN
1407,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,08-Apr-1982,07:00,0,0,-1.010416667,Days,Demographics,Weight,62.8,,kg,NaN,NaN,,NaN,NaN,NaN
1408,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,09-Apr-1982,07:15,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1409,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-May-1982,17:48,0,28,23.43958333,Days,PD,Efficacy marker,28.016,,mm,NaN,NaN,,NaN,NaN,NaN
1410,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-May-1982,07:15,0.0833333332557231,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1411,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,30-May-1982,17:39,0,56,51.43333333,Days,PD,Efficacy marker,27.117,,mm,NaN,NaN,,NaN,NaN,NaN
1412,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-Jun-1982,07:15,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1413,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,27-Jun-1982,16:58,0,84,79.40486111,Days,PD,Efficacy marker,27.019,,mm,NaN,NaN,,NaN,NaN,NaN
1414,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-Jul-1982,07:15,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1415,NaN,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,29-Jul-1982,18:52,0,112,111.4840278,Days,PD,Efficacy marker,27.575,,mm,NaN,NaN,,NaN,NaN,NaN
1416,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.00694444,Days,Demographics,Age,55,,Years,NaN,NaN,,NaN,NaN,NaN
1417,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.00694444,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1418,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Mar-1982,07:00,0,-14,-29.00694444,Days,Demographics,Weight,57.8,,kg,NaN,NaN,,NaN,NaN,NaN
1419,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-Apr-1982,16:24,0,0,-4.615277778,Days,PD,Efficacy marker,26.422,,mm,NaN,NaN,,NaN,NaN,NaN
1420,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,14-Apr-1982,07:00,0,0,-1.006944444,Days,Demographics,Weight,58.3,,kg,NaN,NaN,,NaN,NaN,NaN
1421,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-Apr-1982,07:10,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1422,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,08-May-1982,18:23,0,28,23.46736111,Days,PD,Efficacy marker,27.295,,mm,NaN,NaN,,NaN,NaN,NaN
1423,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,13-May-1982,07:10,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1424,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-Jun-1982,16:04,0,56,51.37083333,Days,PD,Efficacy marker,26.804,,mm,NaN,NaN,,NaN,NaN,NaN
1425,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,10-Jun-1982,07:10,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1426,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,03-Jul-1982,16:39,0,84,79.39513889,Days,PD,Efficacy marker,27.263,,mm,NaN,NaN,,NaN,NaN,NaN
1427,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,08-Jul-1982,07:10,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1428,NaN,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,05-Aug-1982,16:35,0,112,112.3923611,Days,PD,Efficacy marker,28.114,,mm,NaN,NaN,,NaN,NaN,NaN
1429,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-Mar-1982,07:00,0,-14,-21.00694444,Days,Demographics,Age,53,,Years,NaN,NaN,,NaN,NaN,NaN
1430,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-Mar-1982,07:00,0,-14,-21.00694444,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1431,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-Mar-1982,07:00,0,-14,-21.00694444,Days,Demographics,Weight,56.9,,kg,NaN,NaN,,NaN,NaN,NaN
1432,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,11-Apr-1982,17:44,0,0,-4.559722222,Days,PD,Efficacy marker,24.367,,mm,NaN,NaN,,NaN,NaN,NaN
1433,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,15-Apr-1982,07:00,0,0,-1.006944444,Days,Demographics,Weight,57,,kg,NaN,NaN,,NaN,NaN,NaN
1434,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,16-Apr-1982,07:10,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1435,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,09-May-1982,16:02,0,28,23.36944444,Days,PD,Efficacy marker,24.365,,mm,NaN,NaN,,NaN,NaN,NaN
1436,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,14-May-1982,07:10,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1437,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-Jun-1982,18:52,0,56,54.4875,Days,PD,Efficacy marker,24.332,,mm,NaN,NaN,,NaN,NaN,NaN
1438,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,11-Jun-1982,07:10,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1439,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,04-Jul-1982,15:43,0,84,79.35625,Days,PD,Efficacy marker,24.788,,mm,NaN,NaN,,NaN,NaN,NaN
1440,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,09-Jul-1982,07:12,0.0833333332557231,84,84.00138889,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1441,NaN,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-Aug-1982,16:36,0,112,112.3930556,Days,PD,Efficacy marker,25.079,,mm,NaN,NaN,,NaN,NaN,NaN
1442,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-Mar-1982,07:00,0,-14,-21,Days,Demographics,Age,54,,Years,NaN,NaN,,NaN,NaN,NaN
1443,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-Mar-1982,07:00,0,-14,-21,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1444,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-Mar-1982,07:00,0,-14,-21,Days,Demographics,Weight,73.6,,kg,NaN,NaN,,NaN,NaN,NaN
1445,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,12-Apr-1982,07:34,0,0,-3.976388889,Days,PD,Efficacy marker,40,,mm,NaN,NaN,,NaN,NaN,NaN
1446,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,15-Apr-1982,07:00,0,0,-1,Days,Demographics,Weight,73.1,,kg,NaN,NaN,,NaN,NaN,NaN
1447,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,16-Apr-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1448,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,14-May-1982,07:00,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1449,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,11-Jun-1982,07:00,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1450,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-Jun-1982,16:20,0,56,64.38888889,Days,PD,Efficacy marker,42.868,,mm,NaN,NaN,,NaN,NaN,NaN
1451,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,04-Jul-1982,16:26,0,84,79.39305556,Days,PD,Efficacy marker,43.273,,mm,NaN,NaN,,NaN,NaN,NaN
1452,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,09-Jul-1982,07:00,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1453,NaN,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-Aug-1982,17:02,0,112,112.4180556,Days,PD,Efficacy marker,42.414,,mm,NaN,NaN,,NaN,NaN,NaN
1454,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-20.01041667,Days,Demographics,Age,54,,Years,NaN,NaN,,NaN,NaN,NaN
1455,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-20.01041667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1456,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-20.01041667,Days,Demographics,Weight,71.1,,kg,NaN,NaN,,NaN,NaN,NaN
1457,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,11-Apr-1982,19:53,0,0,-4.473611111,Days,PD,Efficacy marker,26.475,,mm,NaN,NaN,,NaN,NaN,NaN
1458,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,15-Apr-1982,07:00,0,0,-1.010416667,Days,Demographics,Weight,69.5,,kg,NaN,NaN,,NaN,NaN,NaN
1459,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-Apr-1982,07:00,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1460,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-Apr-1982,07:15,0.0833333332557231,0,0,Days,Dose,Dose Z,353.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1461,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-Apr-1982,09:31,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,584.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1462,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,09-May-1982,17:41,0,28,23.43472222,Days,PD,Efficacy marker,28.667,,mm,NaN,NaN,,NaN,NaN,NaN
1463,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,07:00,0,28,27.98958333,Days,PK,Plasma concentration Z,33.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1464,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,07:15,0.0833333332557231,28,28,Days,Dose,Dose Z,358,,mg,NaN,NaN,iv,NaN,NaN,NaN
1465,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,09:28,0,28,28.09236111,Days,PK,Plasma concentration Z,582,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1466,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,06-Jun-1982,18:07,0,56,51.45277778,Days,PD,Efficacy marker,29.85,,mm,NaN,NaN,,NaN,NaN,NaN
1467,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,07:00,0,56,55.98958333,Days,PK,Plasma concentration Z,48.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1468,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,07:15,0.0833333332557231,56,56,Days,Dose,Dose Z,360.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1469,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,09:30,0,56,56.09375,Days,PK,Plasma concentration Z,704.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1470,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,04-Jul-1982,14:41,0,84,79.30972222,Days,PD,Efficacy marker,31.169,,mm,NaN,NaN,,NaN,NaN,NaN
1471,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,07:00,0,84,83.98958333,Days,PK,Plasma concentration Z,66.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1472,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,07:15,0.0833333332557231,84,84,Days,Dose,Dose Z,366,,mg,NaN,NaN,iv,NaN,NaN,NaN
1473,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,09:30,0,84,84.09375,Days,PK,Plasma concentration Z,723.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1474,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,11:15,0,84,84.16666667,Days,PK,Plasma concentration Z,734.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1475,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,13:15,0,84,84.25,Days,PK,Plasma concentration Z,663.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1476,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,16-Jul-1982,07:15,0,91,91,Days,PK,Plasma concentration Z,176.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1477,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,23-Jul-1982,07:15,0,98,98,Days,PK,Plasma concentration Z,132,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1478,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Aug-1982,07:15,0,112,112,Days,PK,Plasma concentration Z,76.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1479,NaN,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Aug-1982,15:54,0,112,112.3604167,Days,PD,Efficacy marker,32.973,,mm,NaN,NaN,,NaN,NaN,NaN
1480,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-21.01388889,Days,Demographics,Age,51,,Years,NaN,NaN,,NaN,NaN,NaN
1481,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-21.01388889,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1482,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-21.01388889,Days,Demographics,Weight,86.8,,kg,NaN,NaN,,NaN,NaN,NaN
1483,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,15-Apr-1982,07:00,0,0,-2.013888889,Days,Demographics,Weight,84.7,,kg,NaN,NaN,,NaN,NaN,NaN
1484,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,15-Apr-1982,18:53,0,0,-1.51875,Days,PD,Efficacy marker,32.794,,mm,NaN,NaN,,NaN,NaN,NaN
1485,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,17-Apr-1982,07:05,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1486,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,17-Apr-1982,07:20,0.0833333333721384,0,0,Days,Dose,Dose Z,422,,mg,NaN,NaN,iv,NaN,NaN,NaN
1487,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,17-Apr-1982,09:33,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,693.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1488,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,07:05,0,28,26.98958333,Days,PK,Plasma concentration Z,45.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1489,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,07:20,0.0833333333721384,28,27,Days,Dose,Dose Z,428,,mg,NaN,NaN,iv,NaN,NaN,NaN
1490,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,09:40,0,28,27.09722222,Days,PK,Plasma concentration Z,674.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1491,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,07:05,0,56,54.98958333,Days,PK,Plasma concentration Z,67.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1492,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,07:20,0.0833333333721384,56,55,Days,Dose,Dose Z,435,,mg,NaN,NaN,iv,NaN,NaN,NaN
1493,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,09:38,0,56,55.09583333,Days,PK,Plasma concentration Z,675.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1494,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,12-Jun-1982,16:46,0,56,56.39305556,Days,PD,Efficacy marker,36.201,,mm,NaN,NaN,,NaN,NaN,NaN
1495,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,07:20,0,84,83,Days,PK,Plasma concentration Z,89.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1496,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,07:23,0.0833333332557231,84,83.00208333,Days,Dose,Dose Z,442.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1497,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,09:37,0,84,83.09513889,Days,PK,Plasma concentration Z,776.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1498,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,11:20,0,84,83.16666667,Days,PK,Plasma concentration Z,741.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1499,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,13:20,0,84,83.25,Days,PK,Plasma concentration Z,651.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1500,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,10-Jul-1982,17:37,0,84,84.42847222,Days,PD,Efficacy marker,37.665,,mm,NaN,NaN,,NaN,NaN,NaN
1501,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,16-Jul-1982,07:20,0,91,90,Days,PK,Plasma concentration Z,234,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1502,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,23-Jul-1982,07:20,0,98,97,Days,PK,Plasma concentration Z,162.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1503,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Aug-1982,07:20,0,112,111,Days,PK,Plasma concentration Z,103.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1504,NaN,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Aug-1982,15:13,0,112,111.3284722,Days,PD,Efficacy marker,37.755,,mm,NaN,NaN,,NaN,NaN,NaN
1505,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-20.00347222,Days,Demographics,Age,53,,Years,NaN,NaN,,NaN,NaN,NaN
1506,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-20.00347222,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1507,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Mar-1982,07:00,0,-14,-20.00347222,Days,Demographics,Weight,71,,kg,NaN,NaN,,NaN,NaN,NaN
1508,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,11-Apr-1982,18:07,0,0,-4.540277778,Days,PD,Efficacy marker,48.387,,mm,NaN,NaN,,NaN,NaN,NaN
1509,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,15-Apr-1982,07:00,0,0,-1.003472222,Days,Demographics,Weight,70.9,,kg,NaN,NaN,,NaN,NaN,NaN
1510,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-Apr-1982,06:50,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1511,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-Apr-1982,07:05,0.0833333333721384,0,0,Days,Dose,Dose Z,353,,mg,NaN,NaN,iv,NaN,NaN,NaN
1512,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-Apr-1982,09:23,0,0.0833,0.095833333,Days,PK,Plasma concentration Z,434.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1513,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,09-May-1982,17:00,0,28,23.41319444,Days,PD,Efficacy marker,51.675,,mm,NaN,NaN,,NaN,NaN,NaN
1514,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,06:50,0,28,27.98958333,Days,PK,Plasma concentration Z,23.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1515,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,07:05,0.0833333333721384,28,28,Days,Dose,Dose Z,359.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1516,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-May-1982,09:22,0,28,28.09513889,Days,PK,Plasma concentration Z,423.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1517,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,06-Jun-1982,17:41,0,56,51.44166667,Days,PD,Efficacy marker,53.187,,mm,NaN,NaN,,NaN,NaN,NaN
1518,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,06:50,0,56,55.98958333,Days,PK,Plasma concentration Z,36.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1519,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,07:05,0.0833333333721384,56,56,Days,Dose,Dose Z,372,,mg,NaN,NaN,iv,NaN,NaN,NaN
1520,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-Jun-1982,09:21,0,56,56.09444444,Days,PK,Plasma concentration Z,482.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1521,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,04-Jul-1982,16:03,0,84,79.37361111,Days,PD,Efficacy marker,53.83,,mm,NaN,NaN,,NaN,NaN,NaN
1522,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,06:50,0,84,83.98958333,Days,PK,Plasma concentration Z,48.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1523,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,07:05,0.0833333333721384,84,84,Days,Dose,Dose Z,369,,mg,NaN,NaN,iv,NaN,NaN,NaN
1524,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,09:21,0,84,84.09444444,Days,PK,Plasma concentration Z,483.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1525,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,11:05,0,84,84.16666667,Days,PK,Plasma concentration Z,480,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1526,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-Jul-1982,13:05,0,84,84.25,Days,PK,Plasma concentration Z,501.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1527,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,16-Jul-1982,07:05,0,91,91,Days,PK,Plasma concentration Z,131.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1528,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,23-Jul-1982,07:25,0,98,98.01388889,Days,PK,Plasma concentration Z,95.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1529,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Aug-1982,07:05,0,112,112,Days,PK,Plasma concentration Z,51.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1530,NaN,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,09-Aug-1982,13:56,0,112,115.2854167,Days,PD,Efficacy marker,53.869,,mm,NaN,NaN,,NaN,NaN,NaN
1531,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01319444,Days,Demographics,Age,54,,Years,NaN,NaN,,NaN,NaN,NaN
1532,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01319444,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1533,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01319444,Days,Demographics,Weight,70.2,,kg,NaN,NaN,,NaN,NaN,NaN
1534,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-May-1982,10:41,0,0,-4.859722222,Days,PD,Efficacy marker,35.292,,mm,NaN,NaN,,NaN,NaN,NaN
1535,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-May-1982,07:00,0,0,-1.013194444,Days,Demographics,Weight,69.5,,kg,NaN,NaN,,NaN,NaN,NaN
1536,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:00,0,0,-0.013194444,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1537,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:19,0.0833333333721384,0,0,Days,Dose,Dose Z,348,,mg,NaN,NaN,iv,NaN,NaN,NaN
1538,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,09:33,0,0.0833,0.093055556,Days,PK,Plasma concentration Z,630,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1539,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,11:27,0,28,23.17222222,Days,PD,Efficacy marker,37.356,,mm,NaN,NaN,,NaN,NaN,NaN
1540,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,07:00,0,28,27.98680556,Days,PK,Plasma concentration Z,44.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1541,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,07:15,0.0833333332557231,28,27.99722222,Days,Dose,Dose Z,356,,mg,NaN,NaN,iv,NaN,NaN,NaN
1542,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,09:36,0,28,28.09513889,Days,PK,Plasma concentration Z,560.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1543,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Jul-1982,12:30,0,56,51.21597222,Days,PD,Efficacy marker,37.734,,mm,NaN,NaN,,NaN,NaN,NaN
1544,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,07:00,0,56,55.98680556,Days,PK,Plasma concentration Z,65.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1545,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,07:15,0.0833333332557231,56,55.99722222,Days,Dose,Dose Z,356,,mg,NaN,NaN,iv,NaN,NaN,NaN
1546,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,09:33,0,56,56.09305556,Days,PK,Plasma concentration Z,636,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1547,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,10:23,0,84,79.12777778,Days,PD,Efficacy marker,38.638,,mm,NaN,NaN,,NaN,NaN,NaN
1548,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,07:00,0,84,83.98680556,Days,PK,Plasma concentration Z,72.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1549,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,07:17,0.0833333333721384,84,83.99861111,Days,Dose,Dose Z,349.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1550,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,09:36,0,84,84.09513889,Days,PK,Plasma concentration Z,702,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1551,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,11:15,0,84,84.16388889,Days,PK,Plasma concentration Z,702,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1552,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,13:15,0,84,84.24722222,Days,PK,Plasma concentration Z,690,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1553,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,28-Aug-1982,07:15,0,91,90.99722222,Days,PK,Plasma concentration Z,230.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1554,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,04-Sep-1982,07:15,0,98,97.99722222,Days,PK,Plasma concentration Z,164.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1555,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Sep-1982,12:12,0,112,111.2034722,Days,PD,Efficacy marker,38.423,,mm,NaN,NaN,,NaN,NaN,NaN
1556,NaN,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,18-Sep-1982,07:15,0,112,111.9972222,Days,PK,Plasma concentration Z,96.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1557,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01388889,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
1558,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01388889,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1559,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01388889,Days,Demographics,Weight,72.5,,kg,NaN,NaN,,NaN,NaN,NaN
1560,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-May-1982,10:01,0,0,-4.888194444,Days,PD,Efficacy marker,25.225,,mm,NaN,NaN,,NaN,NaN,NaN
1561,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-May-1982,07:00,0,0,-1.013888889,Days,Demographics,Weight,73.8,,kg,NaN,NaN,,NaN,NaN,NaN
1562,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:11,0,0,-0.00625,Days,PK,Plasma concentration Z,0.483,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1563,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:20,0.0833333333721384,0,0,Days,Dose,Dose Z,368.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1564,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,09:37,0,0.0833,0.095138889,Days,PK,Plasma concentration Z,609.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1565,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,10:59,0,28,23.15208333,Days,PD,Efficacy marker,25.816,,mm,NaN,NaN,,NaN,NaN,NaN
1566,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,07:05,0,28,27.98958333,Days,PK,Plasma concentration Z,27.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1567,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,07:20,0.0833333333721384,28,28,Days,Dose,Dose Z,368.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1568,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,09:34,0,28,28.09305556,Days,PK,Plasma concentration Z,570,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1569,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Jul-1982,11:41,0,56,51.18125,Days,PD,Efficacy marker,25.423,,mm,NaN,NaN,,NaN,NaN,NaN
1570,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,07:05,0,56,55.98958333,Days,PK,Plasma concentration Z,39,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1571,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,07:20,0.0833333333721384,56,56,Days,Dose,Dose Z,365.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1572,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,09:37,0,56,56.09513889,Days,PK,Plasma concentration Z,585.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1573,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,11:42,0,84,79.18194444,Days,PD,Efficacy marker,26.107,,mm,NaN,NaN,,NaN,NaN,NaN
1574,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,07:05,0,84,83.98958333,Days,PK,Plasma concentration Z,43.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1575,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,07:21,0.0833333332557231,84,84.00069444,Days,Dose,Dose Z,368,,mg,NaN,NaN,iv,NaN,NaN,NaN
1576,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,09:44,0,84,84.1,Days,PK,Plasma concentration Z,600,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1577,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,11:20,0,84,84.16666667,Days,PK,Plasma concentration Z,572.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1578,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,13:20,0,84,84.25,Days,PK,Plasma concentration Z,561.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1579,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,28-Aug-1982,07:20,0,91,91,Days,PK,Plasma concentration Z,165.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1580,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,04-Sep-1982,07:29,0,98,98.00625,Days,PK,Plasma concentration Z,91.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1581,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Sep-1982,13:27,0,112,111.2548611,Days,PD,Efficacy marker,25.748,,mm,NaN,NaN,,NaN,NaN,NaN
1582,NaN,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,18-Sep-1982,07:20,0,112,112,Days,PK,Plasma concentration Z,53.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1583,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01736111,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
1584,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01736111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1585,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,24-Apr-1982,07:00,0,-14,-35.01736111,Days,Demographics,Weight,60.5,,kg,NaN,NaN,,NaN,NaN,NaN
1586,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,24-May-1982,11:33,0,0,-4.827777778,Days,PD,Efficacy marker,22.414,,mm,NaN,NaN,,NaN,NaN,NaN
1587,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-May-1982,07:00,0,0,-1.017361111,Days,Demographics,Weight,59.9,,kg,NaN,NaN,,NaN,NaN,NaN
1588,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,29-May-1982,07:25,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1589,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-Jun-1982,11:55,0,28,23.1875,Days,PD,Efficacy marker,22.979,,mm,NaN,NaN,,NaN,NaN,NaN
1590,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-Jun-1982,07:25,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1591,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-Jul-1982,14:40,0,56,51.30208333,Days,PD,Efficacy marker,23.468,,mm,NaN,NaN,,NaN,NaN,NaN
1592,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-Jul-1982,07:25,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1593,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-Aug-1982,12:53,0,84,79.22777778,Days,PD,Efficacy marker,23.752,,mm,NaN,NaN,,NaN,NaN,NaN
1594,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-Aug-1982,07:27,0.0833333333721384,84,84.00138889,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1595,NaN,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,26-Sep-1982,17:10,0,112,120.40625,Days,PD,Efficacy marker,23.843,,mm,NaN,NaN,,NaN,NaN,NaN
1596,NaN,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,28-Apr-1982,07:00,0,-14,-31.00694444,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
1597,NaN,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,28-Apr-1982,07:00,0,-14,-31.00694444,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1598,NaN,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,28-Apr-1982,07:00,0,-14,-31.00694444,Days,Demographics,Weight,81.1,,kg,NaN,NaN,,NaN,NaN,NaN
1599,NaN,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,24-May-1982,12:02,0,0,-4.797222222,Days,PD,Efficacy marker,48.495,,mm,NaN,NaN,,NaN,NaN,NaN
1600,NaN,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-May-1982,07:00,0,0,-1.006944444,Days,Demographics,Weight,79,,kg,NaN,NaN,,NaN,NaN,NaN
1601,NaN,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,29-May-1982,07:10,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1602,NaN,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-Jun-1982,10:20,0,28,23.13194444,Days,PD,Efficacy marker,50.02,,mm,NaN,NaN,,NaN,NaN,NaN
1603,NaN,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-Jun-1982,07:10,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1604,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.02430556,Days,Demographics,Age,62,,Years,NaN,NaN,,NaN,NaN,NaN
1605,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.02430556,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1606,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.02430556,Days,Demographics,Weight,57.2,,kg,NaN,NaN,,NaN,NaN,NaN
1607,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-May-1982,15:08,0,0,-4.685416667,Days,PD,Efficacy marker,26.489,,mm,NaN,NaN,,NaN,NaN,NaN
1608,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-May-1982,07:00,0,0,-1.024305556,Days,Demographics,Weight,56.3,,kg,NaN,NaN,,NaN,NaN,NaN
1609,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:15,0,0,-0.013888889,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1610,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:35,0.0833333332557231,0,0,Days,Dose,Dose Z,282,,mg,NaN,NaN,iv,NaN,NaN,NaN
1611,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,09:51,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,500.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1612,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,12:22,0,28,23.19930556,Days,PD,Efficacy marker,28.845,,mm,NaN,NaN,,NaN,NaN,NaN
1613,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,07:15,0,28,27.98611111,Days,PK,Plasma concentration Z,24,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1614,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,07:30,0.0833333333721384,28,27.99652778,Days,Dose,Dose Z,292,,mg,NaN,NaN,iv,NaN,NaN,NaN
1615,NaN,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,09:48,0,28,28.09236111,Days,PK,Plasma concentration Z,522,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1616,NaN,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.02916667,Days,Demographics,Age,69,,Years,NaN,NaN,,NaN,NaN,NaN
1617,NaN,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.02916667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1618,NaN,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-May-1982,07:00,0,-14,-27.02916667,Days,Demographics,Weight,72.4,,kg,NaN,NaN,,NaN,NaN,NaN
1619,NaN,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-May-1982,13:27,0,0,-4.760416667,Days,PD,Efficacy marker,26.583,,mm,NaN,NaN,,NaN,NaN,NaN
1620,NaN,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-May-1982,07:00,0,0,-1.029166667,Days,Demographics,Weight,71.4,,kg,NaN,NaN,,NaN,NaN,NaN
1621,NaN,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:20,0,0,-0.015277778,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1622,NaN,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,07:42,0.0833333333721384,0,0,Days,Dose,Dose Z,348.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1623,NaN,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-May-1982,09:57,0,0.0833,0.09375,Days,PK,Plasma concentration Z,464.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1624,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-May-1982,07:00,0,-14,-24.03125,Days,Demographics,Age,62,,Years,NaN,NaN,,NaN,NaN,NaN
1625,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-May-1982,07:00,0,-14,-24.03125,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1626,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-May-1982,07:00,0,-14,-24.03125,Days,Demographics,Weight,59.7,,kg,NaN,NaN,,NaN,NaN,NaN
1627,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,24-May-1982,12:48,0,0,-4.789583333,Days,PD,Efficacy marker,22.971,,mm,NaN,NaN,,NaN,NaN,NaN
1628,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-May-1982,07:00,0,0,-1.03125,Days,Demographics,Weight,59.6,,kg,NaN,NaN,,NaN,NaN,NaN
1629,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,29-May-1982,07:45,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1630,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-Jun-1982,13:05,0,28,23.22222222,Days,PD,Efficacy marker,23.794,,mm,NaN,NaN,,NaN,NaN,NaN
1631,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-Jun-1982,07:40,0.0833333332557231,28,27.99652778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1632,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-Jul-1982,15:17,0,56,51.31388889,Days,PD,Efficacy marker,23.379,,mm,NaN,NaN,,NaN,NaN,NaN
1633,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-Jul-1982,07:40,0.0833333332557231,56,55.99652778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1634,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-Aug-1982,12:22,0,84,79.19236111,Days,PD,Efficacy marker,24.007,,mm,NaN,NaN,,NaN,NaN,NaN
1635,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-Aug-1982,07:40,0.0833333332557231,84,83.99652778,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1636,NaN,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,17-Sep-1982,14:20,0,112,111.2743056,Days,PD,Efficacy marker,23.363,,mm,NaN,NaN,,NaN,NaN,NaN
1637,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04166667,Days,Demographics,Age,55,,Years,NaN,NaN,,NaN,NaN,NaN
1638,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04166667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1639,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04166667,Days,Demographics,Weight,57.2,,kg,NaN,NaN,,NaN,NaN,NaN
1640,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-May-1982,07:00,0,0,-5.041666667,Days,Demographics,Weight,58.5,,kg,NaN,NaN,,NaN,NaN,NaN
1641,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-May-1982,08:42,0,0,-4.970833333,Days,PD,Efficacy marker,25.257,,mm,NaN,NaN,,NaN,NaN,NaN
1642,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-May-1982,08:00,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1643,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,16-Jun-1982,08:33,0,28,23.02291667,Days,PD,Efficacy marker,25.474,,mm,NaN,NaN,,NaN,NaN,NaN
1644,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-Jun-1982,08:00,0.0833333332557231,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1645,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,14-Jul-1982,08:28,0,56,51.01944444,Days,PD,Efficacy marker,25.144,,mm,NaN,NaN,,NaN,NaN,NaN
1646,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-Jul-1982,09:00,0.0833333333721384,56,56.04166667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1647,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,11-Aug-1982,08:33,0,84,79.02291667,Days,PD,Efficacy marker,25.39,,mm,NaN,NaN,,NaN,NaN,NaN
1648,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-Aug-1982,08:00,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1649,NaN,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,15-Sep-1982,08:49,0,112,114.0340278,Days,PD,Efficacy marker,24.778,,mm,NaN,NaN,,NaN,NaN,NaN
1650,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04583333,Days,Demographics,Age,55,,Years,NaN,NaN,,NaN,NaN,NaN
1651,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04583333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1652,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04583333,Days,Demographics,Weight,71.2,,kg,NaN,NaN,,NaN,NaN,NaN
1653,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-May-1982,07:00,0,0,-5.045833333,Days,Demographics,Weight,72.1,,kg,NaN,NaN,,NaN,NaN,NaN
1654,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-May-1982,12:58,0,0,-4.797222222,Days,PD,Efficacy marker,27.493,,mm,NaN,NaN,,NaN,NaN,NaN
1655,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-May-1982,07:36,0,0,-0.020833333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1656,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-May-1982,08:06,0.0833333332557231,0,0,Days,Dose,Dose Z,360.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1657,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-May-1982,10:06,0,0.0833,0.083333333,Days,PK,Plasma concentration Z,564,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1658,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,16-Jun-1982,13:01,0,28,23.20486111,Days,PD,Efficacy marker,28.308,,mm,NaN,NaN,,NaN,NaN,NaN
1659,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,07:36,0,28,27.97916667,Days,PK,Plasma concentration Z,47.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1660,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,08:05,0.0833333333721384,28,27.99930556,Days,Dose,Dose Z,349.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1661,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,10:09,0,28,28.08541667,Days,PK,Plasma concentration Z,530.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1662,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-Jul-1982,12:52,0,56,51.19861111,Days,PD,Efficacy marker,28.994,,mm,NaN,NaN,,NaN,NaN,NaN
1663,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Jul-1982,08:36,0,56,56.02083333,Days,PK,Plasma concentration Z,75,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1664,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Jul-1982,09:06,0.0833333333721384,56,56.04166667,Days,Dose,Dose Z,336.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1665,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Jul-1982,11:11,0,56,56.12847222,Days,PK,Plasma concentration Z,558,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1666,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,11-Aug-1982,13:04,0,84,79.20694444,Days,PD,Efficacy marker,28.973,,mm,NaN,NaN,,NaN,NaN,NaN
1667,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,07:36,0,84,83.97916667,Days,PK,Plasma concentration Z,94.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1668,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,08:06,0.0833333332557231,84,84,Days,Dose,Dose Z,326.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1669,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,10:09,0,84,84.08541667,Days,PK,Plasma concentration Z,549.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1670,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,12:05,0,84,84.16597222,Days,PK,Plasma concentration Z,594,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1671,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,14:05,0,84,84.24930556,Days,PK,Plasma concentration Z,579.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1672,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,23-Aug-1982,08:09,0,91,91.00208333,Days,PK,Plasma concentration Z,183.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1673,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,30-Aug-1982,08:05,0,98,97.99930556,Days,PK,Plasma concentration Z,148.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1674,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-Sep-1982,11:17,0,112,114.1326389,Days,PK,Plasma concentration Z,109.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1675,NaN,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-Sep-1982,13:01,0,112,114.2048611,Days,PD,Efficacy marker,29.005,,mm,NaN,NaN,,NaN,NaN,NaN
1676,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04375,Days,Demographics,Age,63,,Years,NaN,NaN,,NaN,NaN,NaN
1677,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04375,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1678,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-39.04375,Days,Demographics,Weight,65.5,,kg,NaN,NaN,,NaN,NaN,NaN
1679,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-May-1982,07:00,0,0,-5.04375,Days,Demographics,Weight,67.8,,kg,NaN,NaN,,NaN,NaN,NaN
1680,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-May-1982,10:05,0,0,-4.915277778,Days,PD,Efficacy marker,35.26,,mm,NaN,NaN,,NaN,NaN,NaN
1681,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-May-1982,07:33,0,0,-0.020833333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1682,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-May-1982,08:03,0.0833333332557231,0,0,Days,Dose,Dose Z,335,,mg,NaN,NaN,iv,NaN,NaN,NaN
1683,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-May-1982,10:11,0,0.0833,0.088888889,Days,PK,Plasma concentration Z,420,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1684,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,16-Jun-1982,10:10,0,28,23.08819444,Days,PD,Efficacy marker,36.384,,mm,NaN,NaN,,NaN,NaN,NaN
1685,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,07:32,0,28,27.97847222,Days,PK,Plasma concentration Z,23.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1686,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,08:03,0.0833333332557231,28,28,Days,Dose,Dose Z,337,,mg,NaN,NaN,iv,NaN,NaN,NaN
1687,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-Jun-1982,10:09,0,28,28.0875,Days,PK,Plasma concentration Z,410.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1688,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-Jul-1982,10:04,0,56,51.08402778,Days,PD,Efficacy marker,36.105,,mm,NaN,NaN,,NaN,NaN,NaN
1689,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Jul-1982,08:32,0,56,56.02013889,Days,PK,Plasma concentration Z,36.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1690,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Jul-1982,09:03,0.0833333333721384,56,56.04166667,Days,Dose,Dose Z,339,,mg,NaN,NaN,iv,NaN,NaN,NaN
1691,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Jul-1982,11:06,0,56,56.12708333,Days,PK,Plasma concentration Z,368.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1692,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,11-Aug-1982,13:42,0,84,79.23541667,Days,PD,Efficacy marker,38.012,,mm,NaN,NaN,,NaN,NaN,NaN
1693,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,07:33,0,84,83.97916667,Days,PK,Plasma concentration Z,43.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1694,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,08:03,0.0833333332557231,84,84,Days,Dose,Dose Z,344.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1695,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,10:05,0,84,84.08472222,Days,PK,Plasma concentration Z,434.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1696,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,12:02,0,84,84.16597222,Days,PK,Plasma concentration Z,405.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1697,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Aug-1982,14:02,0,84,84.24930556,Days,PK,Plasma concentration Z,408,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1698,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,23-Aug-1982,08:05,0,91,91.00138889,Days,PK,Plasma concentration Z,143.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1699,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,30-Aug-1982,08:03,0,98,98,Days,PK,Plasma concentration Z,94.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1700,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-Sep-1982,08:16,0,112,114.0090278,Days,PK,Plasma concentration Z,57.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1701,NaN,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-Sep-1982,14:50,0,112,122.2826389,Days,PD,Efficacy marker,40.023,,mm,NaN,NaN,,NaN,NaN,NaN
1702,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-67.05,Days,Demographics,Age,63,,Years,NaN,NaN,,NaN,NaN,NaN
1703,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-67.05,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1704,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-67.05,Days,Demographics,Weight,52.3,,kg,NaN,NaN,,NaN,NaN,NaN
1705,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,16-Jun-1982,07:00,0,0,-5.05,Days,Demographics,Weight,53.3,,kg,NaN,NaN,,NaN,NaN,NaN
1706,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,16-Jun-1982,11:46,0,0,-4.851388889,Days,PD,Efficacy marker,25.518,,mm,NaN,NaN,,NaN,NaN,NaN
1707,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,21-Jun-1982,08:12,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1708,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,14-Jul-1982,11:35,0,28,23.14097222,Days,PD,Efficacy marker,24.961,,mm,NaN,NaN,,NaN,NaN,NaN
1709,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,19-Jul-1982,09:12,0.0833333333721384,28,28.04166667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1710,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,11-Aug-1982,11:36,0,56,51.14166667,Days,PD,Efficacy marker,24.525,,mm,NaN,NaN,,NaN,NaN,NaN
1711,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-Aug-1982,08:12,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1712,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,08-Sep-1982,11:57,0,84,79.15625,Days,PD,Efficacy marker,25.309,,mm,NaN,NaN,,NaN,NaN,NaN
1713,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-Sep-1982,08:12,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1714,NaN,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,13-Oct-1982,11:32,0,112,114.1388889,Days,PD,Efficacy marker,25.625,,mm,NaN,NaN,,NaN,NaN,NaN
1715,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-67.04791667,Days,Demographics,Age,57,,Years,NaN,NaN,,NaN,NaN,NaN
1716,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-67.04791667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1717,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-Apr-1982,07:00,0,-14,-67.04791667,Days,Demographics,Weight,61.4,,kg,NaN,NaN,,NaN,NaN,NaN
1718,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,16-Jun-1982,07:00,0,0,-5.047916667,Days,Demographics,Weight,60.9,,kg,NaN,NaN,,NaN,NaN,NaN
1719,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,16-Jun-1982,07:08,0,0,-5.042361111,Days,PD,Efficacy marker,42.399,,mm,NaN,NaN,,NaN,NaN,NaN
1720,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,21-Jun-1982,08:09,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1721,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,14-Jul-1982,07:02,0,28,22.95347222,Days,PD,Efficacy marker,42.918,,mm,NaN,NaN,,NaN,NaN,NaN
1722,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,19-Jul-1982,09:09,0.0833333333721384,28,28.04166667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1723,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,11-Aug-1982,07:34,0,56,50.97569444,Days,PD,Efficacy marker,43.02,,mm,NaN,NaN,,NaN,NaN,NaN
1724,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-Aug-1982,08:09,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1725,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,08-Sep-1982,07:10,0,84,78.95902778,Days,PD,Efficacy marker,41.842,,mm,NaN,NaN,,NaN,NaN,NaN
1726,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-Sep-1982,08:09,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1727,NaN,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,13-Oct-1982,12:49,0,112,114.1944444,Days,PD,Efficacy marker,40.973,,mm,NaN,NaN,,NaN,NaN,NaN
1728,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.08333333,Days,Demographics,Age,69,,Years,NaN,NaN,,NaN,NaN,NaN
1729,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.08333333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1730,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.08333333,Days,Demographics,Weight,58.9,,kg,NaN,NaN,,NaN,NaN,NaN
1731,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-May-1982,07:00,0,0,-5.083333333,Days,Demographics,Weight,59,,kg,NaN,NaN,,NaN,NaN,NaN
1732,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-May-1982,07:08,0,0,-5.077777778,Days,PD,Efficacy marker,25.664,,mm,NaN,NaN,,NaN,NaN,NaN
1733,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-Jun-1982,09:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1734,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-Jun-1982,06:55,0,28,22.91319444,Days,PD,Efficacy marker,25.603,,mm,NaN,NaN,,NaN,NaN,NaN
1735,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-Jul-1982,08:00,0.0833333332557231,28,27.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1736,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-Jul-1982,07:10,0,56,50.92361111,Days,PD,Efficacy marker,25.201,,mm,NaN,NaN,,NaN,NaN,NaN
1737,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-Jul-1982,08:00,0.0833333332557231,56,55.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1738,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,22-Aug-1982,07:13,0,84,79.92569444,Days,PD,Efficacy marker,25.162,,mm,NaN,NaN,,NaN,NaN,NaN
1739,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-Aug-1982,08:00,0.0833333332557231,84,83.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1740,NaN,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,23-Sep-1982,07:26,0,112,111.9347222,Days,PD,Efficacy marker,24.711,,mm,NaN,NaN,,NaN,NaN,NaN
1741,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.0875,Days,Demographics,Age,67,,Years,NaN,NaN,,NaN,NaN,NaN
1742,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.0875,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1743,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.0875,Days,Demographics,Weight,86.6,,kg,NaN,NaN,,NaN,NaN,NaN
1744,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,29-May-1982,07:00,0,0,-5.0875,Days,Demographics,Weight,84.8,,kg,NaN,NaN,,NaN,NaN,NaN
1745,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,29-May-1982,10:03,0,0,-4.960416667,Days,PD,Efficacy marker,43.577,,mm,NaN,NaN,,NaN,NaN,NaN
1746,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-Jun-1982,07:36,0,0,-0.0625,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1747,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-Jun-1982,09:06,0.0833333333721384,0,0,Days,Dose,Dose Z,427,,mg,NaN,NaN,iv,NaN,NaN,NaN
1748,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-Jun-1982,11:11,0,0.0833,0.086805556,Days,PK,Plasma concentration Z,504,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1749,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,10:03,0,28,23.03958333,Days,PD,Efficacy marker,46.519,,mm,NaN,NaN,,NaN,NaN,NaN
1750,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Jul-1982,07:36,0,28,27.9375,Days,PK,Plasma concentration Z,33.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1751,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Jul-1982,08:06,0.0833333332557231,28,27.95833333,Days,Dose,Dose Z,429.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1752,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Jul-1982,10:08,0,28,28.04305556,Days,PK,Plasma concentration Z,444,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1753,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,10:11,0,56,51.04513889,Days,PD,Efficacy marker,48.584,,mm,NaN,NaN,,NaN,NaN,NaN
1754,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Jul-1982,07:35,0,56,55.93680556,Days,PK,Plasma concentration Z,51.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1755,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Jul-1982,08:06,0.0833333332557231,56,55.95833333,Days,Dose,Dose Z,426.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1756,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Jul-1982,10:08,0,56,56.04305556,Days,PK,Plasma concentration Z,582,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1757,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,10:03,0,84,79.03958333,Days,PD,Efficacy marker,48.031,,mm,NaN,NaN,,NaN,NaN,NaN
1758,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,07:35,0,84,83.93680556,Days,PK,Plasma concentration Z,66.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1759,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,08:06,0.0833333332557231,84,83.95833333,Days,Dose,Dose Z,418,,mg,NaN,NaN,iv,NaN,NaN,NaN
1760,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,10:08,0,84,84.04305556,Days,PK,Plasma concentration Z,495.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1761,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,12:05,0,84,84.12430556,Days,PK,Plasma concentration Z,560.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1762,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,14:06,0,84,84.20833333,Days,PK,Plasma concentration Z,489.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1763,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,02-Sep-1982,08:06,0,91,90.95833333,Days,PK,Plasma concentration Z,164.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1764,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,09-Sep-1982,08:06,0,98,97.95833333,Days,PK,Plasma concentration Z,120.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1765,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-Sep-1982,08:16,0,112,111.9652778,Days,PK,Plasma concentration Z,75.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1766,NaN,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-Sep-1982,10:15,0,112,112.0479167,Days,PD,Efficacy marker,47.32,,mm,NaN,NaN,,NaN,NaN,NaN
1767,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.08541667,Days,Demographics,Age,57,,Years,NaN,NaN,,NaN,NaN,NaN
1768,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.08541667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1769,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-Apr-1982,07:00,0,-14,-35.08541667,Days,Demographics,Weight,75.4,,kg,NaN,NaN,,NaN,NaN,NaN
1770,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-May-1982,07:00,0,0,-5.085416667,Days,Demographics,Weight,76,,kg,NaN,NaN,,NaN,NaN,NaN
1771,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-May-1982,08:33,0,0,-5.020833333,Days,PD,Efficacy marker,28.354,,mm,NaN,NaN,,NaN,NaN,NaN
1772,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-Jun-1982,09:03,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1773,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-Jun-1982,08:29,0,28,22.97638889,Days,PD,Efficacy marker,27.985,,mm,NaN,NaN,,NaN,NaN,NaN
1774,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-Jul-1982,08:03,0.0833333332557231,28,27.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1775,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-Jul-1982,08:40,0,56,50.98402778,Days,PD,Efficacy marker,28.474,,mm,NaN,NaN,,NaN,NaN,NaN
1776,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-Jul-1982,08:03,0.0833333332557231,56,55.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1777,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-Aug-1982,08:22,0,84,78.97152778,Days,PD,Efficacy marker,28.502,,mm,NaN,NaN,,NaN,NaN,NaN
1778,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-Aug-1982,08:03,0.0833333332557231,84,83.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1779,NaN,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,23-Sep-1982,08:38,0,112,111.9826389,Days,PD,Efficacy marker,28.993,,mm,NaN,NaN,,NaN,NaN,NaN
1780,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-28.08958333,Days,Demographics,Age,50,,Years,NaN,NaN,,NaN,NaN,NaN
1781,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-28.08958333,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1782,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-28.08958333,Days,Demographics,Weight,83.2,,kg,NaN,NaN,,NaN,NaN,NaN
1783,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-May-1982,07:00,0,0,-5.089583333,Days,Demographics,Weight,81.1,,kg,NaN,NaN,,NaN,NaN,NaN
1784,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-May-1982,15:36,0,0,-3.73125,Days,PD,Efficacy marker,49.802,,mm,NaN,NaN,,NaN,NaN,NaN
1785,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-Jun-1982,09:09,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1786,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-Jun-1982,11:30,0,28,23.09791667,Days,PD,Efficacy marker,52.582,,mm,NaN,NaN,,NaN,NaN,NaN
1787,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-Jul-1982,08:09,0.0833333333721384,28,27.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1788,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-Jul-1982,11:44,0,56,51.10763889,Days,PD,Efficacy marker,52.92,,mm,NaN,NaN,,NaN,NaN,NaN
1789,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-Jul-1982,08:09,0.0833333333721384,56,55.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1790,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-Aug-1982,11:32,0,84,79.09930556,Days,PD,Efficacy marker,50.672,,mm,NaN,NaN,,NaN,NaN,NaN
1791,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-Aug-1982,08:09,0.0833333333721384,84,83.95833333,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1792,NaN,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,23-Sep-1982,11:50,0,112,112.1118056,Days,PD,Efficacy marker,51.73,,mm,NaN,NaN,,NaN,NaN,NaN
1793,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.05,Days,Demographics,Age,52,,Years,NaN,NaN,,NaN,NaN,NaN
1794,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.05,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1795,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.05,Days,Demographics,Weight,106.1,,kg,NaN,NaN,,NaN,NaN,NaN
1796,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-Jun-1982,07:00,0,0,-5.05,Days,Demographics,Weight,107.5,,kg,NaN,NaN,,NaN,NaN,NaN
1797,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-Jun-1982,12:56,0,0,-4.802777778,Days,PD,Efficacy marker,51.354,,mm,NaN,NaN,,NaN,NaN,NaN
1798,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-Jun-1982,07:41,0,0,-0.021527778,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1799,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-Jun-1982,08:12,0.0833333333721384,0,0,Days,Dose,Dose Z,538,,mg,NaN,NaN,iv,NaN,NaN,NaN
1800,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-Jun-1982,10:16,0,0.0833,0.086111111,Days,PK,Plasma concentration Z,528,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1801,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-Jul-1982,13:09,0,28,23.20625,Days,PD,Efficacy marker,53.077,,mm,NaN,NaN,,NaN,NaN,NaN
1802,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-Jul-1982,08:42,0,28,28.02083333,Days,PK,Plasma concentration Z,36.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1803,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-Jul-1982,09:12,0.0833333333721384,28,28.04166667,Days,Dose,Dose Z,533.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1804,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-Jul-1982,11:16,0,28,28.12777778,Days,PK,Plasma concentration Z,501.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1805,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-Aug-1982,12:59,0,56,52.19930556,Days,PD,Efficacy marker,53.676,,mm,NaN,NaN,,NaN,NaN,NaN
1806,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-Aug-1982,07:42,0,56,55.97916667,Days,PK,Plasma concentration Z,51,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1807,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-Aug-1982,08:12,0.0833333333721384,56,56,Days,Dose,Dose Z,530.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1808,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-Aug-1982,10:17,0,56,56.08680556,Days,PK,Plasma concentration Z,561.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1809,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Sep-1982,12:58,0,84,79.19861111,Days,PD,Efficacy marker,53.142,,mm,NaN,NaN,,NaN,NaN,NaN
1810,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,07:41,0,84,83.97847222,Days,PK,Plasma concentration Z,70.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1811,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,08:12,0.0833333333721384,84,84,Days,Dose,Dose Z,527,,mg,NaN,NaN,iv,NaN,NaN,NaN
1812,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,10:18,0,84,84.0875,Days,PK,Plasma concentration Z,678,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1813,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,12:12,0,84,84.16666667,Days,PK,Plasma concentration Z,603.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1814,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,14:11,0,84,84.24930556,Days,PK,Plasma concentration Z,555.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1815,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,13-Sep-1982,08:11,0,91,90.99930556,Days,PK,Plasma concentration Z,191.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1816,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,20-Sep-1982,08:15,0,98,98.00208333,Days,PK,Plasma concentration Z,122.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1817,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Oct-1982,11:11,0,112,114.1243056,Days,PK,Plasma concentration Z,79.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1818,NaN,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Oct-1982,13:02,0,112,114.2013889,Days,PD,Efficacy marker,54.455,,mm,NaN,NaN,,NaN,NaN,NaN
1819,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04791667,Days,Demographics,Age,52,,Years,NaN,NaN,,NaN,NaN,NaN
1820,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04791667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1821,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04791667,Days,Demographics,Weight,57.4,,kg,NaN,NaN,,NaN,NaN,NaN
1822,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-Jun-1982,07:00,0,0,-5.047916667,Days,Demographics,Weight,57.2,,kg,NaN,NaN,,NaN,NaN,NaN
1823,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-Jun-1982,11:29,0,0,-4.861111111,Days,PD,Efficacy marker,31.667,,mm,NaN,NaN,,NaN,NaN,NaN
1824,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-Jun-1982,07:39,0,0,-0.020833333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1825,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-Jun-1982,08:09,0.0833333333721384,0,0,Days,Dose,Dose Z,287,,mg,NaN,NaN,iv,NaN,NaN,NaN
1826,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-Jun-1982,10:13,0,0.0833,0.086111111,Days,PK,Plasma concentration Z,404.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1827,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-Jul-1982,11:28,0,28,23.13819444,Days,PD,Efficacy marker,33.676,,mm,NaN,NaN,,NaN,NaN,NaN
1828,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-Jul-1982,08:39,0,28,28.02083333,Days,PK,Plasma concentration Z,32.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1829,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-Jul-1982,09:09,0.0833333333721384,28,28.04166667,Days,Dose,Dose Z,291,,mg,NaN,NaN,iv,NaN,NaN,NaN
1830,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-Jul-1982,11:14,0,28,28.12847222,Days,PK,Plasma concentration Z,465.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1831,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-Aug-1982,11:29,0,56,52.13888889,Days,PD,Efficacy marker,33.001,,mm,NaN,NaN,,NaN,NaN,NaN
1832,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-Aug-1982,07:38,0,56,55.97847222,Days,PK,Plasma concentration Z,47.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1833,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-Aug-1982,08:09,0.0833333333721384,56,56,Days,Dose,Dose Z,289,,mg,NaN,NaN,iv,NaN,NaN,NaN
1834,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-Aug-1982,10:16,0,56,56.08819444,Days,PK,Plasma concentration Z,410.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1835,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-Sep-1982,11:33,0,84,79.14166667,Days,PD,Efficacy marker,33.857,,mm,NaN,NaN,,NaN,NaN,NaN
1836,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,07:38,0,84,83.97847222,Days,PK,Plasma concentration Z,75.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1837,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,08:09,0.0833333333721384,84,84,Days,Dose,Dose Z,292,,mg,NaN,NaN,iv,NaN,NaN,NaN
1838,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,10:14,0,84,84.08680556,Days,PK,Plasma concentration Z,567.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1839,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,12:09,0,84,84.16666667,Days,PK,Plasma concentration Z,477.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1840,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-Sep-1982,14:09,0,84,84.25,Days,PK,Plasma concentration Z,411.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1841,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,13-Sep-1982,08:08,0,91,90.99930556,Days,PK,Plasma concentration Z,147.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1842,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,20-Sep-1982,08:12,0,98,98.00208333,Days,PK,Plasma concentration Z,113.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1843,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Oct-1982,09:44,0,112,114.0659722,Days,PK,Plasma concentration Z,69.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1844,NaN,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-Oct-1982,11:34,0,112,114.1423611,Days,PD,Efficacy marker,34.53,,mm,NaN,NaN,,NaN,NaN,NaN
1845,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04166667,Days,Demographics,Age,57,,Years,NaN,NaN,,NaN,NaN,NaN
1846,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04166667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1847,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04166667,Days,Demographics,Weight,99.9,,kg,NaN,NaN,,NaN,NaN,NaN
1848,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,07:00,0,0,-5.041666667,Days,Demographics,Weight,100,,kg,NaN,NaN,,NaN,NaN,NaN
1849,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,07:48,0,0,-5.008333333,Days,PD,Efficacy marker,58.087,,mm,NaN,NaN,,NaN,NaN,NaN
1850,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,14-Jun-1982,08:00,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1851,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-Jul-1982,07:07,0,28,22.96319444,Days,PD,Efficacy marker,59.743,,mm,NaN,NaN,,NaN,NaN,NaN
1852,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-Jul-1982,09:00,0.0833333333721384,28,28.04166667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1853,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-Aug-1982,07:06,0,56,51.9625,Days,PD,Efficacy marker,60.388,,mm,NaN,NaN,,NaN,NaN,NaN
1854,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-Aug-1982,08:00,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1855,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,01-Sep-1982,07:12,0,84,78.96666667,Days,PD,Efficacy marker,59.342,,mm,NaN,NaN,,NaN,NaN,NaN
1856,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,06-Sep-1982,08:00,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1857,NaN,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-Oct-1982,07:01,0,112,113.9590278,Days,PD,Efficacy marker,58.891,,mm,NaN,NaN,,NaN,NaN,NaN
1858,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04375,Days,Demographics,Age,57,,Years,NaN,NaN,,NaN,NaN,NaN
1859,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04375,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1860,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04375,Days,Demographics,Weight,79.7,,kg,NaN,NaN,,NaN,NaN,NaN
1861,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,07:00,0,0,-5.04375,Days,Demographics,Weight,79.8,,kg,NaN,NaN,,NaN,NaN,NaN
1862,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,08:36,0,0,-4.977083333,Days,PD,Efficacy marker,44.835,,mm,NaN,NaN,,NaN,NaN,NaN
1863,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,14-Jun-1982,08:03,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1864,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-Jul-1982,08:28,0,28,23.01736111,Days,PD,Efficacy marker,44.769,,mm,NaN,NaN,,NaN,NaN,NaN
1865,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-Jul-1982,09:03,0.0833333333721384,28,28.04166667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1866,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-Aug-1982,08:24,0,56,52.01458333,Days,PD,Efficacy marker,44.099,,mm,NaN,NaN,,NaN,NaN,NaN
1867,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-Aug-1982,08:03,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1868,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,01-Sep-1982,08:33,0,84,79.02083333,Days,PD,Efficacy marker,44.829,,mm,NaN,NaN,,NaN,NaN,NaN
1869,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,06-Sep-1982,08:03,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1870,NaN,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-Oct-1982,08:28,0,112,114.0173611,Days,PD,Efficacy marker,45.577,,mm,NaN,NaN,,NaN,NaN,NaN
1871,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-28.09166667,Days,Demographics,Age,59,,Years,NaN,NaN,,NaN,NaN,NaN
1872,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-28.09166667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1873,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-28.09166667,Days,Demographics,Weight,76.9,,kg,NaN,NaN,,NaN,NaN,NaN
1874,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,29-May-1982,07:00,0,0,-5.091666667,Days,Demographics,Weight,75.2,,kg,NaN,NaN,,NaN,NaN,NaN
1875,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,29-May-1982,13:05,0,0,-4.838194444,Days,PD,Efficacy marker,41.081,,mm,NaN,NaN,,NaN,NaN,NaN
1876,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-Jun-1982,07:42,0,0,-0.0625,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1877,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-Jun-1982,09:12,0.0833333333721384,0,0,Days,Dose,Dose Z,369,,mg,NaN,NaN,iv,NaN,NaN,NaN
1878,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-Jun-1982,11:15,0,0.0833,0.085416667,Days,PK,Plasma concentration Z,578.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1879,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-Jun-1982,13:00,0,28,23.15833333,Days,PD,Efficacy marker,42.152,,mm,NaN,NaN,,NaN,NaN,NaN
1880,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Jul-1982,07:42,0,28,27.9375,Days,PK,Plasma concentration Z,40.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1881,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Jul-1982,08:12,0.0833333333721384,28,27.95833333,Days,Dose,Dose Z,374,,mg,NaN,NaN,iv,NaN,NaN,NaN
1882,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-Jul-1982,10:18,0,28,28.04583333,Days,PK,Plasma concentration Z,600,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1883,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-Jul-1982,13:25,0,56,51.17569444,Days,PD,Efficacy marker,43.731,,mm,NaN,NaN,,NaN,NaN,NaN
1884,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Jul-1982,07:41,0,56,55.93680556,Days,PK,Plasma concentration Z,56.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1885,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Jul-1982,08:12,0.0833333333721384,56,55.95833333,Days,Dose,Dose Z,372,,mg,NaN,NaN,iv,NaN,NaN,NaN
1886,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-Jul-1982,10:15,0,56,56.04375,Days,PK,Plasma concentration Z,542.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1887,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-Aug-1982,13:01,0,84,79.15902778,Days,PD,Efficacy marker,43.435,,mm,NaN,NaN,,NaN,NaN,NaN
1888,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,07:41,0,84,83.93680556,Days,PK,Plasma concentration Z,80.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1889,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,08:12,0.0833333333721384,84,83.95833333,Days,Dose,Dose Z,366,,mg,NaN,NaN,iv,NaN,NaN,NaN
1890,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,10:18,0,84,84.04583333,Days,PK,Plasma concentration Z,636,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1891,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,12:11,0,84,84.12430556,Days,PK,Plasma concentration Z,548.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1892,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-Aug-1982,14:12,0,84,84.20833333,Days,PK,Plasma concentration Z,507.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1893,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,02-Sep-1982,08:12,0,91,90.95833333,Days,PK,Plasma concentration Z,150.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1894,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,08-Sep-1982,08:38,0,98,96.97638889,Days,PK,Plasma concentration Z,122.4,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1895,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-Sep-1982,11:43,0,112,112.1048611,Days,PK,Plasma concentration Z,72.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
1896,NaN,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-Sep-1982,13:19,0,112,112.1715278,Days,PD,Efficacy marker,44.085,,mm,NaN,NaN,,NaN,NaN,NaN
1897,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04583333,Days,Demographics,Age,55,,Years,NaN,NaN,,NaN,NaN,NaN
1898,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04583333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1899,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-May-1982,07:00,0,-14,-39.04583333,Days,Demographics,Weight,77.9,,kg,NaN,NaN,,NaN,NaN,NaN
1900,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,07:00,0,0,-5.045833333,Days,Demographics,Weight,79,,kg,NaN,NaN,,NaN,NaN,NaN
1901,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,10:04,0,0,-4.918055556,Days,PD,Efficacy marker,30.847,,mm,NaN,NaN,,NaN,NaN,NaN
1902,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,14-Jun-1982,08:06,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1903,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-Jul-1982,10:22,0,28,23.09444444,Days,PD,Efficacy marker,31.189,,mm,NaN,NaN,,NaN,NaN,NaN
1904,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-Jul-1982,09:06,0.0833333333721384,28,28.04166667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1905,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-Aug-1982,09:52,0,56,52.07361111,Days,PD,Efficacy marker,31.117,,mm,NaN,NaN,,NaN,NaN,NaN
1906,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-Aug-1982,08:06,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1907,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,01-Sep-1982,09:59,0,84,79.07847222,Days,PD,Efficacy marker,31.206,,mm,NaN,NaN,,NaN,NaN,NaN
1908,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,06-Sep-1982,08:06,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1909,NaN,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-Oct-1982,10:02,0,112,114.0805556,Days,PD,Efficacy marker,31.521,,mm,NaN,NaN,,NaN,NaN,NaN
1910,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04375,Days,Demographics,Age,59,,Years,NaN,NaN,,NaN,NaN,NaN
1911,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04375,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1912,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04375,Days,Demographics,Weight,84.5,,kg,NaN,NaN,,NaN,NaN,NaN
1913,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-Jun-1982,07:00,0,0,-5.04375,Days,Demographics,Weight,82.5,,kg,NaN,NaN,,NaN,NaN,NaN
1914,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-Jun-1982,08:45,0,0,-4.970833333,Days,PD,Efficacy marker,39.849,,mm,NaN,NaN,,NaN,NaN,NaN
1915,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-Jun-1982,08:03,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1916,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,17-Jul-1982,08:43,0,28,23.02777778,Days,PD,Efficacy marker,39.243,,mm,NaN,NaN,,NaN,NaN,NaN
1917,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,22-Jul-1982,08:03,0.0833333332557231,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1918,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,14-Aug-1982,08:44,0,56,51.02847222,Days,PD,Efficacy marker,40.025,,mm,NaN,NaN,,NaN,NaN,NaN
1919,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-Aug-1982,08:03,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1920,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,12-Sep-1982,08:55,0,84,80.03611111,Days,PD,Efficacy marker,39.675,,mm,NaN,NaN,,NaN,NaN,NaN
1921,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-Sep-1982,08:03,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1922,NaN,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,14-Oct-1982,08:38,0,112,112.0243056,Days,PD,Efficacy marker,40.756,,mm,NaN,NaN,,NaN,NaN,NaN
1923,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04166667,Days,Demographics,Age,50,,Years,NaN,NaN,,NaN,NaN,NaN
1924,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04166667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
1925,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04166667,Days,Demographics,Weight,75.7,,kg,NaN,NaN,,NaN,NaN,NaN
1926,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-Jun-1982,07:00,0,0,-5.041666667,Days,Demographics,Weight,77.7,,kg,NaN,NaN,,NaN,NaN,NaN
1927,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-Jun-1982,07:08,0,0,-5.036111111,Days,PD,Efficacy marker,35.532,,mm,NaN,NaN,,NaN,NaN,NaN
1928,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-Jun-1982,08:00,0.0833333332557231,0,0,Days,Dose,Dose Z,387.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1929,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,17-Jul-1982,07:05,0,28,22.96180556,Days,PD,Efficacy marker,37.335,,mm,NaN,NaN,,NaN,NaN,NaN
1930,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,22-Jul-1982,08:00,0.0833333332557231,28,28,Days,Dose,Dose Z,393,,mg,NaN,NaN,iv,NaN,NaN,NaN
1931,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-Aug-1982,07:01,0,56,50.95902778,Days,PD,Efficacy marker,38.617,,mm,NaN,NaN,,NaN,NaN,NaN
1932,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Aug-1982,08:00,0.0833333332557231,56,56,Days,Dose,Dose Z,401.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1933,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,12-Sep-1982,07:07,0,84,79.96319444,Days,PD,Efficacy marker,38.023,,mm,NaN,NaN,,NaN,NaN,NaN
1934,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Sep-1982,08:00,0.0833333332557231,84,84,Days,Dose,Dose Z,392.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1935,NaN,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,14-Oct-1982,06:51,0,112,111.9520833,Days,PD,Efficacy marker,37.549,,mm,NaN,NaN,,NaN,NaN,NaN
1936,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04791667,Days,Demographics,Age,68,,Years,NaN,NaN,,NaN,NaN,NaN
1937,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04791667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1938,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04791667,Days,Demographics,Weight,75.7,,kg,NaN,NaN,,NaN,NaN,NaN
1939,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-Jun-1982,07:00,0,0,-5.047916667,Days,Demographics,Weight,73.2,,kg,NaN,NaN,,NaN,NaN,NaN
1940,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,23-Jun-1982,15:41,0,0,-0.686111111,Days,PD,Efficacy marker,36.566,,mm,NaN,NaN,,NaN,NaN,NaN
1941,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-Jun-1982,08:09,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1942,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,17-Jul-1982,12:59,0,28,23.20138889,Days,PD,Efficacy marker,34.976,,mm,NaN,NaN,,NaN,NaN,NaN
1943,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,22-Jul-1982,08:09,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1944,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-Aug-1982,08:09,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1945,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,03-Sep-1982,08:22,0,56,71.00902778,Days,PD,Efficacy marker,34.847,,mm,NaN,NaN,,NaN,NaN,NaN
1946,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-Sep-1982,08:09,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1947,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,22-Sep-1982,18:02,0,84,90.41180556,Days,PD,Efficacy marker,34.805,,mm,NaN,NaN,,NaN,NaN,NaN
1948,NaN,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,14-Oct-1982,13:00,0,112,112.2020833,Days,PD,Efficacy marker,35.792,,mm,NaN,NaN,,NaN,NaN,NaN
1949,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04583333,Days,Demographics,Age,51,,Years,NaN,NaN,,NaN,NaN,NaN
1950,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04583333,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1951,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-May-1982,07:00,0,-14,-35.04583333,Days,Demographics,Weight,95.3,,kg,NaN,NaN,,NaN,NaN,NaN
1952,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-Jun-1982,07:00,0,0,-5.045833333,Days,Demographics,Weight,95.2,,kg,NaN,NaN,,NaN,NaN,NaN
1953,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-Jun-1982,09:55,0,0,-4.924305556,Days,PD,Efficacy marker,54.17,,mm,NaN,NaN,,NaN,NaN,NaN
1954,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-Jun-1982,08:06,0.0833333332557231,0,0,Days,Dose,Dose Z,485,,mg,NaN,NaN,iv,NaN,NaN,NaN
1955,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,17-Jul-1982,10:03,0,28,23.08125,Days,PD,Efficacy marker,55.516,,mm,NaN,NaN,,NaN,NaN,NaN
1956,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,22-Jul-1982,08:06,0.0833333332557231,28,28,Days,Dose,Dose Z,493.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1957,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-Aug-1982,10:00,0,56,51.07916667,Days,PD,Efficacy marker,56.436,,mm,NaN,NaN,,NaN,NaN,NaN
1958,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-Aug-1982,08:06,0.0833333332557231,56,56,Days,Dose,Dose Z,495.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1959,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,12-Sep-1982,10:09,0,84,80.08541667,Days,PD,Efficacy marker,57.564,,mm,NaN,NaN,,NaN,NaN,NaN
1960,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-Sep-1982,08:06,0.0833333332557231,84,84,Days,Dose,Dose Z,486,,mg,NaN,NaN,iv,NaN,NaN,NaN
1961,NaN,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,14-Oct-1982,10:15,0,112,112.0895833,Days,PD,Efficacy marker,60.41,,mm,NaN,NaN,,NaN,NaN,NaN
1962,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-May-1982,07:00,0,-14,-39.04166667,Days,Demographics,Age,59,,Years,NaN,NaN,,NaN,NaN,NaN
1963,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-May-1982,07:00,0,-14,-39.04166667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1964,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-May-1982,07:00,0,-14,-39.04166667,Days,Demographics,Weight,69.9,,kg,NaN,NaN,,NaN,NaN,NaN
1965,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-Jun-1982,07:00,0,0,-5.041666667,Days,Demographics,Weight,70.4,,kg,NaN,NaN,,NaN,NaN,NaN
1966,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-Jun-1982,08:48,0,0,-4.966666667,Days,PD,Efficacy marker,43.953,,mm,NaN,NaN,,NaN,NaN,NaN
1967,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-Jul-1982,08:00,0.0833333332557231,0,0,Days,Dose,Dose Z,354.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1968,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,28-Jul-1982,08:27,0,28,23.01875,Days,PD,Efficacy marker,46.346,,mm,NaN,NaN,,NaN,NaN,NaN
1969,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,02-Aug-1982,08:00,0.0833333332557231,28,28,Days,Dose,Dose Z,344,,mg,NaN,NaN,iv,NaN,NaN,NaN
1970,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,25-Aug-1982,08:30,0,56,51.02083333,Days,PD,Efficacy marker,45.963,,mm,NaN,NaN,,NaN,NaN,NaN
1971,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-Aug-1982,08:00,0.0833333332557231,56,56,Days,Dose,Dose Z,340.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1972,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Sep-1982,08:40,0,84,79.02777778,Days,PD,Efficacy marker,46.117,,mm,NaN,NaN,,NaN,NaN,NaN
1973,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-Sep-1982,08:00,0.0833333332557231,84,84,Days,Dose,Dose Z,342,,mg,NaN,NaN,iv,NaN,NaN,NaN
1974,NaN,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,27-Oct-1982,08:40,0,112,114.0277778,Days,PD,Efficacy marker,47.1,,mm,NaN,NaN,,NaN,NaN,NaN
1975,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-May-1982,07:00,0,-14,-39.04375,Days,Demographics,Age,69,,Years,NaN,NaN,,NaN,NaN,NaN
1976,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-May-1982,07:00,0,-14,-39.04375,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1977,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-May-1982,07:00,0,-14,-39.04375,Days,Demographics,Weight,86.4,,kg,NaN,NaN,,NaN,NaN,NaN
1978,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-Jun-1982,07:00,0,0,-5.04375,Days,Demographics,Weight,87.3,,kg,NaN,NaN,,NaN,NaN,NaN
1979,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-Jun-1982,09:56,0,0,-4.921527778,Days,PD,Efficacy marker,41.563,,mm,NaN,NaN,,NaN,NaN,NaN
1980,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,05-Jul-1982,08:03,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1981,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,28-Jul-1982,10:05,0,28,23.08472222,Days,PD,Efficacy marker,39.331,,mm,NaN,NaN,,NaN,NaN,NaN
1982,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-Aug-1982,08:03,0.0833333332557231,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1983,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,25-Aug-1982,09:54,0,56,51.07708333,Days,PD,Efficacy marker,40.588,,mm,NaN,NaN,,NaN,NaN,NaN
1984,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,30-Aug-1982,08:03,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1985,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,22-Sep-1982,10:18,0,84,79.09375,Days,PD,Efficacy marker,40.293,,mm,NaN,NaN,,NaN,NaN,NaN
1986,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,27-Sep-1982,08:03,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
1987,NaN,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,27-Oct-1982,10:03,0,112,114.0833333,Days,PD,Efficacy marker,40.507,,mm,NaN,NaN,,NaN,NaN,NaN
1988,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-24.04583333,Days,Demographics,Age,50,,Years,NaN,NaN,,NaN,NaN,NaN
1989,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-24.04583333,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
1990,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-24.04583333,Days,Demographics,Weight,82.1,,kg,NaN,NaN,,NaN,NaN,NaN
1991,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-Jun-1982,07:00,0,0,-5.045833333,Days,Demographics,Weight,82.3,,kg,NaN,NaN,,NaN,NaN,NaN
1992,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-Jun-1982,11:22,0,0,-4.863888889,Days,PD,Efficacy marker,55.053,,mm,NaN,NaN,,NaN,NaN,NaN
1993,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-Jul-1982,08:06,0.0833333332557231,0,0,Days,Dose,Dose Z,414.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1994,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,28-Jul-1982,11:32,0,28,23.14305556,Days,PD,Efficacy marker,57.838,,mm,NaN,NaN,,NaN,NaN,NaN
1995,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,02-Aug-1982,08:06,0.0833333332557231,28,28,Days,Dose,Dose Z,415,,mg,NaN,NaN,iv,NaN,NaN,NaN
1996,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,25-Aug-1982,11:18,0,56,51.13333333,Days,PD,Efficacy marker,57.828,,mm,NaN,NaN,,NaN,NaN,NaN
1997,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-Aug-1982,08:06,0.0833333332557231,56,56,Days,Dose,Dose Z,410.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
1998,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-Sep-1982,11:51,0,84,79.15625,Days,PD,Efficacy marker,59.375,,mm,NaN,NaN,,NaN,NaN,NaN
1999,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-Sep-1982,08:06,0.0833333332557231,84,84,Days,Dose,Dose Z,413.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2000,NaN,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,27-Oct-1982,11:24,0,112,114.1375,Days,PD,Efficacy marker,58.831,,mm,NaN,NaN,,NaN,NaN,NaN
2001,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-24.04791667,Days,Demographics,Age,57,,Years,NaN,NaN,,NaN,NaN,NaN
2002,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-24.04791667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2003,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-24.04791667,Days,Demographics,Weight,52,,kg,NaN,NaN,,NaN,NaN,NaN
2004,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-Jun-1982,07:00,0,0,-5.047916667,Days,Demographics,Weight,51.7,,kg,NaN,NaN,,NaN,NaN,NaN
2005,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-Jun-1982,13:03,0,0,-4.795833333,Days,PD,Efficacy marker,31.874,,mm,NaN,NaN,,NaN,NaN,NaN
2006,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,05-Jul-1982,08:09,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2007,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,28-Jul-1982,12:58,0,28,23.20069444,Days,PD,Efficacy marker,33.01,,mm,NaN,NaN,,NaN,NaN,NaN
2008,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-Aug-1982,08:09,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2009,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,25-Aug-1982,13:03,0,56,51.20416667,Days,PD,Efficacy marker,33.542,,mm,NaN,NaN,,NaN,NaN,NaN
2010,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,30-Aug-1982,08:09,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2011,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,22-Sep-1982,14:04,0,84,79.24652778,Days,PD,Efficacy marker,32.902,,mm,NaN,NaN,,NaN,NaN,NaN
2012,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,27-Sep-1982,08:09,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2013,NaN,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,27-Oct-1982,13:03,0,112,114.2041667,Days,PD,Efficacy marker,32.102,,mm,NaN,NaN,,NaN,NaN,NaN
2014,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04375,Days,Demographics,Age,58,,Years,NaN,NaN,,NaN,NaN,NaN
2015,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04375,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2016,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04375,Days,Demographics,Weight,86.1,,kg,NaN,NaN,,NaN,NaN,NaN
2017,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-Jul-1982,07:00,0,0,-5.04375,Days,Demographics,Weight,85.1,,kg,NaN,NaN,,NaN,NaN,NaN
2018,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-Jul-1982,08:31,0,0,-4.980555556,Days,PD,Efficacy marker,50.812,,mm,NaN,NaN,,NaN,NaN,NaN
2019,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-Jul-1982,08:03,0.0833333332557231,0,0,Days,Dose,Dose Z,424,,mg,NaN,NaN,iv,NaN,NaN,NaN
2020,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-Aug-1982,08:43,0,28,23.02777778,Days,PD,Efficacy marker,53.023,,mm,NaN,NaN,,NaN,NaN,NaN
2021,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-Aug-1982,08:03,0.0833333332557231,28,28,Days,Dose,Dose Z,432,,mg,NaN,NaN,iv,NaN,NaN,NaN
2022,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-Sep-1982,17:46,0,56,52.40486111,Days,PD,Efficacy marker,52.745,,mm,NaN,NaN,,NaN,NaN,NaN
2023,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-Sep-1982,08:03,0.0833333332557231,56,56,Days,Dose,Dose Z,430,,mg,NaN,NaN,iv,NaN,NaN,NaN
2024,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Oct-1982,08:31,0,84,79.01944444,Days,PD,Efficacy marker,53.747,,mm,NaN,NaN,,NaN,NaN,NaN
2025,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,07-Oct-1982,08:03,0.0833333332557231,84,84,Days,Dose,Dose Z,434.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2026,NaN,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,04-Nov-1982,09:07,0,112,112.0444444,Days,PD,Efficacy marker,52.702,,mm,NaN,NaN,,NaN,NaN,NaN
2027,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04166667,Days,Demographics,Age,72,,Years,NaN,NaN,,NaN,NaN,NaN
2028,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04166667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2029,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04166667,Days,Demographics,Weight,54.3,,kg,NaN,NaN,,NaN,NaN,NaN
2030,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-Jul-1982,06:56,0,0,-5.044444444,Days,PD,Efficacy marker,23.67,,mm,NaN,NaN,,NaN,NaN,NaN
2031,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-Jul-1982,07:00,0,0,-5.041666667,Days,Demographics,Weight,54.3,,kg,NaN,NaN,,NaN,NaN,NaN
2032,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-Jul-1982,08:00,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2033,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-Aug-1982,06:58,0,28,22.95694444,Days,PD,Efficacy marker,23.097,,mm,NaN,NaN,,NaN,NaN,NaN
2034,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-Aug-1982,08:00,0.0833333332557231,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2035,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-Sep-1982,07:04,0,56,50.96111111,Days,PD,Efficacy marker,23.666,,mm,NaN,NaN,,NaN,NaN,NaN
2036,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-Sep-1982,08:00,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2037,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-Oct-1982,07:21,0,84,78.97291667,Days,PD,Efficacy marker,23.638,,mm,NaN,NaN,,NaN,NaN,NaN
2038,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,07-Oct-1982,08:00,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2039,NaN,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,04-Nov-1982,07:09,0,112,111.9645833,Days,PD,Efficacy marker,22.66,,mm,NaN,NaN,,NaN,NaN,NaN
2040,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04583333,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2041,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04583333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2042,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-Jun-1982,07:00,0,-14,-34.04583333,Days,Demographics,Weight,70.8,,kg,NaN,NaN,,NaN,NaN,NaN
2043,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-Jul-1982,07:00,0,0,-5.045833333,Days,Demographics,Weight,72.6,,kg,NaN,NaN,,NaN,NaN,NaN
2044,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-Jul-1982,09:57,0,0,-4.922916667,Days,PD,Efficacy marker,33.935,,mm,NaN,NaN,,NaN,NaN,NaN
2045,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-Jul-1982,08:06,0.0833333332557231,0,0,Days,Dose,Dose Z,352.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2046,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-Aug-1982,10:05,0,28,23.08263889,Days,PD,Efficacy marker,35.112,,mm,NaN,NaN,,NaN,NaN,NaN
2047,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-Aug-1982,08:06,0.0833333332557231,28,28,Days,Dose,Dose Z,361.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2048,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-Sep-1982,10:23,0,56,51.09513889,Days,PD,Efficacy marker,35.538,,mm,NaN,NaN,,NaN,NaN,NaN
2049,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-Sep-1982,08:06,0.0833333332557231,56,56,Days,Dose,Dose Z,353,,mg,NaN,NaN,iv,NaN,NaN,NaN
2050,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-Oct-1982,10:03,0,84,79.08125,Days,PD,Efficacy marker,36.011,,mm,NaN,NaN,,NaN,NaN,NaN
2051,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,07-Oct-1982,08:06,0.0833333332557231,84,84,Days,Dose,Dose Z,352.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2052,NaN,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Nov-1982,18:43,0,112,125.4423611,Days,PD,Efficacy marker,36.104,,mm,NaN,NaN,,NaN,NaN,NaN
2053,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Jun-1982,07:00,0,-14,-28.04791667,Days,Demographics,Age,61,,Years,NaN,NaN,,NaN,NaN,NaN
2054,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Jun-1982,07:00,0,-14,-28.04791667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2055,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-Jun-1982,07:00,0,-14,-28.04791667,Days,Demographics,Weight,66.9,,kg,NaN,NaN,,NaN,NaN,NaN
2056,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-Jul-1982,07:00,0,0,-5.047916667,Days,Demographics,Weight,66.3,,kg,NaN,NaN,,NaN,NaN,NaN
2057,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-Jul-1982,11:33,0,0,-4.858333333,Days,PD,Efficacy marker,27.463,,mm,NaN,NaN,,NaN,NaN,NaN
2058,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-Jul-1982,08:09,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2059,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-Aug-1982,11:36,0,28,23.14375,Days,PD,Efficacy marker,28.294,,mm,NaN,NaN,,NaN,NaN,NaN
2060,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-Aug-1982,08:09,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2061,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-Sep-1982,11:52,0,56,51.15486111,Days,PD,Efficacy marker,28.44,,mm,NaN,NaN,,NaN,NaN,NaN
2062,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-Sep-1982,08:09,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2063,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-Oct-1982,11:47,0,84,79.15138889,Days,PD,Efficacy marker,28.956,,mm,NaN,NaN,,NaN,NaN,NaN
2064,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,07-Oct-1982,08:09,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2065,NaN,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,04-Nov-1982,11:35,0,112,112.1430556,Days,PD,Efficacy marker,28.473,,mm,NaN,NaN,,NaN,NaN,NaN
2066,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04583333,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2067,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04583333,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2068,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04583333,Days,Demographics,Weight,77.2,,kg,NaN,NaN,,NaN,NaN,NaN
2069,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Jul-1982,07:00,0,0,-5.045833333,Days,Demographics,Weight,78.3,,kg,NaN,NaN,,NaN,NaN,NaN
2070,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,23-Jul-1982,09:14,0,0,-2.952777778,Days,PD,Efficacy marker,41.363,,mm,NaN,NaN,,NaN,NaN,NaN
2071,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-Jul-1982,08:06,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2072,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-Aug-1982,10:19,0,28,23.09236111,Days,PD,Efficacy marker,40.208,,mm,NaN,NaN,,NaN,NaN,NaN
2073,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-Aug-1982,08:06,0.0833333332557231,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2074,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-Sep-1982,10:01,0,56,52.07986111,Days,PD,Efficacy marker,39.837,,mm,NaN,NaN,,NaN,NaN,NaN
2075,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,20-Sep-1982,08:06,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2076,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-Oct-1982,09:15,0,84,79.04791667,Days,PD,Efficacy marker,37.799,,mm,NaN,NaN,,NaN,NaN,NaN
2077,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-Oct-1982,08:06,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2078,NaN,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,17-Nov-1982,10:01,0,112,114.0798611,Days,PD,Efficacy marker,39.238,,mm,NaN,NaN,,NaN,NaN,NaN
2079,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04791667,Days,Demographics,Age,61,,Years,NaN,NaN,,NaN,NaN,NaN
2080,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04791667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2081,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04791667,Days,Demographics,Weight,85.3,,kg,NaN,NaN,,NaN,NaN,NaN
2082,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Jul-1982,07:00,0,0,-5.047916667,Days,Demographics,Weight,85.1,,kg,NaN,NaN,,NaN,NaN,NaN
2083,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,23-Jul-1982,15:49,0,0,-2.680555556,Days,PD,Efficacy marker,50.484,,mm,NaN,NaN,,NaN,NaN,NaN
2084,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-Jul-1982,08:09,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2085,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-Aug-1982,11:53,0,28,23.15555556,Days,PD,Efficacy marker,52.129,,mm,NaN,NaN,,NaN,NaN,NaN
2086,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-Aug-1982,08:09,0.0833333333721384,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2087,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-Sep-1982,11:52,0,56,52.15486111,Days,PD,Efficacy marker,50.84,,mm,NaN,NaN,,NaN,NaN,NaN
2088,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,20-Sep-1982,08:09,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2089,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-Oct-1982,10:47,0,84,79.10972222,Days,PD,Efficacy marker,51.254,,mm,NaN,NaN,,NaN,NaN,NaN
2090,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-Oct-1982,08:09,0.0833333333721384,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2091,NaN,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,17-Nov-1982,11:41,0,112,114.1472222,Days,PD,Efficacy marker,50.987,,mm,NaN,NaN,,NaN,NaN,NaN
2092,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04375,Days,Demographics,Age,69,,Years,NaN,NaN,,NaN,NaN,NaN
2093,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04375,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2094,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04375,Days,Demographics,Weight,85.4,,kg,NaN,NaN,,NaN,NaN,NaN
2095,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Jul-1982,07:00,0,0,-5.04375,Days,Demographics,Weight,89.1,,kg,NaN,NaN,,NaN,NaN,NaN
2096,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-Jul-1982,09:27,0,0,-4.941666667,Days,PD,Efficacy marker,48.372,,mm,NaN,NaN,,NaN,NaN,NaN
2097,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-Jul-1982,08:03,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2098,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-Aug-1982,09:08,0,28,23.04513889,Days,PD,Efficacy marker,48.337,,mm,NaN,NaN,,NaN,NaN,NaN
2099,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-Aug-1982,08:03,0.0833333332557231,28,28,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2100,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-Sep-1982,08:24,0,56,52.01458333,Days,PD,Efficacy marker,47.543,,mm,NaN,NaN,,NaN,NaN,NaN
2101,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,20-Sep-1982,08:03,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2102,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,14-Oct-1982,11:32,0,84,80.14513889,Days,PD,Efficacy marker,48.835,,mm,NaN,NaN,,NaN,NaN,NaN
2103,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-Oct-1982,08:03,0.0833333332557231,84,84,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2104,NaN,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,17-Nov-1982,08:32,0,112,114.0201389,Days,PD,Efficacy marker,49.957,,mm,NaN,NaN,,NaN,NaN,NaN
2105,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04166667,Days,Demographics,Age,52,,Years,NaN,NaN,,NaN,NaN,NaN
2106,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04166667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2107,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-Jun-1982,07:00,0,-14,-29.04166667,Days,Demographics,Weight,69.6,,kg,NaN,NaN,,NaN,NaN,NaN
2108,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,21-Jul-1982,07:00,0,0,-5.041666667,Days,Demographics,Weight,70.8,,kg,NaN,NaN,,NaN,NaN,NaN
2109,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,21-Jul-1982,08:41,0,0,-4.971527778,Days,PD,Efficacy marker,33.414,,mm,NaN,NaN,,NaN,NaN,NaN
2110,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-Jul-1982,08:00,0.0833333332557231,0,0,Days,Dose,Dose Z,347,,mg,NaN,NaN,iv,NaN,NaN,NaN
2111,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,18-Aug-1982,06:58,0,28,22.95694444,Days,PD,Efficacy marker,35.229,,mm,NaN,NaN,,NaN,NaN,NaN
2112,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-Aug-1982,08:00,0.0833333332557231,28,28,Days,Dose,Dose Z,357,,mg,NaN,NaN,iv,NaN,NaN,NaN
2113,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-Sep-1982,07:01,0,56,52.95902778,Days,PD,Efficacy marker,36.601,,mm,NaN,NaN,,NaN,NaN,NaN
2114,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,20-Sep-1982,08:00,0.0833333332557231,56,56,Days,Dose,Dose Z,357.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2115,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-Oct-1982,13:45,0,84,80.23958333,Days,PD,Efficacy marker,37.061,,mm,NaN,NaN,,NaN,NaN,NaN
2116,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-Oct-1982,08:00,0.0833333332557231,84,84,Days,Dose,Dose Z,357,,mg,NaN,NaN,iv,NaN,NaN,NaN
2117,NaN,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-Nov-1982,07:04,0,112,113.9611111,Days,PD,Efficacy marker,37.767,,mm,NaN,NaN,,NaN,NaN,NaN
2118,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Apr-1981,07:00,0,-14,-22.11527778,Days,Demographics,Age,75,,Years,NaN,NaN,,NaN,NaN,NaN
2119,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Apr-1981,07:00,0,-14,-22.11527778,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2120,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-Apr-1981,07:00,0,-14,-22.11527778,Days,Demographics,Weight,70.9,,kg,NaN,NaN,,NaN,NaN,NaN
2121,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,04-May-1981,11:55,0,0,-11.91041667,Days,PD,Efficacy marker,38.138,,mm,NaN,NaN,,NaN,NaN,NaN
2122,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-May-1981,07:00,0,0,-7.115277778,Days,Demographics,Weight,70.3,,kg,NaN,NaN,,NaN,NaN,NaN
2123,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,16-May-1981,07:00,0,0,-0.115277778,Days,Demographics,Weight,70.5,,kg,NaN,NaN,,NaN,NaN,NaN
2124,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,16-May-1981,09:46,0.0833333333721384,0,0,Days,Dose,Dose Z,1057.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2125,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,16-May-1981,11:58,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,1458,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2126,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,16-May-1981,15:46,0,0.25,0.25,Days,PK,Plasma concentration Z,1322.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2127,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,23-May-1981,08:08,0,7,6.931944444,Days,PK,Plasma concentration Z,344.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2128,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,31-May-1981,08:51,0,14,14.96180556,Days,PK,Plasma concentration Z,207.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2129,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,03-Jun-1981,09:32,0,14,17.99027778,Days,PD,Efficacy marker,39.388,,mm,NaN,NaN,,NaN,NaN,NaN
2130,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-Jun-1981,09:45,0,28,27.99930556,Days,PK,Plasma concentration Z,122.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2131,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,14-Jun-1981,09:49,0,28,29.00208333,Days,PD,Efficacy marker,39.189,,mm,NaN,NaN,,NaN,NaN,NaN
2132,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,27-Jun-1981,09:50,0,42,42.00277778,Days,PK,Plasma concentration Z,61.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2133,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,10-Jul-1981,09:24,0,56,54.98472222,Days,PK,Plasma concentration Z,46.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2134,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,11-Jul-1981,09:39,0,56,55.99513889,Days,PD,Efficacy marker,39.326,,mm,NaN,NaN,,NaN,NaN,NaN
2135,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,25-Jul-1981,08:50,0,70,69.96111111,Days,PK,Plasma concentration Z,25.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2136,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,07-Aug-1981,08:00,0,84,82.92638889,Days,PK,Plasma concentration Z,13.959,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2137,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,04-Sep-1981,08:18,0,112,110.9388889,Days,PK,Plasma concentration Z,1.719,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2138,NaN,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,04-Sep-1981,12:22,0,112,111.1083333,Days,PD,Efficacy marker,38.424,,mm,NaN,NaN,,NaN,NaN,NaN
2139,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-Jun-1981,07:00,0,-14,-14.98333333,Days,Demographics,Age,80,,Years,NaN,NaN,,NaN,NaN,NaN
2140,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-Jun-1981,07:00,0,-14,-14.98333333,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2141,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-Jun-1981,07:00,0,-14,-14.98333333,Days,Demographics,Weight,77.3,,kg,NaN,NaN,,NaN,NaN,NaN
2142,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,03-Jul-1981,07:00,0,0,-7.983333333,Days,Demographics,Weight,78.6,,kg,NaN,NaN,,NaN,NaN,NaN
2143,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,04-Jul-1981,10:25,0,0,-6.840972222,Days,PD,Efficacy marker,38.908,,mm,NaN,NaN,,NaN,NaN,NaN
2144,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,06:05,0,0,-0.021527778,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2145,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,06:36,0.0833333332557231,0,0,Days,Dose,Dose Z,1179,,mg,NaN,NaN,iv,NaN,NaN,NaN
2146,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,07:00,0,0,0.016666667,Days,Demographics,Weight,78.6,,kg,NaN,NaN,,NaN,NaN,NaN
2147,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,09:28,0,0.166,0.119444444,Days,PK,Plasma concentration Z,1227.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2148,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,12:30,0,0.25,0.245833333,Days,PK,Plasma concentration Z,1226.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2149,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,18-Jul-1981,07:25,0,7,7.034027778,Days,PK,Plasma concentration Z,288,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2150,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,25-Jul-1981,07:18,0,14,14.02916667,Days,PK,Plasma concentration Z,173.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2151,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,25-Jul-1981,13:35,0,14,14.29097222,Days,PD,Efficacy marker,39.075,,mm,NaN,NaN,,NaN,NaN,NaN
2152,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,08-Aug-1981,08:27,0,28,28.07708333,Days,PK,Plasma concentration Z,95.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2153,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,09-Aug-1981,12:14,0,28,29.23472222,Days,PD,Efficacy marker,39.711,,mm,NaN,NaN,,NaN,NaN,NaN
2154,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,22-Aug-1981,07:14,0,42,42.02638889,Days,PK,Plasma concentration Z,50.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2155,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,05-Sep-1981,08:41,0,56,56.08680556,Days,PK,Plasma concentration Z,31.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2156,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,05-Sep-1981,13:50,0,56,56.30138889,Days,PD,Efficacy marker,39.191,,mm,NaN,NaN,,NaN,NaN,NaN
2157,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,20-Sep-1981,08:16,0,70,71.06944444,Days,PK,Plasma concentration Z,17.079,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2158,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,04-Oct-1981,07:41,0,84,85.04513889,Days,PK,Plasma concentration Z,7.941,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2159,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,31-Oct-1981,08:01,0,112,112.0590278,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2160,NaN,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,12-Nov-1981,14:27,0,112,124.3270833,Days,PD,Efficacy marker,38.914,,mm,NaN,NaN,,NaN,NaN,NaN
2161,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-Jun-1981,07:00,0,-14,-14.02083333,Days,Demographics,Age,68,,Years,NaN,NaN,,NaN,NaN,NaN
2162,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-Jun-1981,07:00,0,-14,-14.02083333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2163,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-Jun-1981,07:00,0,-14,-14.02083333,Days,Demographics,Weight,67.3,,kg,NaN,NaN,,NaN,NaN,NaN
2164,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,04-Jul-1981,07:00,0,0,-7.020833333,Days,Demographics,Weight,66.4,,kg,NaN,NaN,,NaN,NaN,NaN
2165,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,05-Jul-1981,11:49,0,0,-5.820138889,Days,PD,Efficacy marker,22.899,,mm,NaN,NaN,,NaN,NaN,NaN
2166,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,11-Jul-1981,07:00,0,0,-0.020833333,Days,Demographics,Weight,65,,kg,NaN,NaN,,NaN,NaN,NaN
2167,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,11-Jul-1981,07:30,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2168,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,25-Jul-1981,12:35,0,14,14.21180556,Days,PD,Efficacy marker,22.639,,mm,NaN,NaN,,NaN,NaN,NaN
2169,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,09-Aug-1981,10:04,0,28,29.10694444,Days,PD,Efficacy marker,22.829,,mm,NaN,NaN,,NaN,NaN,NaN
2170,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,06-Sep-1981,12:25,0,56,57.20486111,Days,PD,Efficacy marker,22.212,,mm,NaN,NaN,,NaN,NaN,NaN
2171,NaN,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,06-Nov-1981,10:27,0,112,118.1229167,Days,PD,Efficacy marker,22.093,,mm,NaN,NaN,,NaN,NaN,NaN
2172,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,28-Jun-1981,07:00,0,-14,-13.0625,Days,Demographics,Age,68,,Years,NaN,NaN,,NaN,NaN,NaN
2173,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,28-Jun-1981,07:00,0,-14,-13.0625,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2174,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,28-Jun-1981,07:00,0,-14,-13.0625,Days,Demographics,Weight,70,,kg,NaN,NaN,,NaN,NaN,NaN
2175,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,04-Jul-1981,11:40,0,0,-6.868055556,Days,PD,Efficacy marker,33.268,,mm,NaN,NaN,,NaN,NaN,NaN
2176,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,05-Jul-1981,07:00,0,0,-6.0625,Days,Demographics,Weight,68.6,,kg,NaN,NaN,,NaN,NaN,NaN
2177,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,07:00,0,0,-0.0625,Days,Demographics,Weight,66.4,,kg,NaN,NaN,,NaN,NaN,NaN
2178,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,07:58,0,0,-0.022222222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2179,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,08:30,0.0833333333721384,0,0,Days,Dose,Dose Z,996,,mg,NaN,NaN,iv,NaN,NaN,NaN
2180,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,11:04,0,0.166,0.106944444,Days,PK,Plasma concentration Z,1545.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2181,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Jul-1981,14:34,0,0.25,0.252777778,Days,PK,Plasma concentration Z,1452,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2182,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,18-Jul-1981,10:20,0,7,7.076388889,Days,PK,Plasma concentration Z,368.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2183,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,14-Aug-1981,10:45,0,28,34.09375,Days,PK,Plasma concentration Z,96.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2184,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,14-Aug-1981,15:48,0,28,34.30416667,Days,PD,Efficacy marker,34.854,,mm,NaN,NaN,,NaN,NaN,NaN
2185,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,22-Aug-1981,10:49,0,42,42.09652778,Days,PK,Plasma concentration Z,79.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2186,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,05-Sep-1981,11:20,0,56,56.11805556,Days,PK,Plasma concentration Z,56.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2187,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,05-Sep-1981,14:25,0,56,56.24652778,Days,PD,Efficacy marker,35.094,,mm,NaN,NaN,,NaN,NaN,NaN
2188,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,20-Sep-1981,09:52,0,70,71.05694444,Days,PK,Plasma concentration Z,26.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2189,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,03-Oct-1981,09:18,0,84,84.03333333,Days,PK,Plasma concentration Z,17.88,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2190,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,31-Oct-1981,10:40,0,112,112.0902778,Days,PK,Plasma concentration Z,2.361,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2191,NaN,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,31-Oct-1981,12:47,0,112,112.1784722,Days,PD,Efficacy marker,34.222,,mm,NaN,NaN,,NaN,NaN,NaN
2192,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-Oct-1981,07:00,0,-14,-15.05277778,Days,Demographics,Age,68,,Years,NaN,NaN,,NaN,NaN,NaN
2193,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-Oct-1981,07:00,0,-14,-15.05277778,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2194,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-Oct-1981,07:00,0,-14,-15.05277778,Days,Demographics,Weight,63.4,,kg,NaN,NaN,,NaN,NaN,NaN
2195,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-Oct-1981,07:00,0,0,-7.052777778,Days,Demographics,Weight,63,,kg,NaN,NaN,,NaN,NaN,NaN
2196,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-Oct-1981,13:45,0,0,-6.771527778,Days,PD,Efficacy marker,23.956,,mm,NaN,NaN,,NaN,NaN,NaN
2197,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-Oct-1981,07:00,0,0,-0.052777778,Days,Demographics,Weight,62.7,,kg,NaN,NaN,,NaN,NaN,NaN
2198,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-Oct-1981,07:05,0,0,-0.049305556,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2199,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-Oct-1981,08:16,0.0833333333721384,0,0,Days,Dose,Dose Z,940.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2200,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-Oct-1981,10:34,0,0.0833,0.095833333,Days,PK,Plasma concentration Z,1394.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2201,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-Oct-1981,14:16,0,0.25,0.25,Days,PK,Plasma concentration Z,1656,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2202,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,31-Oct-1981,09:16,0,7,7.041666667,Days,PK,Plasma concentration Z,351.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2203,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,07-Nov-1981,08:13,0,14,13.99791667,Days,PK,Plasma concentration Z,234,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2204,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,08-Nov-1981,15:03,0,14,15.28263889,Days,PD,Efficacy marker,25.014,,mm,NaN,NaN,,NaN,NaN,NaN
2205,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,21-Nov-1981,08:57,0,28,28.02847222,Days,PK,Plasma concentration Z,87.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2206,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,21-Nov-1981,12:13,0,28,28.16458333,Days,PD,Efficacy marker,26.037,,mm,NaN,NaN,,NaN,NaN,NaN
2207,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,05-Dec-1981,08:18,0,42,42.00138889,Days,PK,Plasma concentration Z,58.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2208,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,19-Dec-1981,08:29,0,56,56.00902778,Days,PK,Plasma concentration Z,27.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2209,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-Dec-1981,11:04,0,56,63.11666667,Days,PD,Efficacy marker,25.916,,mm,NaN,NaN,,NaN,NaN,NaN
2210,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,02-Jan-1982,07:35,0,70,69.97152778,Days,PK,Plasma concentration Z,10.959,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2211,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,16-Jan-1982,07:46,0,84,83.97916667,Days,PK,Plasma concentration Z,3.081,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2212,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,13-Feb-1982,09:06,0,112,112.0347222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2213,NaN,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,13-Feb-1982,12:10,0,112,112.1625,Days,PD,Efficacy marker,25.608,,mm,NaN,NaN,,NaN,NaN,NaN
2214,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-Dec-1981,07:00,0,-14,-15.02638889,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2215,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-Dec-1981,07:00,0,-14,-15.02638889,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2216,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-Dec-1981,07:00,0,-14,-15.02638889,Days,Demographics,Weight,75.9,,kg,NaN,NaN,,NaN,NaN,NaN
2217,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,02-Jan-1982,07:00,0,0,-6.026388889,Days,Demographics,Weight,76.3,,kg,NaN,NaN,,NaN,NaN,NaN
2218,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,02-Jan-1982,12:04,0,0,-5.815277778,Days,PD,Efficacy marker,40.263,,mm,NaN,NaN,,NaN,NaN,NaN
2219,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,08-Jan-1982,07:00,0,0,-0.026388889,Days,Demographics,Weight,75.9,,kg,NaN,NaN,,NaN,NaN,NaN
2220,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,08-Jan-1982,07:38,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2221,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,23-Jan-1982,09:05,0,14,15.06041667,Days,PD,Efficacy marker,39.447,,mm,NaN,NaN,,NaN,NaN,NaN
2222,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,05-Feb-1982,06:20,0,28,27.94583333,Days,PD,Efficacy marker,40.276,,mm,NaN,NaN,,NaN,NaN,NaN
2223,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,05-Mar-1982,11:18,0,56,56.15277778,Days,PD,Efficacy marker,40.103,,mm,NaN,NaN,,NaN,NaN,NaN
2224,NaN,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,30-Apr-1982,10:40,0,112,112.1263889,Days,PD,Efficacy marker,40.488,,mm,NaN,NaN,,NaN,NaN,NaN
2225,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-Aug-1981,07:00,0,-14,-27.02430556,Days,Demographics,Age,74,,Years,NaN,NaN,,NaN,NaN,NaN
2226,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-Aug-1981,07:00,0,-14,-27.02430556,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2227,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-Aug-1981,07:00,0,-14,-27.02430556,Days,Demographics,Weight,66.4,,kg,NaN,NaN,,NaN,NaN,NaN
2228,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,13-Sep-1981,07:00,0,0,-10.02430556,Days,Demographics,Weight,66.8,,kg,NaN,NaN,,NaN,NaN,NaN
2229,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,19-Sep-1981,13:32,0,0,-3.752083333,Days,PD,Efficacy marker,32.401,,mm,NaN,NaN,,NaN,NaN,NaN
2230,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,23-Sep-1981,07:00,0,0,-0.024305556,Days,Demographics,Weight,66.8,,kg,NaN,NaN,,NaN,NaN,NaN
2231,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,23-Sep-1981,07:35,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2232,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,07-Oct-1981,12:49,0,14,14.21805556,Days,PD,Efficacy marker,33.085,,mm,NaN,NaN,,NaN,NaN,NaN
2233,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,18-Nov-1981,14:08,0,56,56.27291667,Days,PD,Efficacy marker,32.756,,mm,NaN,NaN,,NaN,NaN,NaN
2234,NaN,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,13-Jan-1982,12:19,0,112,112.1972222,Days,PD,Efficacy marker,33.53,,mm,NaN,NaN,,NaN,NaN,NaN
2235,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-Sep-1981,07:00,0,-14,-26,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2236,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-Sep-1981,07:00,0,-14,-26,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2237,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-Sep-1981,07:00,0,-14,-26,Days,Demographics,Weight,91.81,,kg,NaN,NaN,,NaN,NaN,NaN
2238,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-Sep-1981,07:00,0,0,-13,Days,Demographics,Weight,91.36,,kg,NaN,NaN,,NaN,NaN,NaN
2239,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,19-Sep-1981,14:05,0,0,-10.70486111,Days,PD,Efficacy marker,37.516,,mm,NaN,NaN,,NaN,NaN,NaN
2240,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Sep-1981,06:55,0,0,-0.003472222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2241,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Sep-1981,07:00,0,0,0,Days,Demographics,Weight,91.36,,kg,NaN,NaN,,NaN,NaN,NaN
2242,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Sep-1981,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,1370.4,,mg,NaN,NaN,iv,NaN,NaN,NaN
2243,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Sep-1981,08:50,0,0.0833,0.076388889,Days,PK,Plasma concentration Z,1476,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2244,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Sep-1981,12:55,0,0.25,0.246527778,Days,PK,Plasma concentration Z,1352.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2245,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,07-Oct-1981,07:28,0,7,7.019444444,Days,PK,Plasma concentration Z,356.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2246,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,14-Oct-1981,07:35,0,14,14.02430556,Days,PK,Plasma concentration Z,213.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2247,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,28-Oct-1981,09:05,0,28,28.08680556,Days,PK,Plasma concentration Z,90.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2248,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,28-Oct-1981,13:06,0,28,28.25416667,Days,PD,Efficacy marker,38.991,,mm,NaN,NaN,,NaN,NaN,NaN
2249,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,12-Nov-1981,07:30,0,42,43.02083333,Days,PK,Plasma concentration Z,42,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2250,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,25-Nov-1981,06:12,0,56,55.96666667,Days,PK,Plasma concentration Z,24.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2251,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,25-Nov-1981,13:22,0,56,56.26527778,Days,PD,Efficacy marker,38.99,,mm,NaN,NaN,,NaN,NaN,NaN
2252,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,09-Dec-1981,07:16,0,70,70.01111111,Days,PK,Plasma concentration Z,11.679,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2253,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,23-Dec-1981,07:39,0,84,84.02708333,Days,PK,Plasma concentration Z,3.939,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2254,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,20-Jan-1982,07:27,0,112,112.01875,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2255,NaN,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,20-Jan-1982,13:02,0,112,112.2513889,Days,PD,Efficacy marker,38.135,,mm,NaN,NaN,,NaN,NaN,NaN
2256,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,03-Sep-1981,07:00,0,-14,-27.02083333,Days,Demographics,Age,72,,Years,NaN,NaN,,NaN,NaN,NaN
2257,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,03-Sep-1981,07:00,0,-14,-27.02083333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2258,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,03-Sep-1981,07:00,0,-14,-27.02083333,Days,Demographics,Weight,81.36,,kg,NaN,NaN,,NaN,NaN,NaN
2259,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,12-Sep-1981,07:00,0,0,-18.02083333,Days,Demographics,Weight,80.45,,kg,NaN,NaN,,NaN,NaN,NaN
2260,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,16-Sep-1981,13:53,0,0,-13.73402778,Days,PD,Efficacy marker,23.076,,mm,NaN,NaN,,NaN,NaN,NaN
2261,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,30-Sep-1981,07:00,0,0,-0.020833333,Days,Demographics,Weight,80.45,,kg,NaN,NaN,,NaN,NaN,NaN
2262,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,30-Sep-1981,07:30,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2263,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,14-Oct-1981,14:08,0,14,14.27638889,Days,PD,Efficacy marker,22.683,,mm,NaN,NaN,,NaN,NaN,NaN
2264,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,28-Oct-1981,13:48,0,28,28.2625,Days,PD,Efficacy marker,23.269,,mm,NaN,NaN,,NaN,NaN,NaN
2265,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,25-Nov-1981,13:45,0,56,56.26041667,Days,PD,Efficacy marker,23.465,,mm,NaN,NaN,,NaN,NaN,NaN
2266,NaN,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,20-Jan-1982,12:35,0,112,112.2118056,Days,PD,Efficacy marker,24.19,,mm,NaN,NaN,,NaN,NaN,NaN
2267,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,15-Jan-1982,07:00,0,-14,-26.98958333,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2268,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,15-Jan-1982,07:00,0,-14,-26.98958333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2269,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,15-Jan-1982,07:00,0,-14,-26.98958333,Days,Demographics,Weight,67.7,,kg,NaN,NaN,,NaN,NaN,NaN
2270,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,04-Feb-1982,12:25,0,0,-6.763888889,Days,PD,Efficacy marker,26.035,,mm,NaN,NaN,,NaN,NaN,NaN
2271,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Feb-1982,06:44,0,0,-0.000694444,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2272,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Feb-1982,06:45,0.0833333333721384,0,0,Days,Dose,Dose Z,1015.8,,mg,NaN,NaN,iv,NaN,NaN,NaN
2273,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Feb-1982,07:00,0,0,0.010416667,Days,Demographics,Weight,67.72,,kg,NaN,NaN,,NaN,NaN,NaN
2274,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Feb-1982,08:46,0,0.0833,0.084027778,Days,PK,Plasma concentration Z,1094.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2275,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-Feb-1982,12:45,0,0.25,0.25,Days,PK,Plasma concentration Z,1230,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2276,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,18-Feb-1982,07:42,0,7,7.039583333,Days,PK,Plasma concentration Z,336,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2277,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,25-Feb-1982,09:12,0,14,14.10208333,Days,PK,Plasma concentration Z,264,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2278,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,25-Feb-1982,12:53,0,14,14.25555556,Days,PD,Efficacy marker,27.461,,mm,NaN,NaN,,NaN,NaN,NaN
2279,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-Mar-1982,09:02,0,28,30.09513889,Days,PK,Plasma concentration Z,135.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2280,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,25-Mar-1982,07:35,0,42,42.03472222,Days,PK,Plasma concentration Z,83.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2281,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,08-Apr-1982,07:23,0,56,56.02638889,Days,PK,Plasma concentration Z,68.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2282,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,08-Apr-1982,12:45,0,56,56.25,Days,PD,Efficacy marker,30.128,,mm,NaN,NaN,,NaN,NaN,NaN
2283,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,22-Apr-1982,07:36,0,70,70.03541667,Days,PK,Plasma concentration Z,45.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2284,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,06-May-1982,08:05,0,84,84.05555556,Days,PK,Plasma concentration Z,26.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2285,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,02-Jun-1982,07:42,0,112,111.0395833,Days,PK,Plasma concentration Z,5.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2286,NaN,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,03-Jun-1982,13:02,0,112,112.2618056,Days,PD,Efficacy marker,30.468,,mm,NaN,NaN,,NaN,NaN,NaN
2287,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-May-1982,07:00,0,-14,-28.22916667,Days,Demographics,Age,70,,Years,NaN,NaN,,NaN,NaN,NaN
2288,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-May-1982,07:00,0,-14,-28.22916667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2289,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-May-1982,07:00,0,-14,-28.22916667,Days,Demographics,Weight,100,,kg,NaN,NaN,,NaN,NaN,NaN
2290,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,28-May-1982,07:00,0,0,-7.229166667,Days,Demographics,Weight,100,,kg,NaN,NaN,,NaN,NaN,NaN
2291,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,28-May-1982,12:39,0,0,-6.99375,Days,PD,Efficacy marker,43.465,,mm,NaN,NaN,,NaN,NaN,NaN
2292,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,04-Jun-1982,07:00,0,0,-0.229166667,Days,Demographics,Weight,100,,kg,NaN,NaN,,NaN,NaN,NaN
2293,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,04-Jun-1982,12:30,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2294,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,18-Jun-1982,12:46,0,14,14.01111111,Days,PD,Efficacy marker,43.888,,mm,NaN,NaN,,NaN,NaN,NaN
2295,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,02-Jul-1982,11:09,0,28,27.94375,Days,PD,Efficacy marker,43.951,,mm,NaN,NaN,,NaN,NaN,NaN
2296,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,30-Jul-1982,06:47,0.0833333332557231,56,55.76180556,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2297,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,30-Jul-1982,12:26,0,56,55.99722222,Days,PD,Efficacy marker,43.806,,mm,NaN,NaN,,NaN,NaN,NaN
2298,NaN,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,24-Sep-1982,12:33,0,112,112.0020833,Days,PD,Efficacy marker,42.806,,mm,NaN,NaN,,NaN,NaN,NaN
2299,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,08-May-1982,07:00,0,-14,-26,Days,Demographics,Age,69,,Years,NaN,NaN,,NaN,NaN,NaN
2300,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,08-May-1982,07:00,0,-14,-26,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2301,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,08-May-1982,07:00,0,-14,-26,Days,Demographics,Weight,73.63,,kg,NaN,NaN,,NaN,NaN,NaN
2302,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,22-May-1982,07:00,0,0,-12,Days,Demographics,Weight,73.18,,kg,NaN,NaN,,NaN,NaN,NaN
2303,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,02-Jun-1982,12:25,0,0,-0.774305556,Days,PD,Efficacy marker,26.207,,mm,NaN,NaN,,NaN,NaN,NaN
2304,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-Jun-1982,06:50,0,0,-0.006944444,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2305,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-Jun-1982,07:00,0,0,0,Days,Demographics,Weight,73.18,,kg,NaN,NaN,,NaN,NaN,NaN
2306,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-Jun-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,1097.7,,mg,NaN,NaN,iv,NaN,NaN,NaN
2307,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-Jun-1982,08:55,0,0.0833,0.079861111,Days,PK,Plasma concentration Z,1569.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2308,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-Jun-1982,13:00,0,0.25,0.25,Days,PK,Plasma concentration Z,1806,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2309,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,10-Jun-1982,07:30,0,7,7.020833333,Days,PK,Plasma concentration Z,477.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2310,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,17-Jun-1982,07:23,0,14,14.01597222,Days,PK,Plasma concentration Z,314.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2311,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,18-Jun-1982,11:02,0,14,15.16805556,Days,PD,Efficacy marker,27.825,,mm,NaN,NaN,,NaN,NaN,NaN
2312,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,08-Jul-1982,08:30,0,28,35.0625,Days,PK,Plasma concentration Z,137.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2313,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,10-Jul-1982,12:40,0,28,37.23611111,Days,PD,Efficacy marker,27.841,,mm,NaN,NaN,,NaN,NaN,NaN
2314,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,15-Jul-1982,07:30,0,42,42.02083333,Days,PK,Plasma concentration Z,121.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2315,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,29-Jul-1982,12:01,0,56,56.20902778,Days,PD,Efficacy marker,28.518,,mm,NaN,NaN,,NaN,NaN,NaN
2316,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-Jul-1982,06:35,0,56,56.98263889,Days,PK,Plasma concentration Z,74.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2317,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-Jul-1982,06:45,0.0833333333721384,56,56.98958333,Days,Dose,Dose Z,1104.45,,mg,NaN,NaN,iv,NaN,NaN,NaN
2318,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-Jul-1982,08:50,0,56,57.07638889,Days,PK,Plasma concentration Z,2120.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2319,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,12-Aug-1982,07:27,0,70,70.01875,Days,PK,Plasma concentration Z,380.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2320,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,26-Aug-1982,08:15,0,84,84.05208333,Days,PK,Plasma concentration Z,243.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2321,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,23-Sep-1982,06:25,0,112,111.9756944,Days,PK,Plasma concentration Z,110.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2322,NaN,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,23-Sep-1982,12:32,0,112,112.2305556,Days,PD,Efficacy marker,28.432,,mm,NaN,NaN,,NaN,NaN,NaN
2323,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,08-May-1982,07:00,0,-14,-32.125,Days,Demographics,Age,74,,Years,NaN,NaN,,NaN,NaN,NaN
2324,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,08-May-1982,07:00,0,-14,-32.125,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2325,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,08-May-1982,07:00,0,-14,-32.125,Days,Demographics,Weight,76.81,,kg,NaN,NaN,,NaN,NaN,NaN
2326,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,04-Jun-1982,07:00,0,0,-5.125,Days,Demographics,Weight,76.81,,kg,NaN,NaN,,NaN,NaN,NaN
2327,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,04-Jun-1982,12:50,0,0,-4.881944444,Days,PD,Efficacy marker,20.58,,mm,NaN,NaN,,NaN,NaN,NaN
2328,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,07:00,0,0,-0.125,Days,Demographics,Weight,76.59,,kg,NaN,NaN,,NaN,NaN,NaN
2329,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,10:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2330,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,24-Jun-1982,11:41,0,14,15.07013889,Days,PD,Efficacy marker,20.131,,mm,NaN,NaN,,NaN,NaN,NaN
2331,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,07-Jul-1982,12:53,0,28,28.12013889,Days,PD,Efficacy marker,20.691,,mm,NaN,NaN,,NaN,NaN,NaN
2332,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,05-Aug-1982,07:55,0.0833333333721384,56,56.91319444,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2333,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,06-Aug-1982,12:34,0,56,58.10694444,Days,PD,Efficacy marker,20.908,,mm,NaN,NaN,,NaN,NaN,NaN
2334,NaN,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,29-Sep-1982,13:02,0,112,112.1263889,Days,PD,Efficacy marker,20.83,,mm,NaN,NaN,,NaN,NaN,NaN
2335,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,18-Jul-1982,07:00,0,-14,-26.99305556,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2336,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,18-Jul-1982,07:00,0,-14,-26.99305556,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2337,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,18-Jul-1982,07:00,0,-14,-26.99305556,Days,Demographics,Weight,61.81,,kg,NaN,NaN,,NaN,NaN,NaN
2338,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,07-Aug-1982,07:00,0,0,-6.993055556,Days,Demographics,Weight,62.27,,kg,NaN,NaN,,NaN,NaN,NaN
2339,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,07-Aug-1982,13:20,0,0,-6.729166667,Days,PD,Efficacy marker,24.185,,mm,NaN,NaN,,NaN,NaN,NaN
2340,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,14-Aug-1982,06:50,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2341,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,14-Aug-1982,07:00,0,0,0.006944444,Days,Demographics,Weight,62.27,,kg,NaN,NaN,,NaN,NaN,NaN
2342,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,28-Aug-1982,13:06,0,14,14.26111111,Days,PD,Efficacy marker,23.097,,mm,NaN,NaN,,NaN,NaN,NaN
2343,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,10-Sep-1982,13:16,0,28,27.26805556,Days,PD,Efficacy marker,25.62,,mm,NaN,NaN,,NaN,NaN,NaN
2344,NaN,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,09-Oct-1982,07:00,0.0833333333721384,56,56.00694444,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2345,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,12-Jun-1981,07:00,0,-14,-22.04513889,Days,Demographics,Age,77,,Years,NaN,NaN,,NaN,NaN,NaN
2346,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,12-Jun-1981,07:00,0,-14,-22.04513889,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2347,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,12-Jun-1981,07:00,0,-14,-22.04513889,Days,Demographics,Weight,63,,kg,NaN,NaN,,NaN,NaN,NaN
2348,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,19-Jun-1981,11:49,0,0,-14.84444444,Days,PD,Efficacy marker,32.149,,mm,NaN,NaN,,NaN,NaN,NaN
2349,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,21-Jun-1981,07:00,0,0,-13.04513889,Days,Demographics,Weight,63,,kg,NaN,NaN,,NaN,NaN,NaN
2350,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,04-Jul-1981,07:00,0,0,-0.045138889,Days,Demographics,Weight,63,,kg,NaN,NaN,,NaN,NaN,NaN
2351,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,04-Jul-1981,08:05,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2352,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,17-Jul-1981,11:49,0,14,13.15555556,Days,PD,Efficacy marker,30.937,,mm,NaN,NaN,,NaN,NaN,NaN
2353,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,31-Jul-1981,12:45,0,28,27.19444444,Days,PD,Efficacy marker,29.129,,mm,NaN,NaN,,NaN,NaN,NaN
2354,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,28-Aug-1981,11:48,0,56,55.15486111,Days,PD,Efficacy marker,28.854,,mm,NaN,NaN,,NaN,NaN,NaN
2355,NaN,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,23-Oct-1981,10:54,0,112,111.1173611,Days,PD,Efficacy marker,26.897,,mm,NaN,NaN,,NaN,NaN,NaN
2356,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,20-Jun-1981,07:00,0,-14,-14.04861111,Days,Demographics,Age,71,,Years,NaN,NaN,,NaN,NaN,NaN
2357,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,20-Jun-1981,07:00,0,-14,-14.04861111,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2358,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,20-Jun-1981,07:00,0,-14,-14.04861111,Days,Demographics,Weight,72,,kg,NaN,NaN,,NaN,NaN,NaN
2359,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jul-1981,07:00,0,0,-0.048611111,Days,Demographics,Weight,76,,kg,NaN,NaN,,NaN,NaN,NaN
2360,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jul-1981,07:53,0,0,-0.011805556,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2361,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jul-1981,08:10,0.0833333333721384,0,0,Days,Dose,Dose Z,1140,,mg,NaN,NaN,iv,NaN,NaN,NaN
2362,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,19-Jun-1981,12:58,0,0,0,Days,PD,Efficacy marker,39.898,,mm,NaN,NaN,,NaN,NaN,NaN
2363,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jul-1981,10:06,0,0.0833,0.080555556,Days,PK,Plasma concentration Z,1112.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2364,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jul-1981,14:10,0,0.25,0.25,Days,PK,Plasma concentration Z,1128,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2365,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,10-Jul-1981,08:15,0,7,6.003472222,Days,PK,Plasma concentration Z,342,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2366,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,17-Jul-1981,08:18,0,14,13.00555556,Days,PK,Plasma concentration Z,234,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2367,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,17-Jul-1981,11:19,0,14,13.13125,Days,PD,Efficacy marker,41.965,,mm,NaN,NaN,,NaN,NaN,NaN
2368,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,31-Jul-1981,07:00,0,28,26.95138889,Days,PK,Plasma concentration Z,117.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2369,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,31-Jul-1981,13:19,0,28,27.21458333,Days,PD,Efficacy marker,42.835,,mm,NaN,NaN,,NaN,NaN,NaN
2370,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,14-Aug-1981,07:50,0,42,40.98611111,Days,PK,Plasma concentration Z,55.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2371,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-Aug-1981,08:00,0,56,54.99305556,Days,PK,Plasma concentration Z,35.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2372,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-Aug-1981,12:46,0,56,55.19166667,Days,PD,Efficacy marker,41.47,,mm,NaN,NaN,,NaN,NaN,NaN
2373,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,12-Sep-1981,08:27,0,70,70.01180556,Days,PK,Plasma concentration Z,18.159,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2374,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,25-Sep-1981,08:43,0,84,83.02291667,Days,PK,Plasma concentration Z,9.321,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2375,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,23-Oct-1981,07:25,0,112,110.96875,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2376,NaN,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,23-Oct-1981,11:27,0,112,111.1368056,Days,PD,Efficacy marker,41.031,,mm,NaN,NaN,,NaN,NaN,NaN
2377,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-Aug-1981,07:00,0,-14,-21.96875,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2378,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-Aug-1981,07:00,0,-14,-21.96875,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2379,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-Aug-1981,07:00,0,-14,-21.96875,Days,Demographics,Weight,91.5,,kg,NaN,NaN,,NaN,NaN,NaN
2380,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,12-Sep-1981,07:00,0,0,-6.96875,Days,Demographics,Weight,93,,kg,NaN,NaN,,NaN,NaN,NaN
2381,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,17-Sep-1981,13:23,0,0,-1.702777778,Days,PD,Efficacy marker,45.246,,mm,NaN,NaN,,NaN,NaN,NaN
2382,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,19-Sep-1981,06:15,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2383,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,19-Sep-1981,07:00,0,0,0.03125,Days,Demographics,Weight,91.5,,kg,NaN,NaN,,NaN,NaN,NaN
2384,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,02-Oct-1981,15:10,0,14,13.37152778,Days,PD,Efficacy marker,46.934,,mm,NaN,NaN,,NaN,NaN,NaN
2385,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,16-Oct-1981,13:51,0,28,27.31666667,Days,PD,Efficacy marker,47.862,,mm,NaN,NaN,,NaN,NaN,NaN
2386,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,03-Dec-1981,15:14,0,56,75.37430556,Days,PD,Efficacy marker,47.9,,mm,NaN,NaN,,NaN,NaN,NaN
2387,NaN,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,08-Jan-1982,14:56,0,112,111.3618056,Days,PD,Efficacy marker,46.304,,mm,NaN,NaN,,NaN,NaN,NaN
2388,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-Apr-1982,07:00,0,-14,-24.01527778,Days,Demographics,Age,76,,Years,NaN,NaN,,NaN,NaN,NaN
2389,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-Apr-1982,07:00,0,-14,-24.01527778,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2390,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-Apr-1982,07:00,0,-14,-24.01527778,Days,Demographics,Weight,72,,kg,NaN,NaN,,NaN,NaN,NaN
2391,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,15-May-1982,09:21,0,0,-6.917361111,Days,PD,Efficacy marker,26.611,,mm,NaN,NaN,,NaN,NaN,NaN
2392,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,20-May-1982,07:00,0,0,-2.015277778,Days,Demographics,Weight,72,,kg,NaN,NaN,,NaN,NaN,NaN
2393,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,22-May-1982,07:00,0,0,-0.015277778,Days,Demographics,Weight,72,,kg,NaN,NaN,,NaN,NaN,NaN
2394,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,22-May-1982,07:22,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2395,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,05-Jun-1982,09:36,0,14,14.09305556,Days,PD,Efficacy marker,25.605,,mm,NaN,NaN,,NaN,NaN,NaN
2396,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,20-Jun-1982,07:32,0,28,29.00694444,Days,PD,Efficacy marker,25.485,,mm,NaN,NaN,,NaN,NaN,NaN
2397,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,16-Jul-1982,09:42,0,56,55.09722222,Days,PD,Efficacy marker,26.912,,mm,NaN,NaN,,NaN,NaN,NaN
2398,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,17-Jul-1982,07:10,0.0833333333721384,56,55.99166667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2399,NaN,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,09-Sep-1982,09:27,0,112,110.0868056,Days,PD,Efficacy marker,27.451,,mm,NaN,NaN,,NaN,NaN,NaN
2400,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,10-Apr-1982,07:00,0,-14,-60,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
2401,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,10-Apr-1982,07:00,0,-14,-60,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2402,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,10-Apr-1982,07:00,0,-14,-60,Days,Demographics,Weight,66.8,,kg,NaN,NaN,,NaN,NaN,NaN
2403,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,09-May-1982,08:58,0,0,-30.91805556,Days,PD,Efficacy marker,26.434,,mm,NaN,NaN,,NaN,NaN,NaN
2404,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,28-May-1982,07:00,0,0,-12,Days,Demographics,Weight,68,,kg,NaN,NaN,,NaN,NaN,NaN
2405,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,07:00,0,0,0,Days,Demographics,Weight,67,,kg,NaN,NaN,,NaN,NaN,NaN
2406,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,09-Jun-1982,07:00,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2407,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,23-Jun-1982,09:56,0,14,14.12222222,Days,PD,Efficacy marker,25.978,,mm,NaN,NaN,,NaN,NaN,NaN
2408,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,07-Jul-1982,09:08,0,28,28.08888889,Days,PD,Efficacy marker,27.553,,mm,NaN,NaN,,NaN,NaN,NaN
2409,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,05-Aug-1982,07:15,0.0833333332557231,56,57.01041667,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2410,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,06-Aug-1982,09:10,0,56,58.09027778,Days,PD,Efficacy marker,27.163,,mm,NaN,NaN,,NaN,NaN,NaN
2411,NaN,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,30-Sep-1982,09:56,0,112,113.1222222,Days,PD,Efficacy marker,27.483,,mm,NaN,NaN,,NaN,NaN,NaN
2412,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-Mar-1982,07:00,0,-14,-29.00138889,Days,Demographics,Age,76,,Years,NaN,NaN,,NaN,NaN,NaN
2413,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-Mar-1982,07:00,0,-14,-29.00138889,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2414,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-Mar-1982,07:00,0,-14,-29.00138889,Days,Demographics,Weight,71.8,,kg,NaN,NaN,,NaN,NaN,NaN
2415,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,11-Apr-1982,07:00,0,0,-7.001388889,Days,Demographics,Weight,71.3,,kg,NaN,NaN,,NaN,NaN,NaN
2416,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,16-Apr-1982,15:07,0,0,-1.663194444,Days,PD,Efficacy marker,21.921,,mm,NaN,NaN,,NaN,NaN,NaN
2417,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-Apr-1982,07:00,0,0,-0.001388889,Days,Demographics,Weight,71.8,,kg,NaN,NaN,,NaN,NaN,NaN
2418,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-Apr-1982,07:02,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2419,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,02-May-1982,18:37,0,14,14.48263889,Days,PD,Efficacy marker,22.528,,mm,NaN,NaN,,NaN,NaN,NaN
2420,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,17-May-1982,12:27,0,28,29.22569444,Days,PD,Efficacy marker,22.235,,mm,NaN,NaN,,NaN,NaN,NaN
2421,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-Jun-1982,07:02,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2422,NaN,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-Jun-1982,15:05,0,56,56.33541667,Days,PD,Efficacy marker,22.255,,mm,NaN,NaN,,NaN,NaN,NaN
2423,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,20-Mar-1982,07:00,0,-14,-29.00694444,Days,Demographics,Age,86,,Years,NaN,NaN,,NaN,NaN,NaN
2424,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,20-Mar-1982,07:00,0,-14,-29.00694444,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2425,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,20-Mar-1982,07:00,0,-14,-29.00694444,Days,Demographics,Weight,76.2,,kg,NaN,NaN,,NaN,NaN,NaN
2426,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,01-Apr-1982,17:20,0,0,-16.57638889,Days,PD,Efficacy marker,30.239,,mm,NaN,NaN,,NaN,NaN,NaN
2427,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,11-Apr-1982,07:00,0,0,-7.006944444,Days,Demographics,Weight,74.5,,kg,NaN,NaN,,NaN,NaN,NaN
2428,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-Apr-1982,07:00,0,0,-0.006944444,Days,Demographics,Weight,75.2,,kg,NaN,NaN,,NaN,NaN,NaN
2429,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-Apr-1982,07:07,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2430,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-Apr-1982,07:10,0.0833333333721384,0,0,Days,Dose,Dose Z,1128,,mg,NaN,NaN,iv,NaN,NaN,NaN
2431,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-Apr-1982,09:10,0,0.0833,0.083333333,Days,PK,Plasma concentration Z,1292.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2432,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-Apr-1982,13:10,0,0.25,0.25,Days,PK,Plasma concentration Z,1293.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2433,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,25-Apr-1982,07:10,0,7,7,Days,PK,Plasma concentration Z,351.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2434,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,02-May-1982,07:10,0,14,14,Days,PK,Plasma concentration Z,246,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2435,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,02-May-1982,19:28,0,14,14.5125,Days,PD,Efficacy marker,32.49,,mm,NaN,NaN,,NaN,NaN,NaN
2436,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,16-May-1982,07:10,0,28,28,Days,PK,Plasma concentration Z,127.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2437,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,17-May-1982,11:47,0,28,29.19236111,Days,PD,Efficacy marker,32.998,,mm,NaN,NaN,,NaN,NaN,NaN
2438,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,30-May-1982,07:10,0,42,42,Days,PK,Plasma concentration Z,90.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2439,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,13-Jun-1982,07:10,0.0833333333721384,56,56,Days,Dose,Dose Z,1093.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2440,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,13-Jun-1982,16:14,0,56,56.37777778,Days,PD,Efficacy marker,33.783,,mm,NaN,NaN,,NaN,NaN,NaN
2441,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,27-Jun-1982,07:10,0,70,70,Days,PK,Plasma concentration Z,266.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2442,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,11-Jul-1982,08:30,0,84,84.05555556,Days,PK,Plasma concentration Z,160.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2443,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,08-Aug-1982,07:10,0,112,112,Days,PK,Plasma concentration Z,51.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2444,NaN,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,08-Aug-1982,14:52,0,112,112.3208333,Days,PD,Efficacy marker,33.733,,mm,NaN,NaN,,NaN,NaN,NaN
2445,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-Mar-1982,07:00,0,-14,-25.02083333,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
2446,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-Mar-1982,07:00,0,-14,-25.02083333,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2447,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-Mar-1982,07:00,0,-14,-25.02083333,Days,Demographics,Weight,63.5,,kg,NaN,NaN,,NaN,NaN,NaN
2448,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,01-Apr-1982,17:50,0,0,-16.56944444,Days,PD,Efficacy marker,21.425,,mm,NaN,NaN,,NaN,NaN,NaN
2449,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,11-Apr-1982,07:00,0,0,-7.020833333,Days,Demographics,Weight,63,,kg,NaN,NaN,,NaN,NaN,NaN
2450,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-Apr-1982,07:00,0,0,-0.020833333,Days,Demographics,Weight,62.8,,kg,NaN,NaN,,NaN,NaN,NaN
2451,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-Apr-1982,07:30,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2452,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,02-May-1982,20:05,0,14,14.52430556,Days,PD,Efficacy marker,21.63,,mm,NaN,NaN,,NaN,NaN,NaN
2453,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,17-May-1982,11:14,0,28,29.15555556,Days,PD,Efficacy marker,21.451,,mm,NaN,NaN,,NaN,NaN,NaN
2454,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-Jun-1982,07:30,0.0833333333721384,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2455,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-Jun-1982,17:08,0,56,56.40138889,Days,PD,Efficacy marker,21.467,,mm,NaN,NaN,,NaN,NaN,NaN
2456,NaN,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,08-Aug-1982,15:33,0,112,112.3354167,Days,PD,Efficacy marker,22.852,,mm,NaN,NaN,,NaN,NaN,NaN
2457,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,14-Mar-1982,07:00,0,-14,-41.97916667,Days,Demographics,Age,83,,Years,NaN,NaN,,NaN,NaN,NaN
2458,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,14-Mar-1982,07:00,0,-14,-41.97916667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2459,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,14-Mar-1982,07:00,0,-14,-41.97916667,Days,Demographics,Weight,66.2,,kg,NaN,NaN,,NaN,NaN,NaN
2460,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,27-Mar-1982,19:13,0,0,-28.47013889,Days,PD,Efficacy marker,21.372,,mm,NaN,NaN,,NaN,NaN,NaN
2461,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,16-Apr-1982,07:00,0,0,-8.979166667,Days,Demographics,Weight,67.8,,kg,NaN,NaN,,NaN,NaN,NaN
2462,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,25-Apr-1982,06:30,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2463,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,25-Apr-1982,07:00,0,0,0.020833333,Days,Demographics,Weight,65.7,,kg,NaN,NaN,,NaN,NaN,NaN
2464,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,12-May-1982,14:06,0,14,17.31666667,Days,PD,Efficacy marker,21.095,,mm,NaN,NaN,,NaN,NaN,NaN
2465,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,23-May-1982,15:46,0,28,28.38611111,Days,PD,Efficacy marker,21.026,,mm,NaN,NaN,,NaN,NaN,NaN
2466,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,20-Jun-1982,06:30,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2467,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,20-Jun-1982,15:19,0,56,56.36736111,Days,PD,Efficacy marker,21.097,,mm,NaN,NaN,,NaN,NaN,NaN
2468,NaN,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,28-Aug-1982,16:00,0,112,125.3958333,Days,PD,Efficacy marker,21.25,,mm,NaN,NaN,,NaN,NaN,NaN
2469,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,14-Mar-1982,07:00,0,-14,-41.98611111,Days,Demographics,Age,83,,Years,NaN,NaN,,NaN,NaN,NaN
2470,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,14-Mar-1982,07:00,0,-14,-41.98611111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2471,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,14-Mar-1982,07:00,0,-14,-41.98611111,Days,Demographics,Weight,55.7,,kg,NaN,NaN,,NaN,NaN,NaN
2472,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,27-Mar-1982,18:43,0,0,-28.49791667,Days,PD,Efficacy marker,18.249,,mm,NaN,NaN,,NaN,NaN,NaN
2473,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,16-Apr-1982,07:00,0,0,-8.986111111,Days,Demographics,Weight,56,,kg,NaN,NaN,,NaN,NaN,NaN
2474,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-Apr-1982,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2475,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-Apr-1982,06:40,0.0833333333721384,0,0,Days,Dose,Dose Z,834,,mg,NaN,NaN,iv,NaN,NaN,NaN
2476,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-Apr-1982,07:00,0,0,0.013888889,Days,Demographics,Weight,55.6,,kg,NaN,NaN,,NaN,NaN,NaN
2477,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-Apr-1982,08:50,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,1773.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2478,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-Apr-1982,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1538.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2479,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,02-May-1982,06:40,0,7,7,Days,PK,Plasma concentration Z,294,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2480,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,09-May-1982,06:40,0,14,14,Days,PK,Plasma concentration Z,178.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2481,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,12-May-1982,15:16,0,14,17.35833333,Days,PD,Efficacy marker,18.858,,mm,NaN,NaN,,NaN,NaN,NaN
2482,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,23-May-1982,06:40,0,28,28,Days,PK,Plasma concentration Z,90.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2483,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,23-May-1982,15:12,0,28,28.35555556,Days,PD,Efficacy marker,18.709,,mm,NaN,NaN,,NaN,NaN,NaN
2484,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,06-Jun-1982,06:40,0,42,42,Days,PK,Plasma concentration Z,49.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2485,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,20-Jun-1982,06:37,0,56,55.99791667,Days,PK,Plasma concentration Z,33.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2486,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,20-Jun-1982,06:43,0.0833333333721384,56,56.00208333,Days,Dose,Dose Z,831,,mg,NaN,NaN,iv,NaN,NaN,NaN
2487,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,20-Jun-1982,08:52,0,56,56.09166667,Days,PK,Plasma concentration Z,1706.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2488,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,20-Jun-1982,14:45,0,56,56.33680556,Days,PD,Efficacy marker,19.799,,mm,NaN,NaN,,NaN,NaN,NaN
2489,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,04-Jul-1982,06:40,0,70,70,Days,PK,Plasma concentration Z,222,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2490,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,18-Jul-1982,06:40,0,84,84,Days,PK,Plasma concentration Z,124.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2491,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,15-Aug-1982,06:52,0,112,112.0083333,Days,PK,Plasma concentration Z,46.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2492,NaN,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,15-Aug-1982,15:49,0,112,112.38125,Days,PD,Efficacy marker,19.986,,mm,NaN,NaN,,NaN,NaN,NaN
2493,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,27-Mar-1982,07:00,0,-14,-28.99305556,Days,Demographics,Age,69,,Years,NaN,NaN,,NaN,NaN,NaN
2494,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,27-Mar-1982,07:00,0,-14,-28.99305556,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2495,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,27-Mar-1982,07:00,0,-14,-28.99305556,Days,Demographics,Weight,61.8,,kg,NaN,NaN,,NaN,NaN,NaN
2496,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-Apr-1982,15:50,0,0,-7.625,Days,PD,Efficacy marker,28.59,,mm,NaN,NaN,,NaN,NaN,NaN
2497,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,18-Apr-1982,07:00,0,0,-6.993055556,Days,Demographics,Weight,61.8,,kg,NaN,NaN,,NaN,NaN,NaN
2498,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-Apr-1982,06:47,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2499,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-Apr-1982,06:50,0.0833333332557231,0,0,Days,Dose,Dose Z,811.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2500,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-Apr-1982,07:00,0,0,0.006944444,Days,Demographics,Weight,54.1,,kg,NaN,NaN,,NaN,NaN,NaN
2501,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-Apr-1982,09:00,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,1059.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2502,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-Apr-1982,12:50,0,0.25,0.25,Days,PK,Plasma concentration Z,920.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2503,NaN,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,02-May-1982,06:50,0,7,7,Days,PK,Plasma concentration Z,236.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2504,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,31-Mar-1982,07:00,0,-14,-29.97916667,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
2505,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,31-Mar-1982,07:00,0,-14,-29.97916667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2506,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,31-Mar-1982,07:00,0,-14,-29.97916667,Days,Demographics,Weight,63.6,,kg,NaN,NaN,,NaN,NaN,NaN
2507,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,22-Apr-1982,19:38,0,0,-7.452777778,Days,PD,Efficacy marker,21.298,,mm,NaN,NaN,,NaN,NaN,NaN
2508,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,23-Apr-1982,07:00,0,0,-6.979166667,Days,Demographics,Weight,66.5,,kg,NaN,NaN,,NaN,NaN,NaN
2509,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,30-Apr-1982,06:30,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2510,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,30-Apr-1982,07:00,0,0,0.020833333,Days,Demographics,Weight,65.3,,kg,NaN,NaN,,NaN,NaN,NaN
2511,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,17-May-1982,13:56,0,14,17.30972222,Days,PD,Efficacy marker,20.98,,mm,NaN,NaN,,NaN,NaN,NaN
2512,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,31-May-1982,10:12,0,28,31.15416667,Days,PD,Efficacy marker,20.807,,mm,NaN,NaN,,NaN,NaN,NaN
2513,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,25-Jun-1982,06:30,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2514,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,14-Jul-1982,18:14,0,56,75.48888889,Days,PD,Efficacy marker,21.159,,mm,NaN,NaN,,NaN,NaN,NaN
2515,NaN,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,20-Aug-1982,18:13,0,112,112.4881944,Days,PD,Efficacy marker,20.6,,mm,NaN,NaN,,NaN,NaN,NaN
2516,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-Apr-1982,07:00,0,-14,-25.98611111,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
2517,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-Apr-1982,07:00,0,-14,-25.98611111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2518,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-Apr-1982,07:00,0,-14,-25.98611111,Days,Demographics,Weight,74.5,,kg,NaN,NaN,,NaN,NaN,NaN
2519,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,22-Apr-1982,19:08,0,0,-7.480555556,Days,PD,Efficacy marker,23.409,,mm,NaN,NaN,,NaN,NaN,NaN
2520,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,23-Apr-1982,07:00,0,0,-6.986111111,Days,Demographics,Weight,76.2,,kg,NaN,NaN,,NaN,NaN,NaN
2521,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Apr-1982,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2522,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Apr-1982,06:40,0.0833333333721384,0,0,Days,Dose,Dose Z,1128,,mg,NaN,NaN,iv,NaN,NaN,NaN
2523,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Apr-1982,07:00,0,0,0.013888889,Days,Demographics,Weight,75.2,,kg,NaN,NaN,,NaN,NaN,NaN
2524,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Apr-1982,08:47,0,0.0833,0.088194444,Days,PK,Plasma concentration Z,1670.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2525,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-Apr-1982,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1580.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2526,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,07-May-1982,06:40,0,7,7,Days,PK,Plasma concentration Z,480,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2527,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,14-May-1982,06:40,0,14,14,Days,PK,Plasma concentration Z,290.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2528,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,17-May-1982,14:28,0,14,17.325,Days,PD,Efficacy marker,24.046,,mm,NaN,NaN,,NaN,NaN,NaN
2529,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,28-May-1982,06:40,0,28,28,Days,PK,Plasma concentration Z,120.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2530,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,03-Jun-1982,18:14,0,28,34.48194444,Days,PD,Efficacy marker,24.647,,mm,NaN,NaN,,NaN,NaN,NaN
2531,NaN,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,11-Jun-1982,06:40,0,42,42,Days,PK,Plasma concentration Z,71.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2532,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,27-Mar-1982,07:00,0,-14,-45.97916667,Days,Demographics,Age,67,,Years,NaN,NaN,,NaN,NaN,NaN
2533,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,27-Mar-1982,07:00,0,-14,-45.97916667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2534,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,27-Mar-1982,07:00,0,-14,-45.97916667,Days,Demographics,Weight,61.4,,kg,NaN,NaN,,NaN,NaN,NaN
2535,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,16-Apr-1982,19:27,0,0,-25.46041667,Days,PD,Efficacy marker,33.27,,mm,NaN,NaN,,NaN,NaN,NaN
2536,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,05-May-1982,07:00,0,0,-6.979166667,Days,Demographics,Weight,62.5,,kg,NaN,NaN,,NaN,NaN,NaN
2537,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-May-1982,06:27,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2538,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-May-1982,06:30,0.0833333332557231,0,0,Days,Dose,Dose Z,924,,mg,NaN,NaN,iv,NaN,NaN,NaN
2539,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-May-1982,07:00,0,0,0.020833333,Days,Demographics,Weight,61.6,,kg,NaN,NaN,,NaN,NaN,NaN
2540,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-May-1982,08:45,0,0.0833,0.09375,Days,PK,Plasma concentration Z,1647.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2541,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-May-1982,12:30,0,0.25,0.25,Days,PK,Plasma concentration Z,1287.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2542,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,19-May-1982,06:30,0,7,7,Days,PK,Plasma concentration Z,326.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2543,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,26-May-1982,06:30,0,14,14,Days,PK,Plasma concentration Z,183.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2544,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,27-May-1982,15:52,0,14,15.39027778,Days,PD,Efficacy marker,35.482,,mm,NaN,NaN,,NaN,NaN,NaN
2545,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,09-Jun-1982,06:30,0,28,28,Days,PK,Plasma concentration Z,113.799,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2546,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,09-Jun-1982,17:27,0,28,28.45625,Days,PD,Efficacy marker,35.171,,mm,NaN,NaN,,NaN,NaN,NaN
2547,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,23-Jun-1982,06:30,0,42,42,Days,PK,Plasma concentration Z,55.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2548,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,07-Jul-1982,06:27,0,56,55.99791667,Days,PK,Plasma concentration Z,30,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2549,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,07-Jul-1982,06:30,0.0833333332557231,56,56,Days,Dose,Dose Z,954,,mg,NaN,NaN,iv,NaN,NaN,NaN
2550,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,07-Jul-1982,08:40,0,56,56.09027778,Days,PK,Plasma concentration Z,1347.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2551,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,07-Jul-1982,16:16,0,56,56.40694444,Days,PD,Efficacy marker,36.697,,mm,NaN,NaN,,NaN,NaN,NaN
2552,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,21-Jul-1982,06:30,0,70,70,Days,PK,Plasma concentration Z,237.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2553,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,04-Aug-1982,06:30,0,84,84,Days,PK,Plasma concentration Z,121.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2554,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,01-Sep-1982,06:30,0,112,112,Days,PK,Plasma concentration Z,37.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2555,NaN,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,03-Sep-1982,16:05,0,112,114.3993056,Days,PD,Efficacy marker,36.341,,mm,NaN,NaN,,NaN,NaN,NaN
2556,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-19.03194444,Days,Demographics,Age,72,,Years,NaN,NaN,,NaN,NaN,NaN
2557,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-19.03194444,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2558,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-19.03194444,Days,Demographics,Weight,78.9,,kg,NaN,NaN,,NaN,NaN,NaN
2559,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,03-May-1982,13:24,0,0,-8.765277778,Days,PD,Efficacy marker,27.88,,mm,NaN,NaN,,NaN,NaN,NaN
2560,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,05-May-1982,07:00,0,0,-7.031944444,Days,Demographics,Weight,79.8,,kg,NaN,NaN,,NaN,NaN,NaN
2561,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,12-May-1982,07:00,0,0,-0.031944444,Days,Demographics,Weight,78.5,,kg,NaN,NaN,,NaN,NaN,NaN
2562,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,12-May-1982,07:46,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2563,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,27-May-1982,16:26,0,14,15.36111111,Days,PD,Efficacy marker,27.115,,mm,NaN,NaN,,NaN,NaN,NaN
2564,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,17-Jun-1982,17:49,0,28,36.41875,Days,PD,Efficacy marker,28.059,,mm,NaN,NaN,,NaN,NaN,NaN
2565,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,07-Jul-1982,07:46,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2566,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,17-Jul-1982,16:48,0,56,66.37638889,Days,PD,Efficacy marker,28.491,,mm,NaN,NaN,,NaN,NaN,NaN
2567,NaN,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,01-Sep-1982,16:59,0,112,112.3840278,Days,PD,Efficacy marker,28.134,,mm,NaN,NaN,,NaN,NaN,NaN
2568,NaN,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,04-Apr-1982,07:00,0,-14,-38.00763889,Days,Demographics,Age,77,,Years,NaN,NaN,,NaN,NaN,NaN
2569,NaN,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,04-Apr-1982,07:00,0,-14,-38.00763889,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2570,NaN,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,04-Apr-1982,07:00,0,-14,-38.00763889,Days,Demographics,Weight,55.1,,kg,NaN,NaN,,NaN,NaN,NaN
2571,NaN,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,30-Apr-1982,13:35,0,0,-11.73333333,Days,PD,Efficacy marker,32.081,,mm,NaN,NaN,,NaN,NaN,NaN
2572,NaN,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,05-May-1982,07:00,0,0,-7.007638889,Days,Demographics,Weight,55.4,,kg,NaN,NaN,,NaN,NaN,NaN
2573,NaN,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,12-May-1982,07:00,0,0,-0.007638889,Days,Demographics,Weight,56.5,,kg,NaN,NaN,,NaN,NaN,NaN
2574,NaN,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,12-May-1982,07:11,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2575,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-22.98055556,Days,Demographics,Age,67,,Years,NaN,NaN,,NaN,NaN,NaN
2576,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-22.98055556,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2577,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-22.98055556,Days,Demographics,Weight,47.7,,kg,NaN,NaN,,NaN,NaN,NaN
2578,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,09-May-1982,07:00,0,0,-6.980555556,Days,Demographics,Weight,47.5,,kg,NaN,NaN,,NaN,NaN,NaN
2579,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,13-May-1982,09:26,0,0,-2.879166667,Days,PD,Efficacy marker,22.654,,mm,NaN,NaN,,NaN,NaN,NaN
2580,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-May-1982,06:27,0,0,-0.003472222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2581,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-May-1982,06:32,0.0833333333721384,0,0,Days,Dose,Dose Z,666,,mg,NaN,NaN,iv,NaN,NaN,NaN
2582,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-May-1982,07:00,0,0,0.019444444,Days,Demographics,Weight,44.4,,kg,NaN,NaN,,NaN,NaN,NaN
2583,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-May-1982,08:49,0,0.0833,0.095138889,Days,PK,Plasma concentration Z,1022.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2584,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-May-1982,12:49,0,0.25,0.261805556,Days,PK,Plasma concentration Z,1184.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2585,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,23-May-1982,06:32,0,7,7,Days,PK,Plasma concentration Z,290.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2586,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,30-May-1982,06:32,0,14,14,Days,PK,Plasma concentration Z,174.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2587,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,04-Jun-1982,18:48,0,14,19.51111111,Days,PD,Efficacy marker,23.646,,mm,NaN,NaN,,NaN,NaN,NaN
2588,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,13-Jun-1982,06:32,0,28,28,Days,PK,Plasma concentration Z,89.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2589,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,13-Jun-1982,17:33,0,28,28.45902778,Days,PD,Efficacy marker,24.001,,mm,NaN,NaN,,NaN,NaN,NaN
2590,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,27-Jun-1982,06:32,0,42,42,Days,PK,Plasma concentration Z,51.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2591,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,11-Jul-1982,06:29,0,56,55.99791667,Days,PK,Plasma concentration Z,39.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2592,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,11-Jul-1982,06:32,0.0833333333721384,56,56,Days,Dose,Dose Z,705,,mg,NaN,NaN,iv,NaN,NaN,NaN
2593,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,11-Jul-1982,08:39,0,56,56.08819444,Days,PK,Plasma concentration Z,1298.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2594,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,11-Jul-1982,15:09,0,56,56.35902778,Days,PD,Efficacy marker,25.229,,mm,NaN,NaN,,NaN,NaN,NaN
2595,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,25-Jul-1982,06:33,0,70,70.00069444,Days,PK,Plasma concentration Z,204,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2596,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,07-Aug-1982,06:32,0,84,83,Days,PK,Plasma concentration Z,144.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2597,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,05-Sep-1982,06:35,0,112,112.0020833,Days,PK,Plasma concentration Z,44.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2598,NaN,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,05-Sep-1982,15:42,0,112,112.3819444,Days,PD,Efficacy marker,26.645,,mm,NaN,NaN,,NaN,NaN,NaN
2599,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-32.97916667,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2600,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-32.97916667,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2601,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-Apr-1982,07:00,0,-14,-32.97916667,Days,Demographics,Weight,81.8,,kg,NaN,NaN,,NaN,NaN,NaN
2602,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,19-May-1982,19:05,0,0,-6.475694444,Days,PD,Efficacy marker,38.463,,mm,NaN,NaN,,NaN,NaN,NaN
2603,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-May-1982,06:27,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2604,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-May-1982,06:30,0.0833333332557231,0,0,Days,Dose,Dose Z,1245,,mg,NaN,NaN,iv,NaN,NaN,NaN
2605,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-May-1982,07:00,0,0,0.020833333,Days,Demographics,Weight,83,,kg,NaN,NaN,,NaN,NaN,NaN
2606,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-May-1982,08:43,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,1599.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2607,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-May-1982,12:30,0,0.25,0.25,Days,PK,Plasma concentration Z,1371.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2608,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,02-Jun-1982,06:30,0,7,7,Days,PK,Plasma concentration Z,344.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2609,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,09-Jun-1982,06:30,0,14,14,Days,PK,Plasma concentration Z,243.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2610,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,23-Jun-1982,06:30,0,28,28,Days,PK,Plasma concentration Z,129.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2611,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,07-Jul-1982,06:30,0,42,42,Days,PK,Plasma concentration Z,76.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2612,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,21-Jul-1982,06:27,0,56,55.99791667,Days,PK,Plasma concentration Z,47.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2613,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,21-Jul-1982,06:30,0.0833333332557231,56,56,Days,Dose,Dose Z,1264.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2614,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,21-Jul-1982,16:24,0,56,56.4125,Days,PD,Efficacy marker,41.578,,mm,NaN,NaN,,NaN,NaN,NaN
2615,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,04-Aug-1982,06:30,0,70,70,Days,PK,Plasma concentration Z,306,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2616,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,18-Aug-1982,06:34,0,84,84.00277778,Days,PK,Plasma concentration Z,162.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2617,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,15-Sep-1982,06:30,0,112,112,Days,PK,Plasma concentration Z,56.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2618,NaN,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,15-Sep-1982,14:53,0,112,112.3493056,Days,PD,Efficacy marker,42.371,,mm,NaN,NaN,,NaN,NaN,NaN
2619,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,12-May-1982,07:00,0,-14,-22.98055556,Days,Demographics,Age,78,,Years,NaN,NaN,,NaN,NaN,NaN
2620,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,12-May-1982,07:00,0,-14,-22.98055556,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2621,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,12-May-1982,07:00,0,-14,-22.98055556,Days,Demographics,Weight,50,,kg,NaN,NaN,,NaN,NaN,NaN
2622,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,28-May-1982,07:00,0,0,-6.980555556,Days,Demographics,Weight,51,,kg,NaN,NaN,,NaN,NaN,NaN
2623,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,31-May-1982,12:13,0,0,-3.763194444,Days,PD,Efficacy marker,21.118,,mm,NaN,NaN,,NaN,NaN,NaN
2624,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-Jun-1982,06:27,0,0,-0.003472222,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2625,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-Jun-1982,06:32,0.0833333333721384,0,0,Days,Dose,Dose Z,772.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2626,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-Jun-1982,07:00,0,0,0.019444444,Days,Demographics,Weight,51.5,,kg,NaN,NaN,,NaN,NaN,NaN
2627,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-Jun-1982,08:53,0,0.0833,0.097916667,Days,PK,Plasma concentration Z,1062,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2628,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-Jun-1982,12:32,0,0.25,0.25,Days,PK,Plasma concentration Z,822,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2629,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,11-Jun-1982,06:32,0,7,7,Days,PK,Plasma concentration Z,218.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2630,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,18-Jun-1982,06:32,0,14,14,Days,PK,Plasma concentration Z,136.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2631,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,18-Jun-1982,15:05,0,14,14.35625,Days,PD,Efficacy marker,22.721,,mm,NaN,NaN,,NaN,NaN,NaN
2632,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,02-Jul-1982,06:32,0,28,28,Days,PK,Plasma concentration Z,69.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2633,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,02-Jul-1982,15:03,0,28,28.35486111,Days,PD,Efficacy marker,22.267,,mm,NaN,NaN,,NaN,NaN,NaN
2634,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,16-Jul-1982,06:32,0,42,42,Days,PK,Plasma concentration Z,46.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2635,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,29-Jul-1982,18:04,0,56,55.48055556,Days,PD,Efficacy marker,22.87,,mm,NaN,NaN,,NaN,NaN,NaN
2636,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-Jul-1982,06:26,0,56,55.99583333,Days,PK,Plasma concentration Z,22.599,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2637,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-Jul-1982,06:32,0.0833333333721384,56,56,Days,Dose,Dose Z,781.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2638,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-Jul-1982,08:38,0,56,56.0875,Days,PK,Plasma concentration Z,1190.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2639,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,13-Aug-1982,06:32,0,70,70,Days,PK,Plasma concentration Z,146.601,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2640,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,27-Aug-1982,06:32,0,84,84,Days,PK,Plasma concentration Z,105.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2641,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,24-Sep-1982,06:32,0,112,112,Days,PK,Plasma concentration Z,36,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2642,NaN,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,24-Sep-1982,12:36,0,112,112.2527778,Days,PD,Efficacy marker,22.457,,mm,NaN,NaN,,NaN,NaN,NaN
2643,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,13-May-1982,07:00,0,-14,-21.98611111,Days,Demographics,Age,65,,Years,NaN,NaN,,NaN,NaN,NaN
2644,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,13-May-1982,07:00,0,-14,-21.98611111,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2645,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,13-May-1982,07:00,0,-14,-21.98611111,Days,Demographics,Weight,77.3,,kg,NaN,NaN,,NaN,NaN,NaN
2646,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,28-May-1982,07:00,0,0,-6.986111111,Days,Demographics,Weight,76.8,,kg,NaN,NaN,,NaN,NaN,NaN
2647,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,28-May-1982,15:04,0,0,-6.65,Days,PD,Efficacy marker,36.208,,mm,NaN,NaN,,NaN,NaN,NaN
2648,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jun-1982,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2649,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jun-1982,06:40,0.0833333333721384,0,0,Days,Dose,Dose Z,1165.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2650,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jun-1982,07:00,0,0,0.013888889,Days,Demographics,Weight,77.7,,kg,NaN,NaN,,NaN,NaN,NaN
2651,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jun-1982,09:57,0,0.166,0.136805556,Days,PK,Plasma concentration Z,1272,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2652,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-Jun-1982,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1164,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2653,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,11-Jun-1982,06:40,0,7,7,Days,PK,Plasma concentration Z,278.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2654,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,18-Jun-1982,06:40,0,14,14,Days,PK,Plasma concentration Z,150.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2655,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,18-Jun-1982,15:59,0,14,14.38819444,Days,PD,Efficacy marker,38.259,,mm,NaN,NaN,,NaN,NaN,NaN
2656,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,02-Jul-1982,06:40,0,28,28,Days,PK,Plasma concentration Z,84.801,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2657,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,02-Jul-1982,15:33,0,28,28.37013889,Days,PD,Efficacy marker,38.743,,mm,NaN,NaN,,NaN,NaN,NaN
2658,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,16-Jul-1982,06:40,0,42,42,Days,PK,Plasma concentration Z,66.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2659,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,29-Jul-1982,15:31,0,56,55.36875,Days,PD,Efficacy marker,40.038,,mm,NaN,NaN,,NaN,NaN,NaN
2660,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,13-Aug-1982,06:40,0,70,70,Days,PK,Plasma concentration Z,14.679,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2661,NaN,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,27-Aug-1982,06:40,0,84,84,Days,PK,Plasma concentration Z,9.321,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2662,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-May-1982,07:00,0,-14,-28.98125,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
2663,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-May-1982,07:00,0,-14,-28.98125,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2664,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-May-1982,07:00,0,-14,-28.98125,Days,Demographics,Weight,72.7,,kg,NaN,NaN,,NaN,NaN,NaN
2665,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,11-Jun-1982,07:00,0,0,-6.98125,Days,Demographics,Weight,74.4,,kg,NaN,NaN,,NaN,NaN,NaN
2666,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,14-Jun-1982,13:54,0,0,-3.69375,Days,PD,Efficacy marker,25.381,,mm,NaN,NaN,,NaN,NaN,NaN
2667,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-Jun-1982,06:33,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2668,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-Jun-1982,07:00,0,0,0.01875,Days,Demographics,Weight,73,,kg,NaN,NaN,,NaN,NaN,NaN
2669,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,02-Jul-1982,16:02,0,14,14.39513889,Days,PD,Efficacy marker,26.404,,mm,NaN,NaN,,NaN,NaN,NaN
2670,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,16-Jul-1982,16:04,0,28,28.39652778,Days,PD,Efficacy marker,25.725,,mm,NaN,NaN,,NaN,NaN,NaN
2671,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-Aug-1982,06:33,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2672,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,22-Sep-1982,15:56,0,56,96.39097222,Days,PD,Efficacy marker,26.187,,mm,NaN,NaN,,NaN,NaN,NaN
2673,NaN,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,23-Oct-1982,16:33,0,112,127.4166667,Days,PD,Efficacy marker,25.814,,mm,NaN,NaN,,NaN,NaN,NaN
2674,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,22-May-1982,07:00,0,-14,-32.97916667,Days,Demographics,Age,75,,Years,NaN,NaN,,NaN,NaN,NaN
2675,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,22-May-1982,07:00,0,-14,-32.97916667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2676,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,22-May-1982,07:00,0,-14,-32.97916667,Days,Demographics,Weight,68.2,,kg,NaN,NaN,,NaN,NaN,NaN
2677,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,11-Jun-1982,07:00,0,0,-12.97916667,Days,Demographics,Weight,69.5,,kg,NaN,NaN,,NaN,NaN,NaN
2678,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,14-Jun-1982,13:00,0,0,-9.729166667,Days,PD,Efficacy marker,24.199,,mm,NaN,NaN,,NaN,NaN,NaN
2679,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,24-Jun-1982,06:30,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2680,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,24-Jun-1982,07:00,0,0,0.020833333,Days,Demographics,Weight,69,,kg,NaN,NaN,,NaN,NaN,NaN
2681,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,08-Jul-1982,14:51,0,14,14.34791667,Days,PD,Efficacy marker,24.467,,mm,NaN,NaN,,NaN,NaN,NaN
2682,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,22-Jul-1982,16:18,0,28,28.40833333,Days,PD,Efficacy marker,23.91,,mm,NaN,NaN,,NaN,NaN,NaN
2683,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,18-Aug-1982,15:44,0,56,55.38472222,Days,PD,Efficacy marker,23.794,,mm,NaN,NaN,,NaN,NaN,NaN
2684,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,19-Aug-1982,06:50,0.0833333332557231,56,56.01388889,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2685,NaN,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,29-Oct-1982,15:14,0,112,127.3638889,Days,PD,Efficacy marker,24.094,,mm,NaN,NaN,,NaN,NaN,NaN
2686,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,05-Jun-1982,07:00,0,-14,-18.98611111,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
2687,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,05-Jun-1982,07:00,0,-14,-18.98611111,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2688,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,05-Jun-1982,07:00,0,-14,-18.98611111,Days,Demographics,Weight,72.7,,kg,NaN,NaN,,NaN,NaN,NaN
2689,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,17-Jun-1982,07:00,0,0,-6.986111111,Days,Demographics,Weight,72.7,,kg,NaN,NaN,,NaN,NaN,NaN
2690,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,18-Jun-1982,15:31,0,0,-5.63125,Days,PD,Efficacy marker,32.987,,mm,NaN,NaN,,NaN,NaN,NaN
2691,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-Jun-1982,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2692,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-Jun-1982,06:40,0.0833333333721384,0,0,Days,Dose,Dose Z,1095,,mg,NaN,NaN,iv,NaN,NaN,NaN
2693,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-Jun-1982,07:00,0,0,0.013888889,Days,Demographics,Weight,73,,kg,NaN,NaN,,NaN,NaN,NaN
2694,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-Jun-1982,08:51,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,1404,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2695,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-Jun-1982,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1302,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2696,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,01-Jul-1982,06:40,0,7,7,Days,PK,Plasma concentration Z,318,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2697,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,08-Jul-1982,07:05,0,14,14.01736111,Days,PK,Plasma concentration Z,162.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2698,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,17-Jul-1982,17:16,0,14,23.44166667,Days,PD,Efficacy marker,35.692,,mm,NaN,NaN,,NaN,NaN,NaN
2699,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,22-Jul-1982,06:40,0,28,28,Days,PK,Plasma concentration Z,86.199,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2700,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,22-Jul-1982,15:49,0,28,28.38125,Days,PD,Efficacy marker,36.362,,mm,NaN,NaN,,NaN,NaN,NaN
2701,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,05-Aug-1982,06:40,0,42,42,Days,PK,Plasma concentration Z,53.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2702,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,18-Aug-1982,16:49,0,56,55.42291667,Days,PD,Efficacy marker,36.365,,mm,NaN,NaN,,NaN,NaN,NaN
2703,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,19-Aug-1982,06:34,0,56,55.99583333,Days,PK,Plasma concentration Z,25.8,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2704,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,19-Aug-1982,06:40,0.0833333333721384,56,56,Days,Dose,Dose Z,1123.5,,mg,NaN,NaN,iv,NaN,NaN,NaN
2705,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,19-Aug-1982,08:46,0,56,56.0875,Days,PK,Plasma concentration Z,2000.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2706,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,02-Sep-1982,06:40,0,70,70,Days,PK,Plasma concentration Z,201.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2707,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,16-Sep-1982,06:44,0,84,84.00277778,Days,PK,Plasma concentration Z,107.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2708,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,14-Oct-1982,06:40,0,112,112,Days,PK,Plasma concentration Z,40.401,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2709,NaN,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,23-Oct-1982,14:25,0,112,121.3229167,Days,PD,Efficacy marker,36.839,,mm,NaN,NaN,,NaN,NaN,NaN
2710,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-Jul-1982,07:00,0,-14,-36.98611111,Days,Demographics,Age,74,,Years,NaN,NaN,,NaN,NaN,NaN
2711,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-Jul-1982,07:00,0,-14,-36.98611111,Days,Demographics,Gender,NaN,Male,.,NaN,NaN,,NaN,NaN,NaN
2712,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-Jul-1982,07:00,0,-14,-36.98611111,Days,Demographics,Weight,72.7,,kg,NaN,NaN,,NaN,NaN,NaN
2713,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,30-Jul-1982,16:08,0,0,-13.60555556,Days,PD,Efficacy marker,31.715,,mm,NaN,NaN,,NaN,NaN,NaN
2714,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,06-Aug-1982,07:00,0,0,-6.986111111,Days,Demographics,Weight,72.5,,kg,NaN,NaN,,NaN,NaN,NaN
2715,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,13-Aug-1982,06:40,0.0833333333721384,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2716,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,13-Aug-1982,07:00,0,0,0.013888889,Days,Demographics,Weight,72.2,,kg,NaN,NaN,,NaN,NaN,NaN
2717,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,27-Aug-1982,15:15,0,14,14.35763889,Days,PD,Efficacy marker,32.466,,mm,NaN,NaN,,NaN,NaN,NaN
2718,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,10-Sep-1982,15:24,0,28,28.36388889,Days,PD,Efficacy marker,32.032,,mm,NaN,NaN,,NaN,NaN,NaN
2719,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,07-Oct-1982,15:38,0,56,55.37361111,Days,PD,Efficacy marker,32.192,,mm,NaN,NaN,,NaN,NaN,NaN
2720,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,08-Oct-1982,09:00,0.0833333333721384,56,56.09722222,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2721,NaN,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,02-Dec-1982,12:43,0,112,111.2520833,Days,PD,Efficacy marker,32.973,,mm,NaN,NaN,,NaN,NaN,NaN
2722,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,28-Jul-1982,07:00,0,-14,-23.98611111,Days,Demographics,Age,73,,Years,NaN,NaN,,NaN,NaN,NaN
2723,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,28-Jul-1982,07:00,0,-14,-23.98611111,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2724,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,28-Jul-1982,07:00,0,-14,-23.98611111,Days,Demographics,Weight,65.9,,kg,NaN,NaN,,NaN,NaN,NaN
2725,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,09-Aug-1982,12:46,0,0,-11.74583333,Days,PD,Efficacy marker,23.673,,mm,NaN,NaN,,NaN,NaN,NaN
2726,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-Aug-1982,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2727,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-Aug-1982,06:40,0.0833333333721384,0,0,Days,Dose,Dose Z,1023,,mg,NaN,NaN,iv,NaN,NaN,NaN
2728,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-Aug-1982,07:00,0,0,0.013888889,Days,Demographics,Weight,68.2,,kg,NaN,NaN,,NaN,NaN,NaN
2729,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-Aug-1982,08:46,0,0.0833,0.0875,Days,PK,Plasma concentration Z,1320,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2730,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-Aug-1982,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1362,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2731,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,28-Aug-1982,06:40,0,7,7,Days,PK,Plasma concentration Z,338.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2732,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,04-Sep-1982,06:40,0,14,14,Days,PK,Plasma concentration Z,234,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2733,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,04-Sep-1982,15:34,0,14,14.37083333,Days,PD,Efficacy marker,24.49,,mm,NaN,NaN,,NaN,NaN,NaN
2734,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,18-Sep-1982,06:40,0,28,28,Days,PK,Plasma concentration Z,126.399,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2735,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,02-Oct-1982,07:43,0,42,42.04375,Days,PK,Plasma concentration Z,60.6,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2736,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,02-Oct-1982,16:45,0,42,42.42013889,Days,PD,Efficacy marker,25.145,,mm,NaN,NaN,,NaN,NaN,NaN
2737,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,15-Oct-1982,15:41,0,56,55.37569444,Days,PD,Efficacy marker,25.372,,mm,NaN,NaN,,NaN,NaN,NaN
2738,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,16-Oct-1982,06:37,0,56,55.99791667,Days,PK,Plasma concentration Z,21.201,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2739,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,16-Oct-1982,06:41,0.0833333332557231,56,56.00069444,Days,Dose,Dose Z,1029,,mg,NaN,NaN,iv,NaN,NaN,NaN
2740,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,16-Oct-1982,09:00,0,56.0833,56.09722222,Days,PK,Plasma concentration Z,1826.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2741,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,30-Oct-1982,06:40,0,70,70,Days,PK,Plasma concentration Z,213.999,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2742,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,13-Nov-1982,06:45,0,84,84.00347222,Days,PK,Plasma concentration Z,116.001,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2743,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,11-Dec-1982,06:40,0,112,112,Days,PK,Plasma concentration Z,25.2,,ug/ml,NaN,0.8,,NaN,NaN,NaN
2744,NaN,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,11-Dec-1982,15:50,0,112,112.3819444,Days,PD,Efficacy marker,25.296,,mm,NaN,NaN,,NaN,NaN,NaN
2745,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,29-Aug-1982,07:00,0,-14,-26.97916667,Days,Demographics,Age,66,,Years,NaN,NaN,,NaN,NaN,NaN
2746,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,29-Aug-1982,07:00,0,-14,-26.97916667,Days,Demographics,Gender,NaN,Female,.,NaN,NaN,,NaN,NaN,NaN
2747,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,29-Aug-1982,07:00,0,-14,-26.97916667,Days,Demographics,Weight,65.5,,kg,NaN,NaN,,NaN,NaN,NaN
2748,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,16-Sep-1982,17:49,0,0,-8.528472222,Days,PD,Efficacy marker,25.637,,mm,NaN,NaN,,NaN,NaN,NaN
2749,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,18-Sep-1982,07:00,0,0,-6.979166667,Days,Demographics,Weight,65.1,,kg,NaN,NaN,,NaN,NaN,NaN
2750,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,25-Sep-1982,06:30,0.0833333332557231,0,0,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
2751,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,25-Sep-1982,07:00,0,0,0.020833333,Days,Demographics,Weight,64,,kg,NaN,NaN,,NaN,NaN,NaN
2752,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,09-Oct-1982,15:58,0,14,14.39444444,Days,PD,Efficacy marker,26.024,,mm,NaN,NaN,,NaN,NaN,NaN
2753,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,06-Nov-1982,17:07,0,28,42.44236111,Days,PD,Efficacy marker,25.393,,mm,NaN,NaN,,NaN,NaN,NaN
2754,NaN,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,20-Nov-1982,06:30,0.0833333332557231,56,56,Days,Dose,Dose Z,0,,mg,NaN,NaN,iv,NaN,NaN,NaN
